Document and Entity Information - USD ($) $ in Billions	12 Months Ended
Document and Entity Information - USD ($) $ in Billions	Dec. 31, 2015	Jan. 31, 2016	Jun. 30, 2015
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	FY
Trading Symbol	UHS
Entity Registrant Name	UNIVERSAL HEALTH SERVICES INC
Entity Central Index Key	0000352915
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 12.9
Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		6,595,308
Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		90,384,960
Class C
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		663,940
Class D
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		23,202

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Net revenues before provision for doubtful accounts									$ 9,784,724	$ 8,904,071	$ 8,495,089
Less: Provision for doubtful accounts									741,273	698,983	1,127,216
Net revenues	$ 2,315,239	$ 2,227,655	$ 2,275,204	$ 2,225,353	$ 2,176,291	$ 2,038,717	$ 2,051,766	$ 1,938,314	9,043,451	8,205,088	7,367,873
Operating charges:
Salaries, wages and benefits									4,212,387	3,845,461	3,604,620
Other operating expenses									2,119,805	1,922,743	1,552,795
Supplies expense									974,088	895,693	821,089
Depreciation and amortization									398,618	375,624	337,172
Lease and rental expense									94,973	93,993	97,758
Electronic health records incentive income									(15,815)	(27,902)	(61,024)
Costs related to extinguishment of debt									0	36,171	0
Operating Expenses, Total									7,784,056	7,141,783	6,352,410
Income from operations									1,259,395	1,063,305	1,015,463
Interest expense, net									113,494	133,638	146,131
Income before income taxes									1,145,901	929,667	869,332
Provision for income taxes									395,203	324,671	315,309
Net income	191,317	163,654	201,404	194,323	190,492	96,038	166,614	151,852	750,698	604,996	554,023
Less: Net income attributable to noncontrolling interests	17,568	13,367	19,211	20,024	17,695	13,241	14,943	13,774	70,170	59,653	43,290
Net income attributable to UHS	$ 173,749	$ 150,287	$ 182,193	$ 174,299	$ 172,797	$ 82,797	$ 151,671	$ 138,078	$ 680,528	$ 545,343	$ 510,733
Basic earnings per share attributable to UHS	$ 1.76	$ 1.52	$ 1.84	$ 1.76	$ 1.75	$ 0.84	$ 1.53	$ 1.40	$ 6.89	$ 5.52	$ 5.21
Diluted earnings per share attributable to UHS	$ 1.74	$ 1.48	$ 1.80	$ 1.73	$ 1.71	$ 0.82	$ 1.51	$ 1.38	$ 6.76	$ 5.42	$ 5.14
Weighted average number of common shares—basic									98,797	98,826	98,033
Add: Other share equivalents									1,897	1,718	1,328
Weighted average number of common shares and equivalents—diluted									100,694	100,544	99,361

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 191,317	$ 163,654	$ 201,404	$ 194,323	$ 190,492	$ 96,038	$ 166,614	$ 151,852	$ 750,698	$ 604,996	$ 554,023
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges									4,970	17,668	16,963
Amortization of terminated hedge									(336)	(336)	(336)
Minimum pension liability									2,177	(14,270)	14,657
Foreign currency translation adjustment									(1,728)	(2,431)	0
Other comprehensive income (loss) before tax									5,083	631	31,284
Income tax (benefit) expense related to items of other comprehensive income									2,980	1,053	11,940
Total other comprehensive income (loss), net of tax									2,103	(422)	19,344
Comprehensive income									752,801	604,574	573,367
Less: Comprehensive income attributable to noncontrolling interests									70,170	59,653	43,290
Comprehensive income attributable to UHS									$ 682,631	$ 544,921	$ 530,077

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 61,228	$ 32,069
Accounts receivable, net	1,302,429	1,282,735
Supplies	116,037	108,115
Deferred income taxes	135,120	114,565
Other current assets	103,490	77,654
Total current assets	1,718,304	1,615,138
Property and Equipment
Land	451,717	435,632
Buildings and improvements	4,181,576	3,948,501
Equipment	1,659,485	1,648,718
Property under capital lease	45,665	40,782
Property Equipment Gross	6,338,443	6,073,633
Accumulated depreciation	(2,694,591)	(2,532,341)
Property and equipment excluding construction in progress net	3,643,852	3,541,292
Construction-in-progress	192,126	138,397
Property, plant and equipment, net, Total	3,835,978	3,679,689
Other assets:
Goodwill	3,596,114	3,291,213
Deferred charges	35,357	40,319
Other	448,360	348,084
Other assets	4,079,831	3,679,616
Total assets	9,634,113	8,974,443
Current liabilities:
Current maturities of long-term debt	62,722	68,319
Accounts payable	366,238	336,447
Accrued liabilities
Compensation and related benefits	245,117	323,425
Interest	13,284	13,977
Taxes other than income	60,255	112,119
Other	348,803	327,094
Current federal and state income taxes	3,987	1,446
Total current liabilities	1,100,406	1,182,827
Other noncurrent liabilities	278,834	268,555
Long-term debt	3,387,303	3,210,215
Deferred income taxes	$ 315,900	$ 282,214
Commitments and contingencies (Note 8)
Redeemable noncontrolling interest	$ 242,509	$ 239,552
Equity:
Cumulative dividends	(294,728)	(255,196)
Retained earnings	4,566,521	4,015,387
Accumulated other comprehensive loss	(23,129)	(25,232)
Universal Health Services, Inc. common stockholders’ equity	4,249,647	3,735,946
Noncontrolling interest	59,514	55,134
Total Equity	4,309,161	3,791,080
Liabilities and Equity, Total	9,634,113	8,974,443
Class A
Equity:
Common Stock	66	66
Total Equity	66	66
Class B
Equity:
Common Stock	910	914
Total Equity	910	914
Class C
Equity:
Common Stock	7	7
Total Equity	7	7
Class D
Equity:
Common Stock	0	0
Total Equity	$ 0	$ 0

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Class A
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	12,000,000	12,000,000
Common Stock, shares issued	6,595,308	6,595,708
Common Stock, shares outstanding	6,595,308	6,595,708
Class B
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	150,000,000	150,000,000
Common Stock, shares issued	91,013,487	91,427,258
Common Stock, shares outstanding	91,013,487	91,427,258
Class C
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	1,200,000	1,200,000
Common Stock, shares issued	663,940	664,000
Common Stock, shares outstanding	663,940	664,000
Class D
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	5,000,000	5,000,000
Common Stock, shares issued	23,742	29,121
Common Stock, shares outstanding	23,742	29,121

Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	Total	Redeemable Noncontrolling Interest	Class A	Class B	Class C	Class D	Cumulative Dividends	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	UHS Common Stockholders' Equity	Noncontrolling Interest
Balance at Dec. 31, 2012	$ 2,765,949		$ 66	$ 903	$ 7	$ 0	$ (205,910)	$ 2,962,433	$ (44,154)	$ 2,713,345	$ 52,604
Balance at Dec. 31, 2012		$ 234,303
Common Stock
Issued/(converted) including tax benefits from exercise of stock options	26,880			11				26,869		26,880
Repurchased	(27,201)			(4)				(27,197)		(27,201)
Restricted share-based compensation expense	664							664		664
Dividends paid	(19,621)						(19,621)			(19,621)
Stock option expense	25,835							25,835		25,835
Distributions to noncontrolling interests	(13,039)	(48,290)									(13,039)
Other	(511)										(511)
Comprehensive income:
Net income	521,929							510,733		510,733	11,196
Net income attributable to redeemable noncontrolling interest		32,094
Amortization of terminated hedge (net of income tax effect)	(216)								(216)	(216)
Unrealized derivative gains on cash flow hedges (net of income tax effect)	10,573								10,573	10,573
Minimum pension liability (net of income tax effect)	8,987								8,987	8,987
Subtotal - comprehensive income	541,273							510,733	19,344	530,077	11,196
Subtotal - comprehensive income attributable to redeemable noncontrolling interest		32,094
Balance at Dec. 31, 2013	3,300,229		66	910	7	0	(225,531)	3,499,337	(24,810)	3,249,979	50,250
Balance at Dec. 31, 2013		218,107
Common Stock
Issued/(converted) including tax benefits from exercise of stock options	41,801			14				41,787		41,801
Repurchased	(100,749)			(10)				(100,739)		(100,749)
Restricted share-based compensation expense	491							491		491
Dividends paid	(29,665)						(29,665)			(29,665)
Stock option expense	29,168							29,168		29,168
Distributions to noncontrolling interests	(7,666)	(26,016)									(7,666)
Other	358										358
Comprehensive income:
Net income	557,535							545,343		545,343	12,192
Net income attributable to redeemable noncontrolling interest		47,461
Foreign currency translation adjustments	(2,431)								(2,431)	(2,431)
Amortization of terminated hedge (net of income tax effect)	(216)								(216)	(216)
Unrealized derivative gains on cash flow hedges (net of income tax effect)	11,139								11,139	11,139
Minimum pension liability (net of income tax effect)	(8,914)								(8,914)	(8,914)
Subtotal - comprehensive income	557,113							545,343	(422)	544,921	12,192
Subtotal - comprehensive income attributable to redeemable noncontrolling interest		47,461
Balance at Dec. 31, 2014	3,791,080		66	914	7	0	(255,196)	4,015,387	(25,232)	3,735,946	55,134
Balance at Dec. 31, 2014	240,000	239,552
Common Stock
Issued/(converted) including tax benefits from exercise of stock options	56,487			14				56,473		56,487
Repurchased	(224,260)			(18)				(224,242)		(224,260)
Restricted share-based compensation expense	393							393		393
Dividends paid	(39,532)						(39,532)			(39,532)
Stock option expense	37,982							37,982		37,982
Distributions to noncontrolling interests	(11,114)	(51,106)									(11,114)
Other	(613)										(613)
Comprehensive income:
Net income	696,635							680,528		680,528	16,107
Net income attributable to redeemable noncontrolling interest		54,063
Foreign currency translation adjustments	(1,728)								(1,728)	(1,728)
Amortization of terminated hedge (net of income tax effect)	(216)								(216)	(216)
Unrealized derivative gains on cash flow hedges (net of income tax effect)	2,687								2,687	2,687
Minimum pension liability (net of income tax effect)	1,360								1,360	1,360
Subtotal - comprehensive income	698,738							680,528	2,103	682,631	16,107
Subtotal - comprehensive income attributable to redeemable noncontrolling interest		54,063
Balance at Dec. 31, 2015	4,309,161		$ 66	$ 910	$ 7	$ 0	$ (294,728)	$ 4,566,521	$ (23,129)	$ 4,249,647	$ 59,514
Balance at Dec. 31, 2015	$ 243,000	$ 239,552

Consolidated Statements of Changes in Equity (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Statement Of Stockholders Equity [Abstract]
Amortization of terminated hedge, income tax effect	$ 120	$ 120	$ 120
Unrealized derivative gains and losses on cash flow hedges, income tax effect	2,283	6,529	6,390
Minimum pension liability, income tax effect	$ (817)	$ 5,356	$ 5,670

Consolidated Statements of Cash Flows - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Cash Flows from Operating Activities:

Net income

$ 750,698

$ 604,996

$ 554,023

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation & amortization

398,618

375,624

337,356

Gains on sales of assets and businesses, net of losses

(3,615)

(7,837)

(3,114)

Stock-based compensation expense

39,971

31,092

27,783

Costs related to extinguishment of debt

19,730

Changes in assets & liabilities, net of effects from acquisitions and dispositions:

Accounts receivable

(45,814)

(105,708)

(49,708)

Accrued interest

(693)

4,400

(1,197)

Accrued and deferred income taxes

(34,394)

33,920

34,861

Other working capital accounts

(125,556)

73,912

26,234

Other assets and deferred charges

6,631

13,667

8,984

Other

23,295

2,449

23,485

Accrued insurance expense, net of commercial premiums paid

90,895

59,276

^[1]

(3,821)

^[1]

Payments made in settlement of self-insurance claims

(79,138)

(69,645)

(70,645)

Net cash provided by operating activities

1,020,898

1,035,876

884,241

Cash Flows from Investing Activities:

Property and equipment additions, net of disposals

(379,321)

(391,150)

(358,493)

Acquisition of property and businesses

(533,655)

(431,386)

(12,636)

Proceeds received from sales of assets and businesses

3,391

15,178

37,482

Costs incurred for purchase and implementation of electronic health records application

(13,488)

(49,811)

Increase in insurance subsidiary investments

(3,300)

(12,000)

Net cash used in investing activities

(912,885)

(832,846)

(383,458)

Cash Flows from Financing Activities:

Reduction of long-term debt

(68,166)

(879,129)

(440,224)

Additional borrowings

234,400

830,000

15,761

Financing costs

(515)

(14,976)

(231)

Repurchase of common shares

(209,782)

(100,749)

(27,201)

Dividends paid

(39,532)

(29,665)

(19,621)

Issuance of common stock

8,441

6,863

5,708

Excess income tax benefits related to stock based compensation

47,364

33,912

20,121

Profit distributions to noncontrolling interests

(62,220)

(33,680)

(61,329)

Proceeds received from sale/leaseback of real property

12,765

Net cash used in financing activities

(77,245)

(187,424)

(507,016)

Effect of exchange rate changes on cash and cash equivalents

(1,609)

(775)

Increase (decrease) in cash and cash equivalents

29,159

14,831

(6,233)

Cash and cash equivalents, beginning of period

32,069

17,238

23,471

Cash and cash equivalents, end of period

61,228

32,069

17,238

Supplemental Disclosures of Cash Flow Information:

Interest paid, including early redemption premium and original issue discount write-off in 2014

107,054

130,279

131,259

Income taxes paid, net of refunds

380,658

258,612

259,896

Noncash purchases of property and equipment

$ 49,086

$ 35,469

$ 36,212

[1]	General and professional liability amounts are net of adjustments recorded during 2014 and 2013, as discussed below.

Business and Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Business and Summary of Significant Accounting Policies

1) BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Services provided by our hospitals, all of which are operated by subsidiaries of ours include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. We, through our subsidiaries, provide capital resources as well as a variety of management services to our facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations.

The more significant accounting policies follow:

A) Principles of Consolidation: The consolidated financial statements include the accounts of our majority-owned subsidiaries and partnerships controlled by us or our subsidiaries as the managing general partner. All significant intercompany accounts and transactions have been eliminated.

B) Revenue Recognition: We record revenues and related receivables for health care services at the time the services are provided. Medicare and Medicaid revenues represented 35% of our net patient revenues during 2015, 38% during 2014 and 39% during 2013. Revenues from managed care entities, including health maintenance organizations and managed Medicare and Medicaid programs accounted for 52% of our net patient revenues during 2015, 50% during 2014 and 49% during 2013.

We report net patient service revenue at the estimated net realizable amounts from patients and third-party payors and others for services rendered. We have agreements with third-party payors that provide for payments to us at amounts different from our established rates. Payment arrangements include prospectively determined rates per discharge, reimbursed costs, discounted charges and per diem payments. Estimates of contractual allowances under managed care plans are based upon the payment terms specified in the related contractual agreements. We closely monitor our historical collection rates, as well as changes in applicable laws, rules and regulations and contract terms, to assure that provisions are made using the most accurate information available. However, due to the complexities involved in these estimations, actual payments from payors may be different from the amounts we estimate and record.

We estimate our Medicare and Medicaid revenues using the latest available financial information, patient utilization data, government provided data and in accordance with applicable Medicare and Medicaid payment rules and regulations. The laws and regulations governing the Medicare and Medicaid programs are extremely complex and subject to interpretation and as a result, there is at least a reasonable possibility that recorded estimates will change by material amounts in the near term. Certain types of payments by the Medicare program and state Medicaid programs (e.g. Medicare Disproportionate Share Hospital, Medicare Allowable Bad Debts and Inpatient Psychiatric Services) are subject to retroactive adjustment in future periods as a result of administrative review and audit and our estimates may vary from the final settlements. Such amounts are included in accounts receivable, net, on our Consolidated Balance Sheets. The vast majority of the net revenues generated at our behavioral health facilities located in the United Kingdom are derived from government based payors. The funding of both federal Medicare and state Medicaid programs, and the government based payor programs in the United Kingdom, are subject to legislative and regulatory changes. As such, we cannot provide any assurance that future legislation and regulations, if enacted, will not have a material impact on our future government based reimbursements. Adjustments related to the final settlement of these retrospectively determined amounts did not materially impact our results in 2015, 2014 and 2013. We provide care to patients who meet certain financial or economic criteria without charge or at amounts substantially less than our established rates. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in net revenues or in accounts receivable, net. See additional disclosure below in Charity Care, Uninsured Discounts and Provision for Doubtful Accounts for our estimated uncompensated care provided and estimated cost of providing uncompensated care.

C) Charity Care, Uninsured Discounts and Provision for Doubtful Accounts: Collection of receivables from third-party payers and patients is our primary source of cash and is critical to our operating performance. Our primary collection risks relate to uninsured patients and the portion of the bill which is the patient’s responsibility, primarily co-payments and deductibles. We estimate our provisions for doubtful accounts based on general factors such as payer mix, the agings of the receivables and historical collection experience. We routinely review accounts receivable balances in conjunction with these factors and other economic conditions which might ultimately affect the collectability of the patient accounts and make adjustments to our allowances as warranted. At our acute care hospitals, third party liability accounts are pursued until all payment and adjustments are posted to the patient account. For those accounts with a patient balance after third party liability is finalized or accounts for uninsured patients, the patient receives statements and collection letters. Our hospitals establish a partial reserve for self-pay accounts in the allowance for doubtful accounts for both unbilled balances and those that have been billed and are under 90 days old. All self-pay accounts are fully reserved at 90 days from the date of discharge. Third party liability accounts are fully reserved in the allowance for doubtful accounts when the balance ages past 180 days from the date of discharge. Patients that express an inability to pay are reviewed for potential sources of financial assistance including our charity care policy. If the patient is deemed unwilling to pay, the account is written-off as bad debt and transferred to an outside collection agency for additional collection effort.

Historically, a significant portion of the patients treated throughout our portfolio of acute care hospitals are uninsured patients which, in part, has resulted from patients who are employed but do not have health insurance or who have policies with relatively high deductibles. Patients treated at our hospitals for non-elective services, who have gross income less than 400% of the federal poverty guidelines, are deemed eligible for charity care. The federal poverty guidelines are established by the federal government and are based on income and family size. Because we do not pursue collection of amounts that qualify as charity care, they are not reported in our net revenues or in our accounts receivable, net.

A portion of the accounts receivable at our acute care facilities are comprised of Medicaid accounts that are pending approval from third-party payers but we also have smaller amounts due from other miscellaneous payers such as county indigent programs in certain states. Our patient registration process includes an interview of the patient or the patient’s responsible party at the time of registration. At that time, an insurance eligibility determination is made and an insurance plan code is assigned. There are various pre-established insurance profiles in our patient accounting system which determine the expected insurance reimbursement for each patient based on the insurance plan code assigned and the services rendered. Certain patients may be classified as Medicaid pending at registration based upon a screening evaluation if we are unable to definitively determine if they are currently Medicaid eligible. When a patient is registered as Medicaid eligible or Medicaid pending, our patient accounting system records net revenues for services provided to that patient based upon the established Medicaid reimbursement rates, subject to the ultimate disposition of the patient’s Medicaid eligibility. When the patient’s ultimate eligibility is determined, reclassifications may occur which impacts the reported amounts in future periods for the provision for doubtful accounts and other accounts such as Medicaid pending. Although the patient’s ultimate eligibility determination may result in amounts being reclassified among these accounts from period to period, these reclassifications did not have a material impact on our results of operations in 2015, 2014 or 2013 since our facilities make estimates at each financial reporting period to reserve for amounts that are deemed to be uncollectible.

We also provide discounts to uninsured patients (included in “uninsured discounts” amounts below) who do not qualify for Medicaid or charity care. Because we do not pursue collection of amounts classified as uninsured discounts, they are not reported in our net revenues or in our net accounts receivable. In implementing the discount policy, we first attempt to qualify uninsured patients for governmental programs, charity care or any other discount program. If an uninsured patient does not qualify for these programs, the uninsured discount is applied. Effective January 1, 2014, in response to market conditions and other considerations, we modified our uninsured discount policy and increased the discount to 60% of gross charges from 30% previously. Since we expect to collect only a small portion of amounts due from our uninsured patients, the increase in the uninsured discount as of January 1, 2014 had no material impact on our 2015 and 2014 net revenues, net income attributable to UHS or net accounts receivable, as compared to 2013. However, this change resulted in an increase in uninsured discounts and a decrease in the provision for doubtful accounts.

On a consolidated basis, we monitor our total self-pay receivables to ensure that the total allowance for doubtful accounts provides adequate coverage based on historical collection experience. Our accounts receivable are recorded net of allowance for doubtful accounts of $399 million and $325 million at December 31, 2015 and 2014, respectively.

Uncompensated care (charity care and uninsured discounts):

The following table shows the amounts recorded at our acute care hospitals for charity care and uninsured discounts, based on charges at established rates, for the years ended December 31, 2015, 2014 and 2013:

	(dollar amounts in thousands)
	2015					2014					2013
	Amount		%			Amount		%			Amount		%
Charity care	$	506,571		42	%	$	515,435		45	%	$	593,474		59	%
Uninsured discounts		696,463		58	%		620,587		55	%		405,296		41	%
Total uncompensated care	$	1,203,034		100	%	$	1,136,022		100	%	$	998,770		100	%

The provision for doubtful accounts at our acute care hospitals was approximately $631 million during 2015, $590 million during 2014 and $1.02 billion during 2013. The decrease in the provision for doubtful accounts during 2014, as compared to 2013, was primarily due to the increase in the uninsured discount (effective January 1, 2014, as discussed above in Charity Care, Uninsured discounts and Provision for Doubtful Accounts), and reclassifications among provision for doubtful accounts and other accounts such as Medicaid pending based upon our patients’ ultimate eligibility determination, as discussed above.

The estimated cost of providing uncompensated care:

The estimated cost of providing uncompensated care, as reflected below, were based on a calculation which multiplied the percentage of operating expenses for our acute care hospitals to gross charges for those hospitals by the above-mentioned total uncompensated care amounts. The percentage of cost to gross charges is calculated based on the total operating expenses for our acute care facilities divided by gross patient service revenue for those facilities. An increase in the level of uninsured patients to our facilities and the resulting adverse trends in the provision for doubtful accounts and uncompensated care provided could have a material unfavorable impact on our future operating results.

	(amounts in thousands)
	2015		2014		2013
Estimated cost of providing charity care	$	77,557	$	78,475	$	95,675
Estimated cost of providing uninsured discounts related care		106,630		94,484		65,338
Estimated cost of providing uncompensated care	$	184,187	$	172,959	$	161,013

Our accounts receivable as of December 31, 2015 and 2014 include amounts due from Illinois of approximately $28 million and $44 million, respectively. Collection of the outstanding receivables continues to be delayed due to state budgetary and funding pressures. Approximately $12 million as of December 31, 2015 and $23 million as of December 31, 2014, of the receivables due from Illinois were outstanding in excess of 60 days, as of each respective date. In addition, our accounts receivable as of December 31, 2015 and 2014 includes approximately $80 million and $102 million due from Texas in connection with Medicaid supplemental payment programs. The $80 million due from Texas as of December 31, 2015 consists of $47 million related to uncompensated care program revenues, $9 million related to disproportionate share hospital program revenues and $24 million related to Delivery Service Reform Incentive Payment program (“DSRIP”) revenues. The above-mentioned Texas DSRIP receivables outstanding as of December 31, 2015 were collected in January, 2016. Although the accounts receivable due from Illinois and Texas could remain outstanding for the foreseeable future, since we expect to eventually collect all amounts due to us, no related reserves have been established in our consolidated financial statements. However, we can provide no assurance that we will eventually collect all amounts due to us from Illinois and/or Texas. Failure to ultimately collect all outstanding amounts due from these states would have an adverse impact on our future consolidated results of operations and cash flows.

D) Concentration of Revenues: Our five majority owned acute care hospitals in the Las Vegas, Nevada market contributed, on a combined basis, 13% in 2015, and 14% in both 2014 and 2013 of our consolidated net revenues.

E) Accounting for Medicare and Medicaid Electronic Health Records Incentive Payments: In July 2010, the Department of Health and Human Services published final regulations implementing the health information technology provisions of the American Recovery and Reinvestment Act. The regulation defines the “meaningful use” of Electronic Health Records (“EHR”) and established the requirements for the Medicare and Medicaid EHR payment incentive programs. The implementation period for these new Medicare and Medicaid incentive payments started in federal fiscal year 2011 and can end as late as 2016 for Medicare and 2021 for the state Medicaid programs. We recognize income related to Medicare and Medicaid incentive payments using a gain contingency model that is based upon when our eligible hospitals have demonstrated “meaningful use” of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.

Medicare EHR incentive payments: Federal regulations require that Medicare EHR incentive payments be computed based on the Medicare cost report that begins in the federal fiscal period in which a hospital meets the applicable “meaningful use” requirements. Since the annual Medicare cost report periods for each of our acute care hospitals ends on December 31 st , we will recognize Medicare EHR incentive income for each hospital during the fourth quarter of the year in which the facility meets the “meaningful use” criteria and during the fourth quarter of each applicable subsequent year.

Medicaid EHR incentive payments: Medicaid EHR incentive payments are determined based upon prior period cost report information available at the time our hospitals met the “meaningful use” criteria. Therefore, the majority of the Medicaid EHR incentive income recognition occurred in the period in which the applicable hospitals were deemed to have met initial “meaningful use” criteria. Upon meeting subsequent fiscal year “meaningful use” criteria, our hospitals may become entitled to additional Medicaid EHR incentive payments which will be recognized as incentive income in future periods. Medicaid EHR incentive payments received prior to our hospitals meeting the “meaningful use” criteria were included in other current liabilities (as deferred EHR incentive income) in our consolidated balance sheet.

F) Cash and Cash Equivalents: We consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents.

G) Property and Equipment: Property and equipment are stated at cost. Expenditures for renewals and improvements are charged to the property accounts. Replacements, maintenance and repairs which do not improve or extend the life of the respective asset are expensed as incurred. We remove the cost and the related accumulated depreciation from the accounts for assets sold or retired and the resulting gains or losses are included in the results of operations. Construction-in-progress includes both construction projects and equipment not yet placed into service.

We capitalize interest expense on major construction projects while in progress. We capitalized interest on major construction projects and the development and implementation of electronic health records applications amounting to $304,000 during 2015, $0 during 2014 and $4.9 million during 2013.

Depreciation is provided on the straight-line method over the estimated useful lives of buildings and improvements (twenty to forty years) and equipment (three to fifteen years). Depreciation expense (excluding discontinued operations) was $337.5 million during 2015, $314.5 million during 2014 and $285.6 million during 2013.

H) Long-Lived Assets: We review our long-lived assets, including intangible assets, for impairment whenever events or circumstances indicate that the carrying value of these assets may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of our asset based on our estimate of its undiscounted future cash flow. If the analysis indicates that the carrying value is not recoverable from future cash flows, the asset is written down to its estimated fair value and an impairment loss is recognized. Fair values are determined based on estimated future cash flows using appropriate discount rates.

I) Goodwill and Intangible Assets: Goodwill and indefinite-lived intangible assets are reviewed for impairment at the reporting unit level on an annual basis or sooner if the indicators of impairment arise. Our judgments regarding the existence of impairment indicators are based on market conditions and operational performance of each reporting unit. During the quarter ended September 30, 2015, we changed our annual goodwill and indefinite-lived intangibles testing date from September 1st to October 1st. Management believes that this voluntary change in accounting method is preferable as it aligns the annual impairment testing date with our annual budgeting process. In connection with this change, we first performed an impairment test as of September 1, 2015, which indicated no impairment of goodwill or indefinite-lived intangible assets. We performed an additional impairment test as of October 1, 2015 which also indicated no impairment of goodwill or indefinite-lived intangible assets. There were also no impairments during 2014 or 2013. The 2015 change in annual testing date does not delay, accelerate or avoid an impairment charge. Future changes in the estimates used to conduct the impairment review, including profitability and market value projections, could indicate impairment in future periods potentially resulting in a write-off of a portion or all of our goodwill or indefinite-lived intangible assets.

Changes in the carrying amount of goodwill for the two years ended December 31, 2015 were as follows (in thousands):

	Acute Care Services			Behavioral Health Services			Total Consolidated
Balance, January 1, 2014	$	383,011		$	2,666,005		$	3,049,016
Goodwill acquired during the period		4,088			246,124			250,212
Adjustments to goodwill (a)		0			(8,015	)		(8,015	)
Balance, December 31, 2014		387,099			2,904,114			3,291,213
Goodwill acquired during the period		2,480			316,427			318,907
Goodwill divested during the period		0			(1,497	)		(1,497	)
Adjustments to goodwill (a)		(72	)		(12,437	)		(12,509	)
Balance, December 31, 2015	$	389,507		$	3,206,607		$	3,596,114

(a)	The decrease in the Behavioral Health Services’ goodwill consists primarily of foreign currency translation adjustments.

J) Other Assets: Other assets consist primarily of amounts related to: (i) intangible assets acquired in connection with our acquisitions of Foundations Recovery Network, LLC during 2015, Ascend Health Corporation during 2012 and Psychiatric Solutions, Inc. during 2010; (ii) prepaid fees for various software and other applications used by our hospitals; (iii) costs incurred in connection with the purchase and implementation of an electronic health records application for each of our acute care facilities; (iv) required capital reserves related to our commercial insurer; (v) deposits; (vi) investments in various businesses, including Universal Health Realty Income Trust and Premier, Inc.; (vii) the invested assets related to a deferred compensation plan that is held by an independent trustee in a rabbi-trust and that has a related payable included in other noncurrent liabilities; (viii) the estimated future payments related to physician-related contractual commitments, as discussed below, and; (ix) other miscellaneous assets. As of December 31, 2015, net intangible assets were $219 million and consisted of the following: Tradename ($124 million), Medicare licenses ($57 million), Certificates of need ($12 million), and contract relationships and other ($25 million, net of $25 million of accumulated amortization). As of December 31, 2014, net intangible assets were $98 million and consistent of the following: Medicare licenses ($57 million), Certificates of need ($12 million), and contract relationships ($29 million, net of $19 million of accumulated amortization).

K) Physician Guarantees and Commitments: As of December 31, 2015 and 2014, our accrued liabilities-other, and our other assets included $1 million and $2 million, respectively, of estimated future payments related to physician-related contractual commitments. The $1 million of potential future financial obligations outstanding as of December 31, 2015 are potential 2016 obligations.

L) Self-Insured/Other Insurance Risks: We provide for self-insured risks, primarily general and professional liability claims and workers’ compensation claims. Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimate of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. All relevant information, including our own historical experience is used in estimating the expected amount of claims. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Our estimated self-insured reserves are reviewed and changed, if necessary, at each reporting date and changes are recognized currently as additional expense or as a reduction of expense. See Note 8 for discussion of adjustments to our prior year reserves for claims related to our self-insured general and professional liability and workers’ compensation liability.

In addition, we also: (i) own commercial health insurers headquartered in Nevada and Puerto Rico, and; (ii) maintain self-insured employee benefits programs for employee healthcare and dental claims. The ultimate costs related to these programs/operations include expenses for claims incurred and paid in addition to an accrual for the estimated expenses incurred in connection with claims incurred but not yet reported. Given our significant insurance-related exposure, there can be no assurance that a sharp increase in the number and/or severity of claims asserted against us will not have a material adverse effect on our future results of operations.

M) Income Taxes: Deferred tax assets and liabilities are recognized for the amount of taxes payable or deductible in future years as a result of differences between the tax bases of assets and liabilities and their reported amounts in the financial statements. We believe that future income will enable us to realize our deferred tax assets net of recorded valuation allowances relating to state net operating loss carry-forwards.

We operate in multiple jurisdictions with varying tax laws. We are subject to audits by any of these taxing authorities. Our tax returns have been examined by the Internal Revenue Service (“IRS”) through the year ended December 31, 2006. We believe that adequate accruals have been provided for federal, foreign and state taxes. See Note 6— Income Taxes, for additional disclosure.

N) Other Noncurrent Liabilities: Other noncurrent liabilities include the long-term portion of our professional and general liability, workers’ compensation reserves, pension and deferred compensation liabilities, and a liability incurred in connection with split-dollar life insurance agreements on the lives of our chief executive officer and his wife.

O) Redeemable Noncontrolling Interests and Noncontrolling Interest: Outside owners hold noncontrolling, minority ownership interests of: (i) approximately 28% in six acute care facilities (including a facility currently under construction) located in Las Vegas, Nevada; (ii) 20% in an acute care facility located in Washington, D.C.; (iii) approximately 11% in an acute care facility located in Laredo, Texas, and; (iv) 20% in a behavioral health care facility located in Philadelphia, Pennsylvania. The redeemable noncontrolling interest balances of $243 million as of December 31, 2015 and $240 million as of December 31, 2014, and the noncontrolling interest balances of $60 million as of December 31, 2015 and $55 million as of December 31, 2014, consist primarily of the third-party ownership interests in these hospitals.

In connection with five acute care facilities (and an additional facility currently under construction) located in Las Vegas, Nevada, the minority ownership interests of which are reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owners have certain “put rights” that, if exercisable, and if exercised, require us to purchase the minority member’s interests at fair market value. The put rights are exercisable upon the occurrence of: (i) certain specified financial conditions falling below established thresholds; (ii) breach of the management contract by the managing member (a subsidiary of ours), or; (iii) if the minority member’s ownership percentage is reduced to less than certain thresholds. In connection with a behavioral health care facility located in Philadelphia, Pennsylvania and acquired by us as part of the PSI acquisition, the minority ownership interest of which is also reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owner has a “put option” to put its entire ownership interest to us at any time. If exercised, the put option requires us to purchase the minority member’s interest at fair market value.

P) Accumulated Other Comprehensive Income: The accumulated other comprehensive income (“AOCI”) component of stockholders’ equity includes: net unrealized gains and losses on effective cash flow hedges, foreign currency translation adjustments and the net minimum pension liability of a non-contributory defined benefit pension plan which covers employees at one of our subsidiaries. See Note 10, “Pension Plan” for additional disclosure regarding the defined benefit pension plan.

The amounts recognized in AOCI for the two years ended December 31, 2015 were as follows (in thousands):

	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Foreign Currency Translation Adjustment			Minimum Pension Liability			Total AOCI
Balance, January 1, 2014, net of income tax	$	(14,170	)	$	0		$	(10,640	)	$	(24,810	)
2014 activity:
Pretax amount		17,332			(2,431	)		(14,270	)		631
Income tax effect		(6,409	)		0			5,356			(1,053	)
Change, net of income tax		10,923			(2,431	)		(8,914	)		(422	)
Balance, January 1, 2015, net of income tax		(3,247	)		(2,431	)		(19,554	)		(25,232	)
2015 activity:
Pretax amount		4,634			(1,728	)		2,177			5,083
Income tax effect		(2,163	)		0			(817	)		(2,980	)
Change, net of income tax		2,471			(1,728	)		1,360			2,103
Balance, December 31, 2015, net of income tax	$	(776	)	$	(4,159	)	$	(18,194	)	$	(23,129	)

Q) Accounting for Derivative Financial Investments and Hedging Activities and Foreign Currency Forward Exchange Contracts: We manage our ratio of fixed to floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts.

We account for our derivative and hedging activities using the Financial Accounting Standard Board’s (“FASB”) guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction.

We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the change in expected cash flows of the hedged item are recognized currently in the income statement.

Derivative instruments designated in a hedge relationship to mitigate exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Fair value hedges are accounted for by recording the changes in the fair value of both the derivative instrument and the hedged item in the income statement.

For hedge transactions that do not qualify for the short-cut method, at the hedge’s inception and on a regular basis thereafter, a formal assessment is performed to determine whether changes in the fair values or cash flows of the derivative instruments have been highly effective in offsetting changes in cash flows of the hedged items and whether they are expected to be highly effective in the future.

We use forward exchange contracts to hedge our net investment in foreign operations against movements in exchange rates. The effective portion of the unrealized gains or losses on these contracts is recorded in foreign currency translation adjustment within accumulated other comprehensive income and remains there until either the sale or liquidation of the subsidiary. The cash flows from these contracts are reported as operating activities in the Consolidated Statements of Cash Flows. For the years ended December 31, 2015 and 2014, we recorded net favorable cash inflows of $22.9 million and $15.6 million, respectively, associated with these forward exchange contracts.

R) Stock-Based Compensation: At December 31, 2015, we have a number of stock-based employee compensation plans. Pursuant to the FASB’s guidance, we expense the grant-date fair value of stock options and other equity-based compensation pursuant to the straight-line method over the stated vesting period of the award using the Black-Scholes option-pricing model.

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities. The applicable FASB guidance requires that cash flows resulting from tax deductions in excess of compensation cost recognized be classified as financing cash flows.

S) Earnings per Share: Basic earnings per share are based on the weighted average number of common shares outstanding during the year. Diluted earnings per share are based on the weighted average number of common shares outstanding during the year adjusted to give effect to common stock equivalents.

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:

	Twelve Months Ended December 31,
	2015			2014			2013
Basic and diluted:
Net Income	$	750,698		$	604,996		$	554,023
Less: Net income attributable to noncontrolling interest		(70,170	)		(59,653	)		(43,290	)
Less: Net income attributable to unvested restricted share grants		(281	)		(236	)		(294	)
Net income attributable to UHS—basic and diluted	$	680,247		$	545,107		$	510,439
Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		98,797			98,826			98,033
Total basic earnings per share	$	6.89		$	5.52		$	5.21
Diluted earnings per share attributable to UHS:
Weighted average number of common shares		98,797			98,826			98,033
Net effect of dilutive stock options and grants based on the treasury stock method		1,897			1,718			1,328
Weighted average number of common shares and equivalents—diluted		100,694			100,544			99,361
Total diluted earnings per share	$	6.76		$	5.42		$	5.14

The “Net effect of dilutive stock options and grants based on the treasury stock method”, for all years presented above, excludes certain outstanding stock options applicable to each year since the effect would have been anti-dilutive. The excluded weighted-average stock options totaled 765,000 during 2015, 2,250 during 2014, and 4,000 during 2013.

T) Fair Value of Financial Instruments: The fair values of our registered debt and investments are based on quoted market prices. The fair values of other long-term debt, including capital lease obligations, are estimated by discounting cash flows using period-end interest rates and market conditions for instruments with similar maturities and credit quality. The carrying amounts reported in the balance sheet for cash, accounts receivable, accounts payable, and short-term borrowings approximates their fair values due to the short-term nature of these instruments. Accordingly, these items have been excluded from the fair value disclosures included elsewhere in these notes to consolidated financial statements.

U) Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

V) Mergers and Acquisitions: The acquisition method of accounting for business combinations requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective fair values with limited exceptions. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Any excess of the purchase price (consideration transferred) over the estimated fair values of net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired company are expensed as incurred. The fair value of intangible assets, including Medicare Licenses, Certificates of Need, Tradenames and certain contracts, is based on significant judgments made by our management, and accordingly, for significant items we typically obtain assistance from third party valuation specialists.

W) GPO Agreement/Minority Ownership Interest: During 2013, we entered into a new group purchasing organization agreement (“GPO”) with Premier, Inc. (“Premier), a healthcare performance improvement alliance, and acquired a minority interest in the GPO for a nominal amount. During the fourth quarter of 2013, in connection with the completion of an initial public offering of the stock of Premier, we received cash proceeds for the sale of a portion of our ownership interest in the GPO, which were recorded as deferred income and included in liabilities on our consolidated balance sheet as of December 31, 2015 and 2014. The deferred income is being recognized, on a pro rata basis, as a reduction to our supplies expense over the expected life of the GPO agreement. Also in connection with this GPO agreement, we received shares of restricted stock in Premier which vest ratably over a seven-year period (2014 through 2020), contingent upon our continued participation and minority ownership interest in the GPO. We are recognizing the fair value of this restricted stock, as a reduction to our supplies expense, in our consolidated statements of income on a pro rata basis over the vesting period.

X) Provider Taxes: We incur health-care related taxes (“Provider Taxes”) imposed by states in the form of a licensing fee, assessment or other mandatory payment which are related to: (i) healthcare items or services; (ii) the provision of, or the authority to provide, the health care items or services, or; (iii) the payment for the health care items or services. Such Provider Taxes are subject to various federal regulations that limit the scope and amount of the taxes that can be levied by states in order to secure federal matching funds as part of their respective state Medicaid programs. We derive a related Medicaid reimbursement benefit from assessed Provider Taxes in the form of Medicaid claims based payment increases and/or lump sum Medicaid supplemental payments. Under these programs, including the impact of Uncompensated Care and Upper Payment Limit programs, and the Texas Delivery System Reform Incentive program, we earned revenues (before Provider Taxes) of approximately $307 million during 2015, $295 million during 2014, and $213 million during 2013. These revenues were offset by Provider Taxes of approximately $137 million during 2015, $140 million during 2014, and $84 million during 2013, which are recorded in other operating expenses on the Consolidated Statements of Income as included herein. Prior to 2015, these Provider Taxes were recorded as a reduction to our net revenues. Accordingly, the Consolidated Statements of Income for 2014 and 2013 have been revised to reflect the current year presentation, resulting in an increase in net revenue and an increase in other operating expenses of $140 million during 2014 and $84 million during 2013. The aggregate net benefit from these programs was $170 million during 2015, $155 million during 2014, and $130 million during 2013. The aggregate net benefit pursuant to these programs is earned from multiple states and therefore no particular state’s portion is individually material to our consolidated financial statements. In addition, under various disproportionate share hospital payment programs and the Nevada state plan amendment program, we earned revenues of $46 million in 2015, $59 million in 2014, and $54 million in 2013.

Y) Recent Accounting Standards:

In November, 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-17, “Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes”, which eliminates the guidance in Topic 740, Income Taxes, that required an entity to separate deferred tax liabilities and assets between current and noncurrent amounts in a classified balance sheet. The amendments require that all deferred tax liabilities and assets of the same tax jurisdiction or a tax filing group, as well as any related valuation allowance, be offset and presented as a single noncurrent amount in a classified balance sheet. The amendments are effective for public business entities for annual fiscal years beginning after December 15, 2016. We do not expect the adoption of these amendments to have a material impact on our condensed consolidated financial statements.

In September 2015, the FASB issued ASU No. 2015-16, “Simplifying the Accounting for Measurement-Period Adjustments,” which changes the reporting requirement for retrospective adjustments to provisional amounts in the measurement period. The amendments in this update require an entity to present separately on the face of the income statement or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The revised guidance is effective for annual fiscal periods beginning after December 15, 2015. We do not expect the adoption of this revised guidance to have a material impact on our condensed consolidated financial statements.

In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers”, which provides guidance for revenue recognition. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosures. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016; however, in July 2015, the FASB approved a one-year deferral of this standard, with a new effective date for fiscal years beginning after December 15, 2017. We are currently in the process of evaluating the impact of adoption of this ASU on our consolidated financial statements.

In August 2014, FASB issued ASU No. 2014-15, “Preparation of Financial Statements—Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (ASU 2014-15). Continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Preparation of financial statements under this presumption is commonly referred to as the going concern basis of accounting. If and when an entity’s liquidation becomes imminent, financial statements should be prepared under the liquidation basis of accounting in accordance with Subtopic 205-30, “Presentation of Financial Statements—Liquidation Basis of Accounting”. Even when an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. In those situations, financial statements should continue to be prepared under the going concern basis of accounting, but the new criteria in ASU 2014-15 should be followed to determine whether to disclose information about the relevant conditions and events. The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We will evaluate the going concern considerations in this ASU.

In April and August 2015, the FASB issued ASU No. 2015-03 and ASU No. 2015-15, “Interest- Imputation of Interest,” respectively, to simplify the presentation of debt issuance costs. The standard requires debt issuance costs be presented in the balance sheet as a direct deduction from the carrying value of the debt liability. The FASB clarified that debt issuance costs related to line-of-credit arrangements can be presented as an asset and amortized over the term of the arrangement. The guidance is effective for annual fiscal periods beginning after December 15, 2015. We do not expect the adoption of this guidance to have a material impact on our condensed consolidated financial statements.

Z) Foreign Currency Translation: Assets and liabilities of our U.K. subsidiaries are denominated in pound sterling and translated into U.S. dollars at: (i) the rates of exchange at the balance sheet date, and; (ii) average rates of exchange prevailing during the year for revenues and expenses. The currency translation adjustments are reported as a component of accumulated other comprehensive income.

Acquisitions and Divestitures

12 Months Ended

Dec. 31, 2015

Business Combinations [Abstract]

Acquisitions and Divestitures

2) ACQUISITIONS AND DIVESTITURES

Year ended December 31, 2015:

2015 Acquisitions of Assets and Businesses:

During 2015 we spent $534 million to:

acquire a 46-bed behavioral health care facility located in the U.K. (acquired during the first quarter);

acquire Alpha Hospitals Holdings Limited consisting of four behavioral health care hospitals with 305 beds located in the U.K. (acquired during the third quarter);

acquire Foundations Recovery Network, LLC consisting of 4 inpatient facilities (322 beds) as well as 8 outpatient centers (during the fourth quarter), and;

various other businesses, a management contract and real property assets.

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their preliminary estimated fair values as follows:

	Amount (000s)
Working capital, net	$	(7,000	)
Property & equipment		116,000
Goodwill		319,000
Other assets		128,000
Income tax assets, net of deferred tax liabilities		(22,000	)
Cash paid in 2015 for acquisitions	$	534,000

Goodwill of the facilities acquired is computed, pursuant to the residual method, by deducting the fair value of the acquired assets and liabilities from the total purchase price. The factors that contribute to the recognition of goodwill, which may also influence the purchase price, include the following for each of the acquired facilities: (i) the historical cash flows and income levels; (ii) the reputations in their respective markets; (iii) the nature of the respective operations, and; (iv) the future cash flows and income growth projections. The vast majority of the goodwill resulting from these transactions is not deductible for federal income tax purposes (see Note 6. Income Taxes).

Other assets includes an indefinite lived tradename for $124 million recorded in connection with the Foundations acquisition.

Included in our consolidated net revenues for the year ended December 31, 2015 was an aggregate of approximately $30 million representing the net revenues generated at the newly acquired facilities from their respective dates of acquisition through December 31, 2015. The aggregate effect of the earnings generated by these facilities since the dates of acquisition, less the cost on the borrowings utilized to finance the acquisition, was not material to our 2015 net income attributable to UHS and net income attributable to UHS per diluted share.

Assuming the acquisitions occurred on January 1, 2015, our 2015 unaudited pro forma net revenues would have been approximately $9.17 billion and our unaudited pro forma net income attributable to UHS would have been approximately $690 million, or $6.85 per diluted share. Assuming the above-mentioned acquisitions occurred on January 1, 2014, our 2014 unaudited pro forma net revenues would have been approximately $8.35 billion and our unaudited pro forma net income attributable to UHS would have been approximately $545 million and $5.42 per diluted share.

2015 Divestiture of Assets and Businesses:

During 2015 we received $3 million in connection with the divestiture of a small operator of behavioral health care services.

Year ended December 31, 2014:

2014 Acquisitions of Assets and Businesses:

During 2014 we spent $431 million to:

acquire the stock of Cygnet Health Care Limited (“Cygnet”) which consists of 17 facilities located throughout the United Kingdom including 15 inpatient behavioral health hospitals and 2 nursing homes with a total of 723 beds (during the third quarter);

acquire and fund the required capital reserves related to Prominence Health Plan, a commercial health insurer headquartered in Reno, Nevada (during the second quarter);

acquire the Psychiatric Institute of Washington, a 124-bed behavioral health care facility and outpatient treatment center located in Washington, D.C. (during the second quarter);

acquire the operations of Palo Verde Behavioral Health, a 48-bed behavioral health facility in Tucson, Arizona (during the first quarter);

acquire the real property of The Bridgeway, a 103-bed behavioral health care facility located in North Little Rock, Arkansas, that was previously leased from Universal Health Realty Income Trust (during the fourth quarter);

acquire the previously leased real property of Cygnet Hospital-Harrow, a 44-bed behavioral health care facility located in the U.K., the operations of which were acquired as part of our acquisition of Cygnet (during the fourth quarter), and;

acquire physician practices.

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their preliminary estimated fair values as follows:

	Amount (000s)
Working capital, net	$	(41,000	)
Property & equipment		174,000
Goodwill		250,000
Other assets		59,000
Income tax assets, net of deferred tax liabilities		4,000
Debt		(16,000	)
Other		1,000
Cash paid in 2014 for acquisitions	$	431,000

Included in our consolidated net revenues for the year ended December 31, 2014 was an aggregate of approximately $175 million representing the net revenues generated at the Cygnet facilities, the commercial health insurer located in Reno, Nevada and the 124-bed behavioral health care facility and outpatient treatment center located in Washington, D.C., from their respective dates of acquisition through December 31, 2014. The aggregate effect of the earnings generated by these facilities since the dates of acquisition, less the cost on the borrowings utilized to finance the acquisition, was not material to our 2014 net income attributable to UHS and net income attributable to UHS per diluted share.

Assuming the acquisitions occurred on January 1, 2014, our 2014 unaudited pro forma net revenues would have been approximately $8.28 billion and our unaudited pro forma net income attributable to UHS would have been approximately $558 million, or $5.55 per diluted share. Assuming the above-mentioned acquisitions occurred on January 1, 2013, our 2013 unaudited pro forma net revenues would have been approximately $7.62 billion and our unaudited pro forma net income attributable to UHS would have been approximately $522 million and $5.25 per diluted share.

2014 Divestiture of Assets and Businesses:

During 2014 we received $15 million in connection with the divestiture of a non-operating investment (during the first quarter) and the real property of a closed behavioral health facility (during the second quarter).

Year ended December 31, 2013:

2013 Acquisitions of Assets and Businesses:

During 2013, we spent an aggregate of $13 million for the purchase of real property located in Pennsylvania, Nevada and Arizona. The aggregate net purchase price of these properties was allocated to property and equipment on our consolidated balance sheet.

2013 Divestiture of Assets and Businesses:

During 2013, we received an aggregate of $37 million in connection with the divestiture of Peak Behavioral Health Services (sold during the second quarter of 2013) and certain other assets and real property including three previously closed behavioral health care facilities. As discussed below in Discontinued Operations, we agreed to sell Peak Behavioral Health Services as part of our agreement with the Federal Trade Commission in connection with our acquisition of Ascend Health Corporation (“Ascend”) in October of 2012. The aggregate pre-tax gain on these divestitures was approximately $3 million and in included in our 2013 consolidated results of operations.

Discontinued Operations

There were no material divestitures during 2015 or 2014.

In connection with the receipt of antitrust clearance from the Federal Trade Commission (“FTC”) in connection with our acquisition of Ascend Health Corporation in October of 2012, we agreed to certain conditions, including the divestiture of Peak Behavioral Health Services (“Peak”), a 104-bed behavioral health care facility located in Santa Teresa, New Mexico. The divestiture of Peak was completed during the second quarter of 2013 for total cash proceeds of approximately $24 million resulting in a pre-tax gain of approximately $3 million which is included in our 2013 consolidated financial statements.

The following table shows the results of operations for Peak, which was reflected as discontinued operations during our period of ownership during 2013 (amounts in thousands). Since the aggregate income from discontinued operations before income tax expense is not material to our consolidated financial statements, it is included as a reduction to other operating expenses.

	2013
Net revenues	$	7,813
Income (loss) from discontinued operations, before income Taxes		932
Gain on divestiture		3,080
Income from discontinued operations, before income tax Expense		4,012
Income tax expense		(1,506	)
Income from discontinued operations, net of income taxes	$	2,506

Financial Instruments

12 Months Ended

Dec. 31, 2015

Investments All Other Investments [Abstract]

Financial Instruments

3) FINANCIAL INSTRUMENTS

Fair Value Hedges:

During 2015, 2014 and 2013, we had no fair value hedges outstanding.

Cash Flow Hedges:

We manage our ratio of fixed and floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts. We account for our derivative and hedging activities using the Financial Accounting Standard Board’s (“FASB”) guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction.

Derivative instruments designated in a hedge relationship to mitigate exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Cash flow hedges are accounted for by recording the fair value of the derivative instrument on the balance sheet as either an asset or liability, with a corresponding amount recorded in accumulated other comprehensive income (“AOCI”) within shareholders’ equity. Amounts are reclassified from AOCI to the income statement in the period or periods the hedged transaction affects earnings. We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the change in expected cash flows of the hedged item are recognized currently in the income statement.

The fair value of interest rate swap agreements approximates the amount at which they could be settled, based on estimates obtained from the counterparties. We assess the effectiveness of our hedge instruments on a quarterly basis. We performed periodic assessments of the cash flow hedge instruments during 2015 and 2014 and determined the hedges to be highly effective. We also determined that any portion of the hedges deemed to be ineffective was de minimis and therefore there was no material effect on our consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose us to credit risk in the event of nonperformance. We do not anticipate nonperformance by our counterparties. We do not hold or issue derivative financial instruments for trading purposes.

Seven interest rate swaps on a total notional amount of $825 million matured in May, 2015. Four of these swaps, with a total notional amount of $600 million, became effective in December, 2011 and provided that we receive three-month LIBOR while the average fixed rate payable was 2.38%. The remaining three swaps, with a total notional amount of $225 million, became effective in March, 2011 and provided that we receive three-month LIBOR while the average fixed rate payable was 1.91%.

During 2015, we entered into nine forward starting interest rate swaps whereby we pay a fixed rate on a total notional amount of $1.0 billion and receive one-month LIBOR. The average fixed rate payable on these swaps, which are scheduled to mature on April 15, 2019, is 1.31%. These interest rates swaps consist of:

Four forward starting interest rate swaps, entered into during the second quarter of 2015, whereby we pay a fixed rate on a total notional amount of $500 million and receive one-month LIBOR. Each of the four swaps became effective on July 15, 2015 and are scheduled to mature on April 15, 2019. The average fixed rate payable on these swaps is 1.40%;

Four forward starting interest rate swaps, entered into during the third quarter of 2015, whereby we pay a fixed rate on a total notional amount of $400 million and receive one-month LIBOR. One swap on a notional amount of $100 million became effective on July 15, 2015, two swaps on a total notional amount of $200 million became effective on September 15, 2015 and another swap on a notional amount of $100 million became effective on December 15, 2015. All of these swaps are scheduled to mature on April 15, 2019. The average fixed rate payable on these four swaps is 1.23%, and;

One interest rate swap, entered into during the fourth quarter of 2015, whereby we pay a fixed rate on a total notional amount of $100 million and receive one-month LIBOR. The swap became effective on December 15, 2015 and is scheduled to mature on April 15, 2019. The fixed rate payable on this swap is 1.21%.

We measure our interest rate swaps at fair value on a recurring basis. The fair value of our interest rate swaps is based on quotes from our counterparties. We consider those inputs to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with derivative instruments and hedging activities. At December 31, 2015, the fair value of our interest rate swaps was a net liability of $1 million comprised of a $5 million asset which is included in other assets offset by a $6 million liability which is included in other current liabilities on the accompanying balance sheet. At December 31, 2014, the fair value of our interest rate swaps was a liability of $6 million, all of which is included in other current liabilities.

Long-Term Debt

12 Months Ended

Dec. 31, 2015

Debt Disclosure [Abstract]

Long-Term Debt

4) LONG-TERM DEBT

A summary of long-term debt follows:

	December 31,
	2015			2014
	(amounts in thousands)
Long-term debt:
Notes payable and Mortgages payable (including obligations under capitalized leases of $24,900 in 2015 and $21,600 in 2014) and term loans with varying maturities through 2027; weighted average interest rates of 6.8% in 2015 and 6.4% in 2014 (see Note 7 regarding capitalized leases)	$	27,513		$	41,257
Revolving credit and on-demand credit facility		304,900			140,500
Term Loan A, net of unamortized discount of $1,593 in 2015 and $2,035 in 2014		1,717,940			1,761,872
Revenue bonds, interest at floating rates of 0.05% at December 31, 2014		—			5,300
Accounts receivable securitization program		400,000			330,000
3.75% Senior Secured Notes due 2019, net of unamortized discount of $155 in 2015 and $198 in 2014		299,845			299,802
4.75% Senior Secured Notes due 2022, net of unamortized discount of $177 in 2015 and $204 in 2014		299,823			299,796
7.125% Senior Secured Notes due 2016, including unamortized net premium of $4 in 2015 and $7 in 2014		400,004			400,007
Total debt		3,450,025			3,278,534
Less-Amounts due within one year		(62,722	)		(68,319	)
Long-term debt	$	3,387,303		$	3,210,215

During the third quarter of 2014, we completed the following financing transactions:

On August 7, 2014, we entered into a Fourth Amendment (the “Fourth Amendment”) to our credit agreement dated as of November 15, 2010, as amended on March 15, 2011, September 21, 2012 and May 16, 2013, among UHS, as borrower, the several banks and other financial institutions from time to time parties thereto, as lenders (“Credit Agreement”). The Credit Agreement, as amended, which is scheduled to mature in August, 2019, consists of: (i) an $800 million revolving credit facility ($300 million of borrowings outstanding as of December 31, 2015), and; (ii) a $1.775 billion term loan A facility ($1.720 billion of borrowings outstanding as of December 31, 2015) which combined our previously outstanding term loan A and term loan A2 facilities which were scheduled to mature in 2016;

Repaid $550 million of outstanding borrowings pursuant to our previously outstanding term loan B facility which was scheduled to mature in 2016;

Increased the borrowing capacity on our existing accounts receivable securitization program (“Securitization”) to $360 million from $275 million, effective August 1, 2014. In December, 2015, the Securitization was amended to increase the borrowing capacity to $400 million and extend the scheduled maturity date to December 21, 2018;

Issued $300 million aggregate principal amount of 3.750% senior secured notes due in 2019 (see below for additional disclosure);

Issued $300 million aggregate principal amount of 4.750% senior secured notes due in 2022 (see below for additional disclosure);

Redeemed our previously outstanding $250 million, 7.00% senior unsecured notes due in 2018 on July 31, 2014 for an aggregate price equal to 104.56% of the principal amount.

In connection with these transactions, our 2014 results of operations included a $36 million pre-tax charge incurred for the costs related to the extinguishment of debt. This charge consisted of the write-off of deferred charges ($20 million) and original issue discount on the extinguished debt ($5 million) as well as the make-whole premium paid ($11 million) on the early redemption of the $250 million, 7.00% senior unsecured notes.

Borrowings under the Credit Agreement bear interest at either (1) the ABR rate which is defined as the rate per annum equal to, at our election: the greatest of (a) the lender’s prime rate, (b) the weighted average of the federal funds rate, plus 0.5% and (c) one month LIBOR rate plus 1%, in each case, plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 0.50% to 1.25% for revolving credit and term loan-A borrowings, or (2) the one, two, three or six month LIBOR rate (at our election), plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 1.50% to 2.25% for revolving credit and term loan-A borrowings. As of December 31, 2015, the applicable margins were 0.50% for ABR-based loans and 1.50% for LIBOR-based loans under the revolving credit and term loan-A facilities.

As of December 31, 2015, we had $300 million of borrowings outstanding pursuant to the terms of our $800 million revolving credit facility and we had $461 million of available borrowing capacity, net of $5 million of outstanding borrowings pursuant to a short-term, on-demand credit facility and $34 million of outstanding letters of credit. The revolving credit facility includes a $125 million sub-limit for letters of credit. The Credit Agreement is secured by certain assets of the Company (which generally excludes asset classes such as substantially all of the patient-related accounts receivable of our acute care hospitals, certain real estate assets and assets held in joint-ventures with third-parties) and our material subsidiaries and guaranteed by our material subsidiaries.

Pursuant to the terms of the Credit Agreement, term loan-A quarterly installment payments of approximately: (i) $11 million commenced during the fourth quarter of 2014 and are scheduled to continue through September, 2016, and; (ii) $22 million are scheduled from the fourth quarter of 2016 through June, 2019.

As discussed above, in December, 2015, our Securitization with a group of conduit lenders and liquidity banks was amended to increase the borrowing capacity to $400 million from $360 million and extend the scheduled maturity date to December 21, 2018. Substantially all of the patient-related accounts receivable of our acute care hospitals (“Receivables”) serve as collateral for the outstanding borrowings. We have accounted for this Securitization as borrowings. We maintain effective control over the Receivables since, pursuant to the terms of the Securitization, the Receivables are sold from certain of our subsidiaries to special purpose entities that are wholly-owned by us. The Receivables, however, are owned by the special purpose entities, can be used only to satisfy the debts of the wholly-owned special purpose entities, and thus are not available to us except through our ownership interest in the special purpose entities. The wholly-owned special purpose entities use the Receivables to collateralize the loans obtained from the group of third-party conduit lenders and liquidity banks. The group of third-party conduit lenders and liquidity banks do not have recourse to us beyond the assets of the wholly-owned special purpose entities that securitize the loans. At December 31, 2015, we had $400 million of outstanding borrowings and no additional capacity pursuant to the terms of our accounts receivable securitization program.

On August 7, 2014, we issued $300 million aggregate principal amount of 3.750% Senior Secured Notes due 2019 (the “2019 Notes”) and $300 million aggregate principal amount of 4.750% Senior Secured Notes due 2022 (the “2022 Notes”, and together with the 2019 Notes, the “New Senior Secured Notes”). The New Senior Secured Notes were offered only to qualified institutional buyers under Rule 144A and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act of 1933, as amended (the “Securities Act”). The New Senior Secured Notes have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. Interest is payable on the New Senior Secured Notes on February 1 and August 1 of each year to the holders of record at the close of business on the January 15 and July 15 immediately preceding the related interest payment dates, commencing on February 1, 2015 until the maturity date of August 1, 2019 for the 2019 Notes and August 1, 2022 for the 2022 Notes.

On June 30, 2006, we issued $250 million of senior secured notes which have a 7.125% coupon rate and mature on June 30, 2016 (the “7.125% Notes”). Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year. In June, 2008, we issued an additional $150 million of 7.125% Notes which formed a single series with the original 7.125% Notes issued in June, 2006. Other than their date of issuance and initial price to the public, the terms of the 7.125% Notes issued in June, 2008 are identical to and trade interchangeably with, the 7.125% Notes which were originally issued in June, 2006. Since we have the ability and intent to refinance the 7.125% Notes on or before the scheduled maturity date (June 30, 2016) either through the issuance of new long-term notes, a new long-term debt facility, or utilizing funds borrowed pursuant to our revolving credit facility, the 7.125% Notes are classified as long-term on our Consolidated Balance Sheet as of December 31, 2015.

On July 31, 2014, we redeemed the $250 million, 7.00% senior unsecured notes (the “Unsecured Notes”), which were scheduled to mature on October 1, 2018, at a redemption price equal to 104.56% of the principal amount of the Unsecured Notes resulting in a make-whole premium payment of approximately $11 million. The Unsecured Notes were issued on September 29, 2010 and registered in April, 2011. Interest on the Unsecured Note was payable semiannually in arrears on April 1st and October 1st of each year.

In connection with entering into the previous Credit Agreement on November 15, 2010, and in accordance with the Indenture dated January 20, 2000 governing the rights of our existing notes, we entered into a supplemental indenture pursuant to which our 7.125% Notes (due in 2016) were equally and ratably secured with the lenders under the Credit Agreement with respect to the collateral for so long as the lenders under the Credit Agreement are so secured.

The average amounts outstanding during each of years 2015, 2014 and 2013 under the current and prior Credit Agreements, demand notes and accounts receivable securitization programs was $2.1 billion, $2.4 billion and $2.9 billion, respectively, with corresponding interest rates of 1.7%, 1.8% and 2.2%, respectively, including commitment and facility fees. The maximum amounts outstanding at any month-end were $2.3 billion in 2015, $2.7 billion in 2014 and $3.0 billion in 2013. The effective interest rate on our current and prior Credit Agreements, accounts receivable securitization programs, and demand notes, which includes the respective interest expense, commitment and facility fees, designated interest rate swaps expense and amortization of deferred financing costs and original issue discounts, was 2.4% in 2015, 3.1% in 2014 and 3.6% in 2013.

Our Credit Agreement includes a material adverse change clause that must be represented at each draw. The Credit Agreement contains covenants that include a limitation on sales of assets, mergers, change of ownership, liens and indebtedness, transactions with affiliates, dividends and stock repurchases; and requires compliance with financial covenants including maximum leverage and minimum interest coverage ratios. We are in compliance with all required covenants as of December 31, 2015.

At December 31, 2015, the carrying value and fair value of our debt were each approximately $3.5 billion. At December 31, 2014, the carrying value and fair value of our debt were each approximately $3.3 billion. The fair value of our debt was computed based upon quotes received from financial institutions. We consider these to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with debt instruments.

The aggregate scheduled maturities of our total debt outstanding as of December 31, 2015 are as follows:

	(000s)
2016	$	62,722
2017		91,254
2018		491,514
2019		2,486,965
2020		1,650
Later		315,920
Total	$	3,450,025

Common Stock

12 Months Ended

Dec. 31, 2015

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Common Stock

5) COMMON STOCK

Dividends

Cash dividends of $0.40 per share ($39.5 million in the aggregate) were declared and paid during 2015, $0.30 per share ($29.7 million in the aggregate) were declared and paid during 2014, and $.20 per share ($19.6 million in the aggregate) were declared and paid during 2013. All classes of our common stock have similar economic rights.

Stock Repurchase Programs

In July, 2014, our Board of Directors authorized a stock repurchase program whereby, from time to time as conditions allow, we may spend up to $400 million to purchase shares of our Class B Common Stock on the open market at prevailing market prices or in negotiated private transactions. There is no expiration date for our stock repurchase programs.

The following schedule provides information related to our stock repurchase program for each of the three years ended December 31, 2015. During 2015, 1,326,207 shares ($166.2 million) were repurchased pursuant to the terms of our stock repurchase program and 493,296 shares ($58.0 million in the aggregate) were repurchased in connection with the income tax withholding obligations resulting from the exercise of stock options and the vesting of restricted stock grants. During 2014, 548,192 shares ($58.0 million in the aggregate) were repurchased pursuant to the terms of our stock repurchase program and 480,972 shares ($42.7 million in the aggregate) were repurchased in connection with income tax withholding obligations resulting from the exercise of stock options and the vesting of restricted stock grants. No shares were repurchased during 2013 pursuant to publicly announced stock repurchase programs and 427,170 shares ($27.2 million in the aggregate) were repurchased in connection with income tax withholding obligations resulting from the exercise of stock options and the vesting of restricted stock grants.

	Additional dollars authorized for repurchase (in thousands)		Total number of shares purchased		Total number of shares cancelled		Average price paid per share for forfeited restricted shares	Total number of shares purchased as part of publicly announced programs		Average price pad per share for shares purchased as part of publicly announced program		Aggregate purchase price paid (in thousands)		Aggregate purchase price paid for shares purchased as part of publicly announced program		Maximum number of shares that may yet be purchased under the program		Maximum number of dollars that may yet be purchased under the program (in thousands)
Balance as of January 1, 2013																	767,704	N/A
2013		—		427,170		—	N/A		—	N/A		$	27,201	N/A			767,704	N/A
2014		400,000		1,029,164		767,704	N/A		548,192	$	105.71	$	100,749	$	57,950	N/A		$	342,050
2015	$	—		1,819,503		—	N/A		1,326,207	$	125.34	$	224,260	$	166,222	N/A		$	175,828
Total for three year period ended December 31, 2015	$	400,000		3,275,837		767,704	N/A		1,874,399	$	119.60	$	352,210	$	224,172

Stock-based Compensation Plans

At December 31, 2015, we have a number of stock-based employee compensation plans. Pursuant to the FASB’s guidance, we expense the grant-date fair value of stock options and other equity-based compensation pursuant to the straight-line method over the stated vesting period of the award using the Black-Scholes option-pricing model.

Pre-tax compensation costs of $38.0 million during 2015, $29.2 million during 2014 and $25.8 million during 2013 were recognized related to outstanding stock options. In addition, pre-tax compensation costs of $2.0 million during 2015, $1.9 million during 2014 and $2.0 million during 2013 were recognized related to amortization of restricted stock and discounts provided in connection with shares purchased pursuant to our 2005 Employee Stock Purchase Plan. As of December 31, 2015, there was approximately $67.7 million of unrecognized compensation cost related to unvested stock options and restricted stock which is expected to be recognized over the remaining average vesting period of 2.7 years.

The expense associated with stock-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, stock-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities and aggregated to $40.0 million in 2015, $31.1 million in 2014 and $27.8 million in 2013. In accordance with ASC 718, excess income tax benefits related to stock-based compensation are classified as cash inflows from financing activities on the Consolidated Statement of Cash Flows. During 2015, 2014 and 2013 we generated $47.4 million, $33.9 million and $20.1 million, respectively, of excess income tax benefits related to stock based compensation which are reflected as cash inflows from financing activities in our Consolidated Statements of Cash Flows, as included herein.

In 2005, we adopted the 2005 Stock Incentive Plan which was amended in 2008, 2010 and 2015 (the “Stock Incentive Plan”). An aggregate of 29.5 million shares of Class B Common Stock has been reserved under the Stock Incentive Plan. During 2015, 2014 and 2013, stock options, net of cancellations, of approximately 2.9 million, 2.8 million and 2.6 million, respectively, were granted. The per option weighted-average grant-date fair value of options granted during 2015, 2014 and 2013 was $21.37, $17.23 and $13.33, respectively. Stock options to purchase Class B Common Stock have been granted to our officers, key employees and members of our Board of Directors. All stock options were granted with an exercise price equal to the fair market value on the date of the grant. Options are exercisable ratably over a four-year period beginning one year after the date of the grant. All outstanding options expire five years after the date of the grant. As of December 31, 2015, approximately 6.9 million shares of Class B Common Stock remain available for issuance pursuant to the Stock Incentive Plan.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model. The following weighted average assumptions were derived from averaging the number of options granted during the most recent five-year period. The weighted-average assumptions reflected below were based upon twenty-five option grants for the five-year period ending December 31, 2015, twenty-one option grants for the five-year period ending December 31, 2014 and eighteen option grants for the five-year period ended December 31, 2013.

Year Ended December 31,	2015			2014			2013
Volatility		33	%		35	%		36	%
Interest rate		1	%		1	%		1	%
Expected life (years)		3.4			3.4			3.6
Forfeiture rate		10	%		10	%		11	%
Dividend yield		0.4	%		0.4	%		0.5	%

The risk-free rate is based on the U.S. Treasury zero coupon four year yield in effect at the time of grant. The expected life of the stock options granted was estimated using the historical behavior of employees. Expected volatility was based on historical volatility for a period equal to the stock option’s expected life. Expected dividend yield is based on our dividend yield at the time of grant.

The table below summarizes our stock option activity during each of the last three years:

Outstanding Options	Number of Shares			Average Option Price		Range (High-Low)
Balance, January 1, 2013		7,436,238		$	36.31	$54.79-$16.22
Granted		2,889,750		$	53.51	$79.79-$53.38
Exercised		(2,288,666	)	$	32.27	$54.79-$16.22
Cancelled		(416,364	)	$	43.93	$53.38-$16.22
Balance, January 1, 2014		7,620,958		$	43.63	$79.79-$30.32
Granted		2,845,500		$	78.65	$102.21-$78.17
Exercised		(2,277,469	)	$	38.50	$73.65-$30.32
Cancelled		(291,538	)	$	55.63	$78.17-$36.95
Balance, January 1, 2015		7,897,451		$	57.29	$102.21-$36.95
Granted		3,039,350		$	117.70	$142.43-$108.29
Exercised		(2,256,454)		$	48.97	$102.21-$36.95
Cancelled		(280,164)		$	83.63	$134.70-$36.95
Balance, December 31, 2015		8,400,183		$	80.50	$142.43-$36.95
Outstanding options vested and exercisable as of December 31, 2015		1,671,216		$	52.19	$102.21-$36.95

The following table provides information about unvested options for the year December 31, 2015:

	Shares			Weighted Average Grant Date Fair Value
Unvested options as of January 1, 2015		6,485,029		$	14.36
Granted		3,039,350		$	21.37
Vested		(2,515,248	)	$	13.38
Cancelled		(280,164	)	$	17.36
Unvested options as of December 31, 2015		6,728,967		$	17.77

The following table provides information regarding all options outstanding at December 31, 2015:

	Options Outstanding		Options Exercisable
Number of options outstanding		8,400,183		1,671,216
Weighted average exercise price	$	80.50	$	52.19
Aggregate intrinsic value as of December 31, 2015	$	328,564,543	$	112,466,544
Weighted average remaining contractual life		3.0		1.9

The total in-the-money value of all stock options exercised during the years ended December 31, 2015, 2014 and 2013 were $154.1 million, $112.5 million and $70.9 million, respectively.

The weighted average remaining contractual life for options outstanding and weighted average exercise price per share for exercisable options at December 31, 2015 were as follows:

Exercise Price	Options Outstanding		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)		Exercisable Options		Weighted Average Exercise Price Per Share		Expected to Vest Options (a)		Weighted Average Exercise Price Per Share
	Shares						Shares				Shares
$36.95 – $46.97		1,298,145	$	37.13		1.0		717,517	$	37.25		574,626	$	36.97
$53.38 – $73.65		1,805,950		53.49		2.0		571,450		53.45		1,098,889		53.50
$78.17 – $96.98		2,321,238		78.31		3.2		380,249		78.25		1,295,612		78.34
$102.21 – $142.43		2,974,850		117.54		4.2		2,000		102.21		1,980,776		117.52
Total		8,400,183	$	80.50		3.0		1,671,216	$	52.19		4,949,903	$	88.86

(a)	Assumes a weighted average forfeiture rate of 9.95%.

In addition to the Stock Incentive Plan, we have the following stock incentive and purchase plans: (i) the 2010 Employees’ Restricted Stock Purchase Plan, as amended in 2015, (“2010 Plan”) which allows eligible participants to purchase shares of Class B Common Stock at par value, subject to certain restrictions, and; (ii) a 2005 Employee Stock Purchase Plan which allows eligible employees to purchase shares of Class B Common Stock at a ten percent discount. There were 17,789, 26,189 and 10,000 and shares of restricted stock granted pursuant to the 2010 Plan during 2015, 2014 and 2013, respectively, with various ratable vesting periods ranging up to five years from the date of grant. There were 68,213, 75,303 and 90,587 and shares issued pursuant to the Employee Stock Purchase Plan during 2015, 2014 and 2013, respectively.

We have reserved 2.8 million shares of Class B Common Stock for issuance under these various plans (excluding terminated plans and including a reserve reduction during 2015) and have issued approximately 1.3 million shares, net of cancellations, pursuant to the terms of these plans (excluding terminated plans) as of December 31, 2015. As of December 31, 2015, approximately 1.5 million shares of Class B Common Stock remain available for issuance pursuant to these various plans.

At December 31, 2015, 24,056,061 shares of Class B Common Stock were reserved for issuance upon conversion of shares of Class A, C and D Common Stock outstanding, for issuance upon exercise of options to purchase Class B Common Stock and for issuance of stock under other incentive plans. Class A, C and D Common Stock are convertible on a share for share basis into Class B Common Stock.

Income Taxes

12 Months Ended

Dec. 31, 2015

Income Tax Disclosure [Abstract]

Income Taxes

6) INCOME TAXES

Components of income tax expense/(benefit) are as follows (amounts in thousands):

	Year Ended December 31,
	2015			2014		2013
Current
Federal	$	363,734		$	248,172	$	256,545
Foreign		3,151			4,167		1,655
State		38,987			23,224		28,490
		405,872			275,563		286,690
Deferred
Federal		(15,912	)		41,583		25,341
Foreign		5,545			—		—
State		(302	)		7,525		3,278
		(10,669	)		49,108		28,619
Total	$	395,203		$	324,671	$	315,309

Deferred taxes are required to be classified based on the financial statement classification of the related assets and liabilities which give rise to temporary differences. Deferred taxes result from temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities. The components of deferred taxes are as follows (amounts in thousands):

	Year Ended December 31,
	2015			2014
Deferred income tax assets:
Self-insurance reserves	$	88,401		$	84,915
Compensation accruals		66,399			55,788
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets		62,541			60,521
Other currently non-deductible accrued liabilities		17,213			16,739
Net pension liability—OCI only		10,929			11,746
Doubtful accounts and other reserves		29,616			18,428
Other combined items—OCI only		457			2,615
		275,556			250,752
Less: Valuation Allowance		(52,567	)		(52,764	)
Net deferred income tax assets:		222,989			197,988
Deferred income tax liabilities:
Depreciable and amortizable assets		(400,809	)		(362,674	)
Other deferred tax liabilities		(2,960	)		(2,963	)
Net deferred income tax liabilities	$	(180,780	)	$	(167,649	)

Increases in deferred tax assets relating to foreign net operating loss carryforwards reflect the impact of deferred taxes recorded in conjunction with the acquisition of 5 additional behavioral health care facilities located in the U.K. during 2015. Increases in deferred tax liabilities relating to depreciable and separately identifiable intangible assets primarily reflect the impact of deferred taxes recorded in conjunction with the acquisition of Foundations Recovery Network, LLC (“Foundations”).

The effective tax rates, as calculated by dividing the provision for income taxes by income before income taxes, were as follows for each of the years ended December 31, 2015, 2014 and 2013 (dollar amounts in thousands):

	2015			2014			2013
Provision for income taxes	$	395,203		$	324,671		$	315,309
Income before income taxes		1,145,901			929,667			869,332
Effective tax rate		34.5	%		34.9	%		36.3	%

Impacting the effective tax rates during 2015, 2014 and 2013 were favorable discrete tax items of approximately $1 million recorded during each year to adjust the estimated liabilities for uncertain tax positions.

The foreign provision for income taxes is based on foreign pre-tax earnings of $41 million in 2015, $15 million in 2014 and $6 million in 2013. Our consolidated financial statements provide for any related tax liability on undistributed earnings that we do not intend to be indefinitely reinvested outside the U.S. Certain of our undistributed international earnings intended to be indefinitely reinvested in operations outside the U.S. have a statutory rate of 20.25%. As of December 31, 2015, U.S. income taxes have not been provided on a cumulative total of $53 million of such earnings. The amount of unrecognizable deferred tax liability related to these temporary differences is estimated to be approximately $8 million.

A reconciliation between the federal statutory rate and the effective tax rate is as follows:

	Year Ended December 31,
	2015			2014			2013
Federal statutory rate		35.0	%		35.0	%		35.0	%
State taxes, net of federal income tax benefit		2.3	%		2.3	%		2.5	%
Divestiture gain		0.0	%		0.0	%		0.3	%
Other items		-0.6	%		0.0	%		0.4	%
Impact of income attributable to noncontrolling interests		-2.2	%		-2.4	%		-1.9	%
Effective tax rate		34.5	%		34.9	%		36.3	%

Included in “Other current assets” on our Consolidated Balance Sheet are prepaid federal, foreign, and state income taxes amounting to approximately $42 million and $17 million as of December 31, 2015 and 2014, respectively.

The net deferred tax assets and liabilities are comprised as follows (amounts in thousands):

	Year Ended December 31,
	2015			2014
Current deferred taxes
Assets	$	135,120		$	115,870
Liabilities		—			(1,305	)
Total deferred taxes-current		135,120			114,565
Noncurrent deferred taxes
Assets		92,383			85,792
Liabilities		(408,283	)		(368,006	)
Total deferred taxes-noncurrent		(315,900	)		(282,214	)
Total deferred tax liabilities	$	(180,780	)	$	(167,649	)

The assets and liabilities classified as current relate primarily to the allowance for uncollectible patient accounts, compensation-related accruals and the current portion of the temporary differences related to self- insurance reserves. At December 31, 2015, state net operating loss carryforwards (expiring in years 2016 through 2035), and credit carryforwards available to offset future taxable income approximated $1.08 billion representing approximately $53 million in deferred state tax benefit (net of the federal benefit). At December 31, 2015, there were foreign net operating loss carryforwards of approximately $20 million expiring through 2023 representing approximately $5 million in deferred foreign tax benefit.

A valuation allowance is required when it is more likely than not that some portion of the deferred tax assets will not be realized. Based on available evidence, it is more likely than not that certain of our state tax benefits will not be realized. Therefore, valuation allowances of approximately $51 million and $50 million have been reflected as of December 31, 2015 and 2014, respectively. During 2015, the valuation allowance on these state tax benefits increased by $1 million due to additional net operating losses incurred. In addition, valuation allowances of approximately $2 million and $3 million have been reflected as of December 31, 2015 and 2014 related to foreign net operating losses. There were no significant increases in valuation allowances as a result of the acquisition of Foundations.

We adopted the provisions of Accounting for Uncertainty in Income Taxes effective January 1, 2007. During 2015 and 2014, the estimated liabilities for uncertain tax positions (including accrued interest and penalties) were increased less than $1 million due to tax positions taken in the current and prior years. During 2015, the estimated liabilities for uncertain tax positions (including accrued interest and penalties) were reduced due to the lapse of the statute of limitations resulting in a net income tax benefit of approximately $1 million. The balance at each of December 31, 2015 and 2014, if subsequently recognized, that would favorably affect the effective tax rate and the provision for income taxes is approximately $1 million and $2 million, respectively.

We recognize accrued interest and penalties associated with uncertain tax positions as part of the tax provision. As of December 31, 2015 and 2014, we have accrued interest and penalties of less than $1 million as of each date. The U.S. federal statute of limitations remains open for the 2012 and subsequent years. Foreign and U.S. state and local jurisdictions have statutes of limitations generally ranging for 3 to 4 years. The statute of limitations on certain jurisdictions could expire within the next twelve months. It is reasonably possible that the amount of unrecognized tax benefits will change during the next 12 months, however, it is anticipated that any such change, if it were to occur, would not have a material impact on our results of operations.

The tabular reconciliation of unrecognized tax benefits for the years ended December 31, 2015, 2014 and 2013 is as follows (amounts in thousands).

	As of December 31,
	2015			2014			2013
Balance at January 1,	$	2,402		$	3,369		$	6,824
Additions based on tax positions related to the current year		50			50			50
Additions for tax positions of prior years		111			195			283
Reductions for tax positions of prior years		(524	)		(1,212	)		(1,260	)
Settlements		(57	)		—			(2,528	)
Balance at December 31,	$	1,982		$	2,402		$	3,369

Lease Commitments

12 Months Ended

Dec. 31, 2015

Leases [Abstract]

Lease Commitments

7) LEASE COMMITMENTS

Three of our hospital facilities are held under operating leases with Universal Health Realty Income Trust with terms expiring in 2016 (see Note 9 for additional disclosure). We also lease the real property of certain facilities (see Item 2. Properties for additional disclosure).

A summary of property under capital lease follows (amounts in thousands):

	As of December 31,
	2015			2014
Land, buildings and equipment	$	45,665		$	40,782
Less: accumulated amortization		(27,169	)		(27,556	)
	$	18,496		$	13,226

Future minimum rental payments under lease commitments with a term of more than one year as of December 31, 2015, are as follows (amounts in thousands):

Year	Capital Leases			Operating Leases
	(000s)
2016	$	3,849		$	64,049
2017		3,929			42,989
2018		4,061			35,447
2019		3,996			29,721
2020		3,339			21,487
Later years		22,055			137,692
Total minimum rental	$	41,229		$	331,385
Less: Amount representing interest		(16,316	)
Present value of minimum rental commitments		24,913
Less: Current portion of capital lease obligations		(1,557	)
Long-term portion of capital lease obligations	$	23,356

During 2015 and 2014, we assumed capital lease obligations of approximately $7 million and $16 million, respectively, in connection with the leases on certain real estate assets. We incurred no capital lease obligations during 2013. In the ordinary course of business, our facilities routinely lease equipment pursuant to new lease arrangements that will likely result in future lease and rental expense in excess of amounts indicated above.

Commitments and Contingencies

12 Months Ended

Dec. 31, 2015

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

8) COMMITMENTS AND CONTINGENCIES

Professional and General Liability, Workers’ Compensation Liability and Property Insurance

Professional and General Liability and Workers Compensation Liability:

Effective November, 2010, excluding certain subsidiaries acquired since 2010 as discussed below, the vast majority of our subsidiaries are self-insured for professional and general liability exposure up to $10 million and $3 million per occurrence, respectively. Our subsidiaries were provided with several excess policies through commercial insurance carriers which provide for coverage in excess of the applicable per occurrence self-insured retention (either $3 million or $10 million) up to $250 million per occurrence and in the aggregate for claims incurred in 2015 and 2014 and up to $200 million per occurrence and in the aggregate for claims incurred from 2011 through 2013. We remain liable for 10% of the claims paid pursuant to the commercially insured coverage in excess of $10 million up to $60 million per occurrence and in the aggregate.

Since our acquisition of Psychiatric Solutions, Inc. (“PSI”) in November, 2010, the former PSI subsidiaries are self-insured for professional and general liability exposure up to $3 million per occurrence. The nine behavioral health facilities acquired from Ascend Health Corporation (“Ascend”) in October, 2012 have general and professional liability policies through commercial insurance carriers which provide for up to $12 million of aggregate coverage, subject to a $100,000 per occurrence deductible. The 21 behavioral health care facilities located in the U.K. have policies through a commercial insurance carrier located in the U. K. that provides for £10 million of professional liability coverage and £25 million of general liability coverage. The facilities acquired from PSI, Ascend and the facilities located in the U.K., like our other facilities, are also provided excess coverage through commercial insurance carriers for coverage in excess of the underlying commercial policy limitations, as mentioned above.

Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimates of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Given our significant self-insured exposure for professional and general liability claims, there can be no assurance that a sharp increase in the number and/or severity of claims asserted against us will not have a material adverse effect on our future results of operations.

As of December 31, 2015, the total accrual for our professional and general liability claims was $204 million, of which $48 million is included in current liabilities. As of December 31, 2014, the total accrual for our professional and general liability claims was $193 million, of which $51 million is included in current liabilities.

Below is a schedule showing the changes in our general and professional liability and workers’ compensation reserves during the three years ended December 31, 2015 (amount in thousands):

	General and
	Professional			Workers’
	Liability			Compensation			Total
Balance at January 1, 2013	$	278,599		$	65,954		$	344,553
Plus: Accrued insurance expense, net of commercial premiums paid (a)		(35,182	)		31,361			(3,821	)
Less: Payments made in settlement of self-insured claims		(37,127	)		(33,517	)		(70,644	)
Balance at January 1, 2014		206,290			63,798			270,088
Plus: Accrued insurance expense, net of commercial premiums paid (a)		22,601			36,675			59,276
Less: Payments made in settlement of self-insured claims		(35,987	)		(33,659	)		(69,646	)
Balance at January 1, 2015		192,904			66,814			259,718
Plus: Accrued insurance expense, net of commercial premiums paid		58,460			32,435			90,895
Less: Payments made in settlement of self-insured claims		(47,391	)		(31,746	)		(79,137	)
Balance at December 31, 2015	$	203,973		$	67,503		$	271,476

(a)	General and professional liability amounts are net of adjustments recorded during 2014 and 2013, as discussed below.

The adjustments recorded during 2015 to our prior year reserves for professional and general liability claims did not have a material impact on our 2015 consolidated results of operations. We recorded reductions to our professional and general liability self-insurance reserves (relating to prior years) amounting to $20 million during 2014, and $81 million during 2013. The favorable change recorded during 2014 resulted from favorable changes in our estimated future claims payments pursuant to a reserve analysis. The favorable change in our estimated future claims payments recorded during 2013, relating to years prior to 2013, were due primarily to: (i) an increased weighting given to company-specific metrics (to 100% from 75%), and decreased general industry metrics (to 0% from 25%), related to projected incidents per exposure, historical claims experience and loss development factors; (ii) historical data which measured the realized favorable impact of medical malpractice tort reform experienced in several states in which we operate, and; (iii) a decrease in claims related to certain higher risk specialties (such as obstetrical) due to a continuation of the company-wide patient safety initiative undertaken during the last several years. As the number of our facilities and our patient volumes have increased, thereby providing for a statistically significant data group, and taking into consideration our long-history of company-specific risk management programs and claims experience, our reserve analyses have included a greater emphasis on our historical professional and general liability experience which has developed favorably as compared to general industry trends.

As of December 31, 2015, the total accrual for our workers’ compensation liability claims was $68 million, of which $34 million is included in current liabilities. As of December 31, 2014, the total accrual for our workers’ compensation liability claims was $67 million, of which $32 million is included in current liabilities. The adjustments recorded during the last three years to our prior year reserves for workers’ compensation claims did not have a material impact on our consolidated results of operations for the years ended December 31, 2015, 2014 or 2013.

Although we are unable to predict whether or not our future financial statements will include adjustments to our prior year reserves for self-insured general and professional and workers’ compensation claims, given the relatively unpredictable nature of the these potential liabilities and the factors impacting these reserves, as discussed above, it is reasonably likely that our future financial results may include material adjustments to prior period reserves.

Property Insurance:

We have commercial property insurance policies for our properties covering catastrophic losses, including windstorm damage, up to a $1 billion policy limit per occurrence, subject to a deductible ranging from $50,000 to $250,000 per occurrence. Losses resulting from named windstorms are subject to deductibles between 3% and 5% of the declared total insurable value of the property. In addition, we have commercial property insurance policies covering catastrophic losses resulting from earthquake and flood damage, each subject to aggregated loss limits (as opposed to per occurrence losses). Our earthquake limit is $250 million, subject to a deductible of $250,000, except for facilities located within documented fault zones. Earthquake losses that affect facilities located in fault zones within the United States are subject to a $100 million limit and will have applied deductibles ranging from 1% to 5% of the declared total insurable value of the property. The earthquake limit in Puerto Rico is $25 million, subject to a $25,000 deductible. Non-critical flood losses have either a $250,000 or $500,000 deductible, based upon the location of the facility. Since certain of our facilities have been designated by our insurer as flood prone, we have elected to purchase policies from The National Flood Insurance Program to cover a substantial portion of the applicable deductible. Property insurance for the facilities acquired from Cygnet are provided on an all risk basis up to a £180 million limit that includes coverage for real and personal property as well as business interruption losses.

Legal Proceedings

We are subject to claims and suits in the ordinary course of business, including those arising from care and treatment afforded by our hospitals and are party to various government investigations, regulatory matters and litigation, as outlined below.

Office of Inspector General (“OIG”) and Government Investigations:

In February, 2013, the Office of Inspector General for the United States Department of Health and Human Services (“OIG”) served a subpoena requesting various documents from January, 2008 to the date of the subpoena directed at Universal Health Services, Inc. (“UHS”) concerning it and UHS of Delaware, Inc., and certain UHS owned behavioral health facilities including: Keys of Carolina, Old Vineyard Behavioral Health, The Meadows Psychiatric Center, Streamwood Behavioral Health, Hartgrove Hospital, Rock River Academy and Residential Treatment Center, Roxbury Treatment Center, Harbor Point Behavioral Health Center, f/k/a The Pines Residential Treatment Center, including the Crawford, Brighton and Kempsville campuses, Wekiva Springs Center and River Point Behavioral Health. Prior to receiving this subpoena: (i) the Keys of Carolina and Old Vineyard received notification during the second half of 2012 from the DOJ of its intent to proceed with an investigation following requests for documents for the period of January, 2007 to the date of the subpoenas from the North Carolina state Attorney General’s Office; (ii) Harbor Point Behavioral Health Center received a subpoena in December, 2012 from the Attorney General of the Commonwealth of Virginia requesting various documents from July, 2006 to the date of the subpoena, and; (iii) The Meadows Psychiatric Center received a subpoena from the OIG in February, 2013 requesting certain documents from 2008 to the date of the subpoena. Unrelated to these matters, the Keys of Carolina was closed and the real property was sold in January, 2013. We were advised that a qui tam action had been filed against Roxbury Treatment Center but the government declined to intervene and the case was dismissed.

In April, 2013, the OIG served facility specific subpoenas on Wekiva Springs Center and River Point Behavioral Health requesting various documents from January, 2005 to the date of the subpoenas. In July, 2013, another subpoena was issued to Wekiva Springs Center and River Point Behavioral Health requesting additional records. In October, 2013, we were advised by the DOJ’s Criminal Frauds Section that they received a referral from the DOJ Civil Division and opened an investigation of River Point Behavioral Health and Wekiva Springs Center. Subsequent subpoenas have since been issued to River Point Behavioral Health and Wekiva Springs Center requesting additional documentation. In April, 2014, the Centers for Medicare and Medicaid Services (“CMS”) instituted a Medicare payment suspension at River Point Behavioral Health in accordance with federal regulations regarding suspension of payments during certain investigations. The Florida Agency for Health Care Administration subsequently issued a Medicaid payment suspension for the facility. River Point Behavioral Health submitted a rebuttal statement disputing the basis of the suspension and requesting revocation of the suspension. Notwithstanding, CMS continued the payment suspension. River Point Behavioral Health provided additional information to CMS in an effort to obtain relief from the payment suspension but the suspension remains in effect. In August, 2015, we received notification from CMS that, effective September, 2015, the payment suspension will be continued for another 180 days. We cannot predict if and/or when the facility’s suspended payments will resume. Although the operating results of River Point Behavioral Health did not have a material impact on our consolidated results of operations during the years ended December 31, 2015 or 2014, the payment suspension has had a material adverse effect on the facility’s results of operations and financial condition.

In June, 2013, the OIG served a subpoena on Coastal Harbor Health System in Savannah, Georgia requesting documents from January, 2009 to the date of the subpoena.

In February, 2014, we were notified that the investigation conducted by the Criminal Frauds Section had been expanded to include the National Deaf Academy. In March, 2014, a Civil Investigative Demand (“CID”) was served on the National Deaf Academy requesting documents and information from the facility from January 1, 2008 through the date of the CID. We have been advised by the government that the National Deaf Academy has been added to the facilities which are the subject of the coordinated investigation referenced above.

In March, 2014, CIDs were served on Hartgrove Hospital, Rock River Academy and Streamwood Behavioral Health requesting documents and information from those facilities from January, 2008 through the date of the CID.

In September, 2014, the DOJ Civil Division advised us that they were expanding their investigation to include four additional facilities and were requesting production of documents from these facilities. These facilities are Arbour-HRI Hospital, Behavioral Hospital of Bellaire, St. Simons by the Sea, and Turning Point Care Center.

In December, 2014, the DOJ Civil Division requested that Salt Lake Behavioral Health produce documents responsive to the original subpoenas issued in February, 2013.

In March, 2015, the OIG issued subpoenas to Central Florida Behavioral Hospital and University Behavioral Center requesting certain documents from January, 2008 to the date of the subpoena.

In late March, 2015, we were notified that the investigation conducted by the Criminal Frauds Section had been expanded to include UHS as a corporate entity arising out of the coordinated investigation of the facilities described above and, in particular, Hartgrove Hospital.

In December, 2015, we were notified by the DOJ Civil Division that the civil investigation also includes Arbour Hospital, Arbour-Fuller Hospital, Pembroke Hospital and Westwood Lodge located in Massachusetts. To date, these facilities have not received any requests for documentation or other information.

The DOJ has advised us that the civil aspect of the coordinated investigation referenced above is a False Claim Act investigation focused on billings submitted to government payers in relation to services provided at those facilities. At present, we are uncertain as to potential liability and/or financial exposure of the Company and/or named facilities, if any, in connection with these matters.

In December, 2015, we were advised that the DOJ opened an investigation involving the El Paso Behavioral Health System in El Paso, Texas. The DOJ is investigating potential Stark law violations relating to arrangements between the facility and physician(s) at the facility. These agreements were entered into before we acquired the facility as a part of our acquisition of Ascend Health Corporation in October, 2012. To our knowledge, this matter is not a part of the omnibus investigation referenced above. At present, we are uncertain as to potential liability and/or financial exposure, if any, which may be associated with this matter.

In January, 2016, we were notified that the Department of Justice opened an investigation of the South Texas Health System of a potential False Claim Act case regarding compensation paid to cardiologists pursuant to employment agreements entered into in 2005. At present, we are uncertain as to potential liability and/or financial exposure, if any, which may be associated with this matter.

Regulatory Matters:

On July 23, 2015, Timberlawn Mental Health System (“Timberlawn”) received notification from CMS of its intent to terminate Timberlawn’s Medicare provider agreement effective August 7, 2015. This notification resulted from surveys conducted which alleged that Timberlawn was out of compliance with conditions of participation required for participation in the Medicare/Medicaid program. We filed a request for expedited administrative appeal with the U.S. Department of Health and Human Services, Departmental Appeals Board, Civil Remedies Division, seeking review and reversal of the termination action. In conjunction with the administrative appeal, we filed litigation in the U.S District Court for the Northern District of Texas seeking a temporary restraining order and preliminary injunction to have the termination stayed pending the conclusion of the administrative appeal. The trial court denied Timberlawn’s request for a temporary restraining order and dismissed the case. Timberlawn’s provider agreement was terminated effective August 14, 2015. In September, 2015 Timberlawn reached an agreement with CMS relative to its reapplication to the Medicare/Medicaid program. In exchange, Timberlawn agreed to dismiss its administrative appeal as well as not to pursue an appeal of the decision of the trial court. During this time, Timberlawn has remained open. In December, 2015, Timberlawn received notice from the Texas Department of State Health Services of its intent to revoke Timberlawn’s license and impose an administrative penalty. We have appealed and are contesting the proposed revocation and fine. In January, 2016, Timberlawn submitted its application for re-enrollment into the Medicare/Medicaid program. Although the operating results of Timberlawn did not have a material impact on our consolidated results of operations or financial condition for the years ended December 31, 2015 or 2014, the termination of Timberlawn’s provider agreement has had a material adverse effect on the facility’s results of operations and financial condition.

During the second quarter of 2015, Texoma Medical Center (“Texoma”), which includes TMC Behavioral Health Center, entered into a Systems Improvement Agreement (“SIA”) with CMS. The SIA abated a termination action from CMS following surveys which identified alleged failures to comply with conditions of participation primarily involving Texoma’s behavioral health operations. The terms of the SIA required Texoma to engage independent consultants/experts approved by CMS to analyze and develop implementation plans at Texoma to meet Medicare conditions of participation. At the conclusion of the SIA, CMS will conduct a full certification survey to determine if Texoma is in substantial compliance with the Medicare conditions of participation. The term of agreement is set to conclude October 2, 2016 unless the terms of the agreement are fulfilled earlier. During the term of the SIA, Texoma remains eligible to receive reimbursements from Medicare and Medicaid for services rendered to Medicare and Medicaid beneficiaries.

Other Matters:

In late September, 2015, many hospitals in Pennsylvania, including seven of our behavioral health care hospitals located in the state, received letters from the Pennsylvania Department of Public Welfare (“DPW”) demanding repayment of allegedly excess Medicaid Disproportionate Share Hospital payments (“DSH”) for the federal fiscal year 2011 (“FFY2011”) amounting to approximately $4 million in the aggregate. We have filed administrative appeals for all of our facilities contesting the recoupment efforts since we believe DPW’s calculation methodology is inaccurate and conflicts with applicable federal and state laws and regulations. DPW has agreed to postpone the recoupment of the state’s share of the DSH payments until all hospital appeals are resolved. DPW also extended the deadline to recoup the federal share (2011 federal share is 55%) until April 30, 2016. However, if DPW is ultimately successful in its demand related to FFY2011, it could take similar action with regards to FFY2012 through FFY2014. Due to a change in the Pennsylvania Medicaid State Plan and implementation of a CMS-approved Medicaid Section 1115 Waiver, we do not believe the methodology applied by DPW to FFY2011 is applicable to reimbursements received for Medicaid services provided after January 1, 2015 by our behavioral health care facilities located in Pennsylvania. We can provide no assurance that we will ultimately be successful in our legal and administrative appeals related to DPW’s repayment demands. If our legal and administrative appeals are unsuccessful, our future consolidated results of operations and financial condition could be adversely impacted by these repayments.

Matters Relating to Psychiatric Solutions, Inc. (“PSI”):

The following matters pertain to PSI or former PSI facilities (owned by subsidiaries of PSI) which were in existence prior to the acquisition of PSI and for which we have assumed the defense as a result of our acquisition which was completed in November, 2010.

Department of Justice Investigation of Friends Hospital:

In October, 2010, Friends Hospital in Philadelphia, Pennsylvania, received a subpoena from the DOJ requesting certain documents from the facility. The requested documents were collected and provided to the DOJ for review and examination. Another subpoena was issued to the facility in July, 2011 requesting additional documents, which have also been delivered to the DOJ. All documents requested and produced pertained to the operations of the facility while under PSI’s ownership prior to our acquisition. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

Department of Justice Investigation of Riveredge Hospital:

In 2008, Riveredge Hospital in Chicago, Illinois received a subpoena from the DOJ requesting certain information from the facility. Additional requests for documents were also received from the DOJ in 2009 and 2010. The requested documents have been provided to the DOJ. All documents requested and produced pertained to the operations of the facility while under PSI’s ownership prior to our acquisition. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

General:

We operate in a highly regulated and litigious industry which subjects us to various claims and lawsuits in the ordinary course of business as well as regulatory proceedings and government investigations. These claims or suits include claims for damages for personal injuries, medical malpractice, commercial/contractual disputes, wrongful restriction of, or interference with, physicians’ staff privileges, and employment related claims, In addition, health care companies are subject to investigations and/or actions by various state and federal governmental agencies or those bringing claims on their behalf. Government action has increased with respect to investigations and/or allegations against healthcare providers concerning possible violations of fraud and abuse and false claims statutes as well as compliance with clinical and operational regulations. Currently, and from time to time, we and some of our facilities are subjected to inquiries in the form of subpoenas, Civil Investigative Demands, audits and other document requests from various federal and state agencies. These inquiries can lead to notices and/or actions including repayment obligations from state and federal government agencies associated with potential non-compliance with laws and regulations. Further, the federal False Claim Act allows private individuals to bring lawsuits (qui tam actions) against healthcare providers that submit claims for payments to the government. Various states have also adopted similar statutes. When such a claim is filed, the government will investigate the matter and decide if they are going to intervene in the pending case. These qui tam lawsuits are placed under seal by the court to comply with the False Claims Act’s requirements. If the government chooses not to intervene, the private individual(s) can proceed independently on behalf of the government. Health care providers that are found to violate the False Claims Act may be subject to substantial monetary fines/penalties as well as face potential exclusion from participating in government health care programs or be required to comply with Corporate Integrity Agreements as a condition of a settlement of a False Claim Act matter. In September 2014, the Criminal Division of the DOJ, announced that all qui tam cases will be shared with their Division to determine if a parallel criminal investigation should be opened. The DOJ has also announced an intention to pursue civil and criminal actions against individuals within a company as well as the corporate entity or entities. In addition, health care facilities are subject to monitoring by state and federal surveyors to ensure compliance with program Conditions of Participation. In the event a facility is found to be out of compliance with a Condition of Participation and unable to remedy the alleged deficiency(s), the facility faces termination from the Medicare and Medicaid programs or compliance with a System Improvement Agreement to remedy deficiencies and ensure compliance.

The laws and regulations governing the healthcare industry are complex covering, among other things, government healthcare participation requirements, licensure, certification and accreditation, privacy of patient information, reimbursement for patient services as well as fraud and abuse compliance. These laws and regulations are constantly evolving and expanding. Further, the Affordable Care Act has added additional obligations on healthcare providers to report and refund overpayments by government healthcare programs and authorizes the suspension of Medicare and Medicaid payments “pending an investigation of a credible allegation of fraud.” We monitor our business and have developed an ethics and compliance program with respect to these complex laws, rules and regulations. Although we believe our policies, procedures and practices comply with government regulations, there is no assurance that we will not be faced with the sanctions referenced above which include fines, penalties and/or substantial damages, repayment obligations, payment suspensions, licensure revocation, and expulsion from government healthcare programs. Even if we were to ultimately prevail in any action brought against us or our facilities or in responding to any inquiry, such action or inquiry could have a material adverse effect on us.

The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities. We record accruals for such contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because the inherently unpredictable nature of legal proceedings may be exacerbated by various factors, including, but not limited to: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties, or; (vii) there is a wide range of potential outcomes. It is possible that the outcome of these matters could have a material adverse impact on our future results of operations, financial position, cash flows and, potentially, our reputation.

In addition, various suits and claims arising against us in the ordinary course of business are pending. In the opinion of management, the outcome of such claims and litigation will not materially affect our consolidated financial position or results of operations.

In addition to our long-term debt obligations as discussed in Note 4. Long-Term Debt and our operating lease obligations as discussed in Note 7. Lease Commitments, we have various other contractual commitments outstanding as of December 31, 2015 as follows: (i) other combined estimated future purchase obligations of $171 million related to a long-term contract with third-parties consisting primarily of certain revenue cycle data processing services for our acute care facilities ($70 million), expected future costs to be paid to a third-party vendor in connection with the purchase, implementation and on-going operation of an electronic health records application for each of our acute care facilities ($100 million) and estimated minimum liabilities for physician commitments expected to be paid in the future ($1 million); (ii) estimated construction commitment of $110 million made to a third-party for construction of a new acute care hospital located in Henderson, Nevada; (iii) combined estimated future payments of $242 million related to our non-contributory, defined benefit pension plan ($224 million consisting of estimated payments through 2089) and other retirement plan liabilities ($18 million), and; (iv) accrued and unpaid estimated claims expense incurred in connection with our commercial health insurers and self-insured employee benefit plans ($68 million).

Relationship with Universal Health Realty Income Trust and Other Related Party Transactions

12 Months Ended

Dec. 31, 2015

Relationship with Universal Health Realty Income Trust and Other Related Party Transactions

9) RELATIONSHIP WITH UNIVERSAL HEALTH REALTY INCOME TRUST AND OTHER RELATED PARTY TRANSACTIONS

Relationship with Universal Health Realty Income Trust:

At December 31, 2015, we held approximately 5.9% of the outstanding shares of Universal Health Realty Income Trust (the “Trust”). We serve as Advisor to the Trust under an annually renewable advisory agreement, which is scheduled to expire on December 31^st of each year, pursuant to the terms of which we conduct the Trust’s day-to-day affairs, provide administrative services and present investment opportunities. In December, 2015, the advisory agreement was renewed by the Trust for 2016 pursuant to the same terms in place during each of the last three years. During 2015, 2014 and 2013, the advisory fee was computed at 0.70% of the Trust’s average invested real estate assets. In addition, certain of our officers and directors are also officers and/or directors of the Trust. Management believes that it has the ability to exercise significant influence over the Trust, therefore we account for our investment in the Trust using the equity method of accounting. We earned an advisory fee from the Trust, which is included in net revenues in the accompanying consolidated statements of income, of approximately $2.8 million during 2015, $2.5 million during 2014 and $2.4 million during 2013.

Our pre-tax share of income from the Trust was $1.4. million during 2015, $3.2 million during 2014 and $842,000 during 2013, and is included in net revenues in the accompanying consolidated statements of income for each year. Included in our share of the Trust’s income was approximately$500,000 in 2015, and $2.3 million in 2014, related to our share gains on various transactions recorded by the Trust.

The carrying value of our investment in the Trust was $8.7 million and $9.3 million at December 31, 2015 and 2014, respectively, and is included in other assets in the accompanying consolidated balance sheets. The market value of our investment in the Trust was $39.4 million at December 31, 2015 and $37.9 million at December 31, 2014, based on the closing price of the Trust’s stock on the respective dates.

Total rent expense under the operating leases on the three hospital facilities with the Trust during 2015 was $15.6 million. Total rent expense under the operating leases on the four hospital facilities with the Trust during 2014 and 2013 (as discussed below) was $16.8 million and $16.4 million, respectively. In addition, certain of our subsidiaries are tenants in several medical office buildings owned by the Trust or by limited liability companies in which the Trust holds 100% of the ownership interest.

The Trust commenced operations in 1986 by purchasing certain properties from us and immediately leasing the properties back to our respective subsidiaries. Most of the leases were entered into at the time the Trust commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. Each lease also provided for additional or bonus rental, as discussed below. The base rents are paid monthly and the bonus rents are computed and paid on a quarterly basis, based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with our subsidiaries are unconditionally guaranteed by us and are cross-defaulted with one another.

During the first quarter of 2015, wholly-owned subsidiaries of ours sold to and leased back from the Trust, two newly constructed free-standing emergency departments (“FEDs”) located in Texas which were completed and opened during the first quarter of 2015. In conjunction with these transactions, ten-year lease agreements with six, five-year renewal options have been executed with the Trust. We have the option to purchase the properties upon the expiration of the fixed terms and each five-year renewal terms at the fair market value of the property. The aggregate construction cost/sales proceeds of these facilities was approximately $13 million, and the aggregate rent expense paid to the Trust at the commencement of the leases will approximate $900,000 annually.

In December, 2014, upon the expiration of the lease term, we elected to purchase from the Trust for $17.3 million, the real property of The Bridgeway, a 103-bed behavioral health care facility located in North Little Rock, Arkansas. Pursuant to the terms of the lease, we and the Trust were both required to obtain appraisals of the property to determine its fair market value/purchase price. The rent expense paid by us to the Trust, prior to our purchase of The Bridgeway’s real property in December, 2014, was approximately $1.1 million annually.

The table below details the renewal options and terms for each of our three hospital facilities leased from the Trust:

Hospital Name

Type of Facility

Annual

Minimum

Rent

End of Lease Term

Renewal

Term

(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

Pursuant to the terms of the three hospital leases with the Trust, we have the option to renew the leases at the lease terms described above by providing notice to the Trust at least 90 days prior to the termination of the then current term. We also have the right to purchase the respective leased hospitals at the end of the lease terms or any renewal terms at their appraised fair market value as well as purchase any or all of the three leased hospital properties at the appraised fair market value upon one month’s notice should a change of control of the Trust occur. In addition, we have rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer.

Other Related Party Transactions:

In December, 2010, our Board of Directors approved the Company’s entering into supplemental life insurance plans and agreements on the lives of our chief executive officer (“CEO”) and his wife. As a result of these agreements, based on actuarial tables and other assumptions, during the life expectancies of the insureds, we would pay approximately $25 million in premiums, and certain trusts owned by our chief executive officer, would pay approximately $8 million in premiums. Based on the projected premiums mentioned above, and assuming the policies remain in effect until the death of the insureds, we will be entitled to receive death benefit proceeds of no less than $33 million representing the $25 million of aggregate premiums paid by us as well as the $8 million of aggregate premiums paid by the trusts. In connection with these policies, we paid approximately $1.3 million in premium payments , during each of 2015, 2014 and 2013. These agreements did not have a material effect on our consolidated financial statements or results of operations during 2015, 2014 or 2013.

In August, 2015, Marc D. Miller, our President and member of our Board of Directors, was appointed to the Board of Directors of Premier, Inc. (“Premier”), a healthcare performance improvement alliance. During 2013, we entered into a new group purchasing organization agreement (“GPO”) with Premier. In conjunction with the GPO agreement, we acquired a minority interest in Premier for a nominal amount. During the fourth quarter of 2013, in connection with the completion of an initial public offering of the stock of Premier, we received cash proceeds for the sale of a portion of our ownership interest in the GPO. Also in connection with this GPO agreement, we received shares of restricted stock of Premier which vest ratably over a seven-year period (2014 through 2020), contingent upon our continued participation and minority ownership interest in the GPO. See Note 1 to the Consolidated Financial Statements-Business and Summary of Significant Accounting Policies, W) GPO Agreement/Minority Ownership Interest for additional disclosure related to this agreement.

A member of our Board of Directors and member of the Executive Committee is Of Counsel to the law firm used by us as our principal outside counsel. This Board member is also the trustee of certain trusts for the benefit of our CEO and his family. This law firm also provides personal legal services to our CEO.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References + Details

Pension Plan

12 Months Ended

Dec. 31, 2015

Compensation And Retirement Disclosure [Abstract]

Pension Plan

10) PENSION PLAN

We maintain contributory and non-contributory retirement plans for eligible employees. Our contributions to the contributory plan amounted to $40.7 million, $35.7 million and $29.9 million in 2015, 2014 and 2013, respectively. The non-contributory plan is a defined benefit pension plan which covers employees of one of our subsidiaries. The benefits are based on years of service and the employee’s highest compensation for any five years of employment. Our funding policy is to contribute annually at least the minimum amount that should be funded in accordance with the provisions of ERISA.

The following table shows the reconciliation of the defined benefit pension plan as of December 31, 2015 and 2014:

	2015			2014
	(000s)
Change in plan assets:
Fair value of plan assets at beginning of year	$	116,697		$	106,469
Actual return (loss) on plan assets		(3,223	)		16,470
Benefits paid		(6,086	)		(5,605	)
Administrative expenses		(549	)		(637	)
Fair value of plan assets at end of year	$	106,839		$	116,697
Change in benefit obligation:
Benefit obligation at beginning of year	$	127,342		$	103,558
Service cost		1,051			966
Interest cost		4,912			4,986
Benefits paid		(6,086	)		(5,605	)
Actuarial (gain) loss		(9,039	)		23,437
Benefit obligation at end of year	$	118,180		$	127,342
Amounts recognized in the Consolidated Balance Sheet:
Other non-current liabilities		11,341			10,645
Total amounts recognized at end of year	$	11,341		$	10,645

	2015			2014			2013
	(000s)
Components of net periodic cost (benefit)
Service cost	$	1,051		$	966		$	1,060
Interest cost		4,912			4,985			4,528
Expected return on plan assets		(6,254	)		(7,772	)		(7,601	)
Recognized actuarial loss		3,164			1,107			3,305
Net periodic cost	$	2,873		$	(714	)	$	1,292

	2015	2014
Measurement Dates
Benefit obligations	12/31/2015	12/31/2014
Fair value of plan assets	12/31/2015	12/31/2014

	2015			2014
Weighted average assumptions as of December 31
Discount rate		4.34	%		3.95	%
Rate of compensation increase		4.00	%		4.00	%

	2015			2014			2013
Weighted-average assumptions for net periodic benefit cost calculations
Discount rate		3.95	%		4.95	%		4.05	%
Expected long-term rate of return on plan assets		5.50	%		7.50	%		7.50	%
Rate of compensation increase		4.00	%		4.00	%		4.00	%

The accumulated benefit obligation was $117.7 million and $126.4 million as of December 31, 2015 and 2014, respectively. As of December 31, 2015, the accumulated benefit obligation exceeded the fair value of plan assets by $10.9 million. As of December 31, 2014, the accumulated benefit obligation exceeded the fair value of plan assets by $9.7 million.

We estimate that there will be a $3.1 million net loss amortized from accumulated other comprehensive income during 2016.

The market values of our pension plan assets at December 31, 2015 and December 31, 2014 by asset category are as follows:

December 31, 2015	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	8,520	$	—	$	8,520	$	—
U.S. Mid Cap		2,613		—		2,613		—
U.S. Small Cap		2,649		—		2,649		—
International Developed		6,406		—		6,406		—
Emerging Markets		4,114		—		4,114		—
Fixed income:
Core Fixed Income		23,782		—		23,782		—
Long Duration Fixed Income		55,931		—		55,931		—
Real Estate:
REIT Fund		2,212		—		2,212		—
Cash/Currency:
Cash Equivalents		612		—		612		—
Total market value	$	106,839	$	—	$	106,839	$	—

December 31, 2014	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	9,212	$	—	$	9,212	$	—
U.S. Mid Cap		2,852		—		2,852		—
U.S. Small Cap		2,626		—		2,626		—
International Developed		6,181		—		6,181		—
Emerging Markets		4,139		—		4,139		—
Fixed income:
Core Fixed Income		27,062		—		27,062		—
Long Duration Fixed Income		61,718		—		61,718		—
Real Estate:
REIT Fund		2,395		—		2,395		—
Cash/Currency:
Cash Equivalents		512		—		512		—
Total market value	$	116,697	$	—	$	116,697	$	—

To develop the expected long-term rate of return on plan assets assumption, we considered the historical returns and the future expectations for returns for each asset class, as well as the target asset allocation of the pension portfolio.

The following table shows expected benefit payments for the years ended December 31, 2015 through 2025 for our defined pension plan. There will be benefit payments under this plan beyond 2025.

Estimated Future Benefit Payments (000s)
2016	$	6,086
2017		6,343
2018		6,563
2019		6,753
2020		6,900
2021-2025		35,657
Total	$	68,302

	2015			2014
Plan Assets
Asset Category
Equity securities		23	%		21	%
Fixed income securities		75	%		76	%
Other		2	%		3	%
Total		100	%		100	%

Investment Policy, Guidelines and Objectives have been established for the defined benefit pension plan. The investment policy is in keeping with the fiduciary requirements under existing federal laws and managed in accordance with the Prudent Investor Rule. Total portfolio risk is regularly evaluated and compared to that of the plan’s policy target allocation and judged on a relative basis over a market cycle. The following asset allocation policy and ranges have been established in accordance with the overall risk and return objectives of the portfolio:

	As of 12/31/2015			Permitted Range
Total Equity		23	%	10-30%
Total Fixed Income		75	%	70-90%
Other		2	%	0-10%

In accordance with the investment policy, the portfolio will invest in high quality, large and small capitalization companies traded on national exchanges, and investment grade securities. The investment managers will not write or buy options for speculative purposes; securities may not be margined or sold short. The manager may employ futures or options for the purpose of hedging exposure, and will not purchase unregistered sectors, private placements, partnerships or commodities.

Segment Reporting

12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Segment Reporting

11) SEGMENT REPORTING

Our reportable operating segments consist of acute care hospital services and behavioral health care services. The “Other” segment column below includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for our other operating entities including outpatient surgery and radiation centers. The chief operating decision making group for our acute care hospital services and behavioral health care services is comprised of our Chief Executive Officer, the President and the Presidents of each operating segment. The Presidents for each operating segment also manage the profitability of each respective segment’s various facilities. The operating segments are managed separately because each operating segment represents a business unit that offers different types of healthcare services or operates in different healthcare environments. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies included in this Annual Report on Form 10-K for the year ended December 31, 2015. The corporate overhead allocations, as reflected below, are utilized for internal reporting purposes and are comprised of each period’s projected corporate-level operating expenses (excluding interest expense). The overhead expenses are captured and allocated directly to each segment, to the extent possible, with the non-directly allocated overhead expenses allocated based upon each segment’s respective percentage of total facility-based operating expenses.

2015	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	16,847,944		$	7,456,397		$	—		$	24,304,341
Gross outpatient revenues	$	9,604,952		$	839,884		$	15,794		$	10,460,630
Total net revenues	$	4,632,564		$	4,400,335		$	10,552		$	9,043,451
Income (loss) before allocation of corporate overhead and income taxes	$	519,630		$	1,021,823		$	(395,552	)	$	1,145,901
Allocation of corporate overhead	$	(197,699	)	$	(117,203	)	$	314,902		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	321,931		$	904,620		$	(80,650	)	$	1,145,901
Total assets	$	3,413,879		$	5,867,088		$	353,146		$	9,634,113

2014	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	14,943,102		$	6,689,753			—		$	21,632,855
Gross outpatient revenues	$	8,147,031		$	784,309		$	34,238		$	8,965,578
Total net revenues	$	4,178,103		$	4,012,216		$	14,769		$	8,205,088
Income (loss) before allocation of corporate overhead and income taxes	$	465,328		$	944,068		$	(479,729	)	$	929,667
Allocation of corporate overhead	$	(178,781	)	$	(98,811	)	$	277,592		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	286,547		$	845,257		$	(202,137	)	$	929,667
Total assets	$	3,362,870		$	5,286,960		$	324,613		$	8,974,443

2013	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	13,469,269		$	6,294,046			—		$	19,763,315
Gross outpatient revenues	$	6,828,307		$	744,510		$	40,460		$	7,613,277
Total net revenues	$	3,602,874		$	3,725,513		$	39,486		$	7,367,873
Income (loss) before allocation of corporate overhead and income taxes	$	342,191		$	895,869		$	(368,728	)	$	869,332
Allocation of corporate overhead	$	(184,444	)	$	(89,447	)	$	273,891		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	157,747		$	806,422		$	(94,837	)	$	869,332
Total assets	$	3,125,626		$	4,966,182		$	219,915		$	8,311,723

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

Quarterly Results

12 Months Ended

Dec. 31, 2015

Quarterly Financial Information Disclosure [Abstract]

Quarterly Results

12) QUARTERLY RESULTS (unaudited)

The following tables summarize the quarterly financial data for the two years ended December 31, 2015 and 2014:

2015	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	2,225,353	$	2,275,204	$	2,227,655	$	2,315,239	$	9,043,451
Net income	$	194,323	$	201,404	$	163,654	$	191,317	$	750,698
Less: Net income attributable to noncontrolling interests	$	20,024	$	19,211	$	13,367	$	17,568	$	70,170
Net income attributable to UHS	$	174,299	$	182,193	$	150,287	$	173,749	$	680,528
Earnings per share attributable to UHS-Basic:
Total basic earnings per share	$	1.76	$	1.84	$	1.52	$	1.76	$	6.89
Earnings per share attributable to UHS-Diluted:
Total diluted earnings per share	$	1.73	$	1.80	$	1.48	$	1.74	$	6.76

The 2015 quarterly financial data presented above includes the following:

First Quarter:

an unfavorable $8.3 million pre-tax impact ($5.3 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

Second Quarter:

an unfavorable $6.9 million pre-tax impact ($4.4 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications.

Third Quarter:

an unfavorable $8.0 million pre-tax impact ($5.0 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

Fourth Quarter:

a favorable $4.9 million pre-tax impact ($3.1 million, or $.03 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

2014	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,938,314	$	2,051,766	$	2,038,717	$	2,176,291	$	8,205,088
Net income	$	151,852	$	166,614	$	96,038	$	190,492	$	604,996
Less: Net income attributable to noncontrolling interests	$	13,774	$	14,943	$	13,241	$	17,695	$	59,653
Net income attributable to UHS	$	138,078	$	151,671	$	82,797	$	172,797	$	545,343
Earnings per share attributable to UHS-Basic:
Total basic earnings per share	$	1.40	$	1.53	$	0.84	$	1.75	$	5.52
Earnings per share attributable to UHS-Diluted:
Total diluted earnings per share	$	1.38	$	1.51	$	0.82	$	1.71	$	5.42

The 2014 quarterly financial data presented above includes the following:

First Quarter:

an unfavorable $8.9 million pre-tax impact ($4.9 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

a favorable $10.1 million pre-tax impact ($6.3 million, or $0.07 per diluted share, net of taxes) resulting from the gain realized on the sale of a non-operating investment.

Second Quarter:

an unfavorable $7.1 million pre-tax impact ($3.9 million, or $.04 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications.

Third Quarter:

an unfavorable $7.9 million pre-tax impact ($4.5 million, or $.04 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

an unfavorable $36.2 million pre-tax impact ($22.7 million, or $0.23 per diluted share, net of taxes) recorded in connection with the costs related to extinguishment of debt resulting primarily from the early redemption of our previously outstanding $250 million, 7.00% senior unsecured notes that were scheduled to mature in 2018 and the repayment of $550 million of borrowings pursuant to the terms of our previously outstanding Term Loan B facility which was scheduled to mature in 2016;

an unfavorable $44.0 million pre-tax impact ($27.6 million, or $0.27 per diluted share, net of taxes) incurred in connection with the previously disclosed $65 million settlement of the Garden City matter. This matter was a shareholder class action lawsuit filed in 2009 against PSI and certain of its former officers alleging their violations of federal securities laws and we assumed the defense and liability of this matter as a result of our acquisition of PSI in 2010. This charge is net of approximately $17 million of commercial insurance recoveries that we were entitled to and a previously recorded estimated reserve;

Fourth Quarter:

a favorable $13.8 million pre-tax impact ($8.6 million, or $.08 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

A favorable $19.7 million pre-tax impact reduction ($11.7 million, or $.12 per diluted share, net of taxes) to our professional and general liability self-insurance reserves relating to years prior to 2014, as discussed in Self-Insured/Other Insurance Risks.

Supplemental Condensed Consolidating Financial Information

12 Months Ended

Dec. 31, 2015

Condensed Financial Information Of Parent Company Only Disclosure [Abstract]

Supplemental Condensed Consolidating Financial Information

13) SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

Certain of our senior notes are guaranteed by a group of subsidiaries (the “Guarantors”). The Guarantors, each of which is a 100% directly owned subsidiary of Universal Health Services, Inc., fully and unconditionally guarantee the senior notes on a joint and several basis, subject to certain customary release provisions.

The following financial statements present condensed consolidating financial data for (i) Universal Health Services, Inc. (on a parent company only basis), (ii) the combined Guarantors, (iii) the combined non guarantor subsidiaries (all other subsidiaries), (iv) an elimination column for adjustments to arrive at the information for the parent company, Guarantors, and non guarantors on a consolidated basis, and (v) the parent company and our subsidiaries on a consolidated basis.

Investments in subsidiaries are accounted for by the parent company and the Guarantors using the equity method for this presentation. Results of operations of subsidiaries are therefore classified in the parent company’s and Guarantors’ investment in subsidiaries accounts. The elimination entries set forth in the following condensed consolidating financial statements eliminate distributed and undistributed income of subsidiaries, investments in subsidiaries, and intercompany balances and transactions between the parent, Guarantors, and non guarantors.

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2015
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	6,798,664		$	3,018,364		$	(32,304	)	$	9,784,724
Less: Provision for doubtful accounts		0			481,294			259,979			0			741,273
Net revenues		0			6,317,370			2,758,385			(32,304	)		9,043,451
Operating charges:
Salaries, wages and benefits		0			3,014,296			1,198,091			0			4,212,387
Other operating expenses		0			1,459,607			690,341			(30,143	)		2,119,805
Supplies expense		0			583,644			390,444			0			974,088
Depreciation and amortization		0			280,985			117,633			0			398,618
Lease and rental expense		0			58,394			38,740			(2,161	)		94,973
Electronic health records incentive income		0			(12,232	)		(3,583	)		0			(15,815	)
		0			5,384,694			2,431,666			(32,304	)		7,784,056
Income from operations		0			932,676			326,719			0			1,259,395

Interest expense		107,665			4,695			1,134			0			113,494
Interest (income) expense, affiliate		0			86,494			(86,494	)		0			0
Equity in net income of consolidated affiliates		(746,984	)		(215,119	)		0			962,103			0
Income before income taxes		639,319			1,056,606			412,079			(962,103	)		1,145,901

Provision for income taxes		(41,209	)		354,611			81,801			0			395,203
Net income		680,528			701,995			330,278			(962,103	)		750,698

Less: Income attributable to noncontrolling interests		0			0			70,170			0			70,170
Net income attributable to UHS	$	680,528		$	701,995		$	260,108		$	(962,103	)	$	680,528

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	6,225,997		$	2,707,294		$	(29,220	)	$	8,904,071
Less: Provision for doubtful accounts		0			471,181			227,802			0			698,983
Net revenues		0			5,754,816			2,479,492			(29,220	)		8,205,088
Operating charges:
Salaries, wages and benefits		0			2,757,738			1,087,723			0			3,845,461
Other operating expenses		0			1,342,745			607,098			(27,100	)		1,922,743
Supplies expense		0			546,578			349,115			0			895,693
Depreciation and amortization		0			269,490			106,134			0			375,624
Lease and rental expense		0			58,619			37,494			(2,120	)		93,993
Electronic health records incentive income		0			(19,480	)		(8,422	)		0			(27,902	)
Costs related to extinguishment of debt		36,171			0			0			0			36,171
		36,171			4,955,690			2,179,142			(29,220	)		7,141,783
Income from operations		(36,171	)		799,126			300,350			0			1,063,305

Interest expense		127,528			4,516			1,594			0			133,638
Interest (income) expense, affiliate		0			88,246			(88,246	)		0			0
Equity in net income of consolidated affiliates		(646,386	)		(184,385	)		0			830,771			0
Income before income taxes		482,687			890,749			387,002			(830,771	)		929,667

Provision for income taxes		(62,656	)		305,320			82,007			0			324,671
Net income		545,343			585,429			304,995			(830,771	)		604,996

Less: Income attributable to noncontrolling interests		0			0			59,653			0			59,653
Net income attributable to UHS	$	545,343		$	585,429		$	245,342		$	(830,771	)	$	545,343

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	5,734,385		$	2,789,348		$	(28,644	)	$	8,495,089
Less: Provision for doubtful accounts		0			657,106			470,110			0			1,127,216
Net revenues		0			5,077,279			2,319,238			(28,644	)		7,367,873
Operating charges:
Salaries, wages and benefits		0			2,573,205			1,031,415			0			3,604,620
Other operating expenses		0			1,047,856			531,747			(26,808	)		1,552,795
Supplies expense		0			510,078			311,011			0			821,089
Depreciation and amortization		0			236,958			100,214			0			337,172
Lease and rental expense		0			62,518			37,076			(1,836	)		97,758
Electronic health records incentive income		0			(43,027	)		(17,997	)		0			(61,024	)
		0			4,387,588			1,993,466			(28,644	)		6,352,410
Income from operations		0			689,691			325,772			0			1,015,463

Interest expense		139,793			3,365			2,973			0			146,131
Interest (income) expense, affiliate		0			84,640			(84,640	)		0			0
Equity in net income of consolidated affiliates		(597,020	)		(141,004	)		0			738,024			0
Income before income taxes		457,227			742,690			407,439			(738,024	)		869,332

Provision for income taxes		(53,506	)		262,346			106,469			0			315,309
Net income		510,733			480,344			300,970			(738,024	)		554,023

Less: Income attributable to noncontrolling interests		0			0			43,290			0			43,290
Net income attributable to UHS	$	510,733		$	480,344		$	257,680		$	(738,024	)	$	510,733

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2015
(amounts in thousands)

	Parent			Guarantors			Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	680,528		$	701,995		$	330,278	$	(962,103	)	$	750,698
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		4,970			0			0		0			4,970
Amortization of terminated hedge		(336	)		0			0		0			(336	)
Minimum pension liability		2,177			2,177			0		(2,177	)		2,177
Foreign currency translation adjustment		(1,728	)		(1,728	)		0		1,728			(1,728	)
Other comprehensive income before tax		5,083			449			0		(449	)		5,083
Income tax expense related to items of other comprehensive income		2,980			817			0		(817	)		2,980
Total other comprehensive income, net of tax		2,103			(368	)		0		368			2,103
Comprehensive income		682,631			701,627			330,278		(961,735	)		752,801
Less: Comprehensive income attributable to noncontrolling interests		0			0			70,170		0			70,170
Comprehensive income attributable to UHS	$	682,631		$	701,627		$	260,108	$	(961,735	)	$	682,631

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014
(amounts in thousands)

	Parent			Guarantors			Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	545,343		$	585,429		$	304,995	$	(830,771	)	$	604,996
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		17,668			0			0		0			17,668
Amortization of terminated hedge		(336	)		0			0		0			(336	)
Minimum pension liability		(14,270	)		(14,270	)		0		14,270			(14,270	)
Foreign currency translation adjustment		(2,431	)		(2,431	)		0		2,431			(2,431	)
Other comprehensive income before tax		631			(16,701	)		0		16,701			631
Income tax expense related to items of other comprehensive income		1,053			(5,356	)		0		5,356			1,053
Total other comprehensive income, net of tax		(422	)		(11,345	)		0		11,345			(422	)
Comprehensive income		544,921			574,084			304,995		(819,426	)		604,574
Less: Comprehensive income attributable to noncontrolling interests		0			0			59,653		0			59,653
Comprehensive income attributable to UHS	$	544,921		$	574,084		$	245,342	$	(819,426	)	$	544,921

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013
(amounts in thousands)

	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	510,733		$	480,344	$	300,970	$	(738,024	)	$	554,023
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		16,963			0		0		0			16,963
Amortization of terminated hedge		(336	)		0		0		0			(336	)
Minimum pension liability		14,657			14,657		0		(14,657	)		14,657
Other comprehensive income before tax		31,284			14,657		0		(14,657	)		31,284
Income tax expense related to items of other comprehensive income		11,940			5,670		0		(5,670	)		11,940
Total other comprehensive income, net of tax		19,344			8,987		0		(8,987	)		19,344
Comprehensive income		530,077			489,331		300,970		(747,011	)		573,367
Less: Comprehensive income attributable to noncontrolling interests		0			0		43,290		0			43,290
Comprehensive income attributable to UHS	$	530,077		$	489,331	$	257,680	$	(747,011	)	$	530,077

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEET
AS OF DECEMBER 31, 2015
(amounts in thousands)

	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	47,192		$	14,036		$	0		$	61,228
Accounts receivable, net		0		918,699			383,730			0			1,302,429
Supplies		0		72,499			43,538			0			116,037
Deferred income taxes		132,975		2,145			0			0			135,120
Other current assets		0		89,973			13,517			0			103,490
Total current assets		132,975		1,130,508			454,821			0			1,718,304

Investments in subsidiaries		7,760,156		1,876,415			0			(9,636,571	)		0

Intercompany receivable		80,764		0			747,709			(828,473	)		0
Intercompany note receivable		0		0			1,242,937			(1,242,937	)		0

Property and equipment		0		4,722,050			1,808,519			0			6,530,569
Less: accumulated depreciation		0		(1,845,746	)		(848,845	)		0			(2,694,591	)
		0		2,876,304			959,674			0			3,835,978
Other assets:
Goodwill		0		3,070,061			526,053			0			3,596,114
Deferred charges		25,877		5,530			3,950			0			35,357
Other		14,251		394,998			39,111			0			448,360
	$	8,014,023	$	9,353,816		$	3,974,255		$	(11,707,981	)	$	9,634,113
Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	60,368	$	1,223		$	1,131		$	0		$	62,722
Accounts payable and accrued liabilities		19,996		744,137			269,564			0			1,033,697
Federal and state taxes		3,987		0			0			0			3,987
Total current liabilities		84,351		745,360			270,695			0			1,100,406

Intercompany payable		0		828,473			0			(828,473	)		0
Intercompany note payable		0		1,242,937			0			(1,242,937	)		0

Other noncurrent liabilities		1,982		206,287			70,565			0			278,834
Long-term debt		3,362,143		16,790			8,370			0			3,387,303
Deferred income taxes		315,900		0			0			0			315,900

Redeemable noncontrolling interests		0		0			242,509			0			242,509
Equity:
UHS common stockholders’ equity		4,249,647		6,313,969			3,322,602			(9,636,571	)		4,249,647
Noncontrolling interest		0		0			59,514			0			59,514
Total equity		4,249,647		6,313,969			3,382,116			(9,636,571	)		4,309,161
	$	8,014,023	$	9,353,816		$	3,974,255		$	(11,707,981	)	$	9,634,113

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEET
AS OF DECEMBER 31, 2014
(amounts in thousands)

	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	21,784		$	10,285		$	0		$	32,069
Accounts receivable, net		0		933,971			348,764			0			1,282,735
Supplies		0		67,847			40,268			0			108,115
Deferred income taxes		113,822		743			0			0			114,565
Other current assets		0		62,431			15,223			0			77,654
Total current assets		113,822		1,086,776			414,540			0			1,615,138

Investments in subsidiaries		7,013,540		1,661,296			0			(8,674,836	)		0

Intercompany receivable		103,808		0			408,682			(512,490	)		0
Intercompany note receivable		0		0			1,222,637			(1,222,637	)		0

Property and equipment		0		4,494,567			1,717,463			0			6,212,030
Less: accumulated depreciation		0		(1,686,192	)		(846,149	)		0			(2,532,341	)
		0		2,808,375			871,314			0			3,679,689
Other assets:
Goodwill		0		2,764,555			526,658			0			3,291,213
Deferred charges		32,379		5,402			2,538			0			40,319
Other		9,601		283,302			55,181			0			348,084
	$	7,273,150	$	8,609,706		$	3,501,550		$	(10,409,963	)	$	8,974,443
Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	44,874	$	1,260		$	22,185		$	0		$	68,319
Accounts payable and accrued liabilities		20,245		1,051,309			41,508			0			1,113,062
Federal and state taxes		1,446		0			0			0			1,446
Total current liabilities		66,565		1,052,569			63,693			0			1,182,827

Intercompany payable		0		512,490			0			(512,490	)		0
Intercompany note payable		0		1,222,637			0			(1,222,637	)		0

Other noncurrent liabilities		1,322		189,456			77,777			0			268,555
Long-term debt		3,187,103		20,212			2,900			0			3,210,215
Deferred income taxes		282,214		0			0			0			282,214

Redeemable noncontrolling interests		0		0			239,552			0			239,552
Equity:
UHS common stockholders’ equity		3,735,946		5,612,342			3,062,494			(8,674,836	)		3,735,946
Noncontrolling interest		0		0			55,134			0			55,134
Total equity		3,735,946		5,612,342			3,117,628			(8,674,836	)		3,791,080
	$	7,273,150	$	8,609,706		$	3,501,550		$	(10,409,963	)	$	8,974,443

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2015
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash (used in) provided by operating activities	$	(21,287	)	$	655,439		$	386,746		$	0	$	1,020,898

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(209,355	)		(169,966	)		0		(379,321	)
Acquisition of property and businesses					(513,382	)		(20,273	)				(533,655	)
Proceeds received from sale of assets and businesses		0			647			2,744			0		3,391
Increase in insurance subsidiary investments		0			(3,300	)		0			0		(3,300	)
Net cash used in investing activities		0			(725,390	)		(187,495	)		0		(912,885	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(42,133	)		(3,459	)		(22,574	)		0		(68,166	)
Additional borrowings		234,400			0			0			0		234,400
Financing costs		(515	)		0			0			0		(515	)
Repurchase of common shares		(209,782	)		0			0			0		(209,782	)
Dividends paid		(39,532	)		0			0			0		(39,532	)
Issuance of common stock		8,441			0			0			0		8,441
Excess income tax benefits related to stock-based compensation		47,364			0			0			0		47,364
Profit distributions to noncontrolling interests		0			0			(62,220	)		0		(62,220	)
Proceeds received from sale/leaseback of real property		0			0			12,765			0		12,765
Changes in intercompany balances with affiliates, net		23,044			100,427			(123,471	)		0		0
Net cash provided by (used in) financing activities		21,287			96,968			(195,500	)		0		(77,245	)

Effect of exchange rate changes on cash and cash equivalents		0			(1,609	)		0			0		(1,609	)

Increase in cash and cash equivalents		0			25,408			3,751			0		29,159
Cash and cash equivalents, beginning of period		0			21,784			10,285			0		32,069
Cash and cash equivalents, end of period	$	0		$	47,192		$	14,036		$	0	$	61,228

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	18,579		$	687,101		$	330,196		$	0	$	1,035,876

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(230,102	)		(161,048	)		0		(391,150	)
Acquisition of property and businesses		0			(422,081	)		(9,305	)		0		(431,386	)
Proceeds received from sale of assets and businesses		0			11,450			3,728			0		15,178
Costs incurred for purchase and implementation of electronic health records application		0			(13,488	)		0			0		(13,488	)
Increase in insurance subsidiary investments		0			(12,000	)		0			0		(12,000	)
Net cash used in investing activities		0			(666,221	)		(166,625	)		0		(832,846	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(866,748	)		(867	)		(11,514	)		0		(879,129	)
Additional borrowings		830,000			0			0			0		830,000
Financing costs		(14,976	)		0			0			0		(14,976	)
Repurchase of common shares		(100,749	)		0			0			0		(100,749	)
Dividends paid		(29,665	)		0			0			0		(29,665	)
Issuance of common stock		6,863			0			0			0		6,863
Excess income tax benefits related to stock-based compensation		33,912			0			0			0		33,912
Profit distributions to noncontrolling interests		0			0			(33,680	)		0		(33,680	)
Changes in intercompany balances with affiliates, net		122,784			(5,444	)		(117,340	)		0		0
Net cash used in financing activities		(18,579	)		(6,311	)		(162,534	)		0		(187,424	)

Effect of exchange rate changes on cash and cash equivalents		0			(775	)		0			0		(775	)

Increase in cash and cash equivalents		0			13,794			1,037			0		14,831
Cash and cash equivalents, beginning of period		0			7,990			9,248			0		17,238
Cash and cash equivalents, end of period	$	0		$	21,784		$	10,285		$	0	$	32,069

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	17,946		$	587,083		$	279,212		$	0	$	884,241

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(269,419	)		(89,074	)		0		(358,493	)
Acquisition of property and businesses		0			(8,094	)		(4,542	)		0		(12,636	)
Proceeds received from sale of assets and businesses		0			7,916			29,566			0		37,482
Costs incurred for purchase and implementation of electronic health records application		0			(49,811	)		0			0		(49,811	)
Net cash used in investing activities		0			(319,408	)		(64,050	)		0		(383,458	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(429,996	)		(109	)		(10,119	)		0		(440,224	)
Additional borrowings		15,761			0			0			0		15,761
Financing costs		(231	)		0			0			0		(231	)
Repurchase of common shares		(27,201	)		0			0			0		(27,201	)
Dividends paid		(19,621	)		0			0			0		(19,621	)
Issuance of common stock		5,708			0			0			0		5,708
Excess income tax benefits related to stock-based compensation		20,121			0			0			0		20,121
Profit distributions to noncontrolling interests		0			0			(61,329	)		0		(61,329	)
Changes in intercompany balances with affiliates, net		417,513			(271,525	)		(145,988	)		0		0
Net cash used in financing activities		(17,946	)		(271,634	)		(217,436	)		0		(507,016	)

Decrease in cash and cash equivalents		0			(3,959	)		(2,274	)		0		(6,233	)
Cash and cash equivalents, beginning of period		0			11,949			11,522			0		23,471
Cash and cash equivalents, end of period	$	0		$	7,990		$	9,248		$	0	$	17,238

Schedule II-Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2015

Valuation And Qualifying Accounts [Abstract]

Schedule II-Valuation and Qualifying Accounts

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(amounts in thousands)

	Balance at		Charges to				Write-off of			Balance
	beginning		costs and		Acquisitions		uncollectible			at end
Allowance for Doubtful Accounts Receivable:	of period		expenses		of business		accounts			of period
Year ended December 31, 2015	$	324,648	$	741,273	$	-	$	(667,124	)	$	398,797
Year ended December 31, 2014	$	395,035	$	698,983	$	506	$	(769,876	)	$	324,648
Year ended December 31, 2013	$	311,387	$	1,127,216	$	-	$	(1,043,568	)	$	395,035

	Balance at		Charges to							Balance
	beginning		costs and			Acquisitions				at end
Valuation Allowance for Deferred Tax Assets:	of period		expenses			of business		Write-offs		of period
Year ended December 31, 2015	$	52,764	$	(197	)	$	-	$	-	$	52,567
Year ended December 31, 2014	$	46,841	$	5,923		$	-	$	-	$	52,764
Year ended December 31, 2013	$	44,511	$	2,330		$	-	$	-	$	46,841

Business and Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Principles of Consolidation

Revenue Recognition

Charity Care, Uninsured Discounts and Provision for Doubtful Accounts

Uncompensated care (charity care and uninsured discounts):

	(dollar amounts in thousands)
	2015					2014					2013
	Amount		%			Amount		%			Amount		%
Charity care	$	506,571		42	%	$	515,435		45	%	$	593,474		59	%
Uninsured discounts		696,463		58	%		620,587		55	%		405,296		41	%
Total uncompensated care	$	1,203,034		100	%	$	1,136,022		100	%	$	998,770		100	%

The estimated cost of providing uncompensated care:

	(amounts in thousands)
	2015		2014		2013
Estimated cost of providing charity care	$	77,557	$	78,475	$	95,675
Estimated cost of providing uninsured discounts related care		106,630		94,484		65,338
Estimated cost of providing uncompensated care	$	184,187	$	172,959	$	161,013

Concentration of Revenues

Accounting for Medicare and Medicaid Electronic Health Records Incentive Payments

Cash and Cash Equivalents

F) Cash and Cash Equivalents: We consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents.

Property and Equipment

Long-Lived Assets

Goodwill and Intangible Assets

Changes in the carrying amount of goodwill for the two years ended December 31, 2015 were as follows (in thousands):

	Acute Care Services			Behavioral Health Services			Total Consolidated
Balance, January 1, 2014	$	383,011		$	2,666,005		$	3,049,016
Goodwill acquired during the period		4,088			246,124			250,212
Adjustments to goodwill (a)		0			(8,015	)		(8,015	)
Balance, December 31, 2014		387,099			2,904,114			3,291,213
Goodwill acquired during the period		2,480			316,427			318,907
Goodwill divested during the period		0			(1,497	)		(1,497	)
Adjustments to goodwill (a)		(72	)		(12,437	)		(12,509	)
Balance, December 31, 2015	$	389,507		$	3,206,607		$	3,596,114

(a)	The decrease in the Behavioral Health Services’ goodwill consists primarily of foreign currency translation adjustments.

Other Assets

Physician Guarantees and Commitments

Self-Insured Risks

Income Taxes

Other Noncurrent Liabilities

Redeemable Noncontrolling Interests and Noncontrolling Interest

Accumulated Other Comprehensive Income

The amounts recognized in AOCI for the two years ended December 31, 2015 were as follows (in thousands):

	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Foreign Currency Translation Adjustment			Minimum Pension Liability			Total AOCI
Balance, January 1, 2014, net of income tax	$	(14,170	)	$	0		$	(10,640	)	$	(24,810	)
2014 activity:
Pretax amount		17,332			(2,431	)		(14,270	)		631
Income tax effect		(6,409	)		0			5,356			(1,053	)
Change, net of income tax		10,923			(2,431	)		(8,914	)		(422	)
Balance, January 1, 2015, net of income tax		(3,247	)		(2,431	)		(19,554	)		(25,232	)
2015 activity:
Pretax amount		4,634			(1,728	)		2,177			5,083
Income tax effect		(2,163	)		0			(817	)		(2,980	)
Change, net of income tax		2,471			(1,728	)		1,360			2,103
Balance, December 31, 2015, net of income tax	$	(776	)	$	(4,159	)	$	(18,194	)	$	(23,129	)

Accounting for Derivative Financial Investments and Hedging Activities

Stock-Based Compensation

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:

	Twelve Months Ended December 31,
	2015			2014			2013
Basic and diluted:
Net Income	$	750,698		$	604,996		$	554,023
Less: Net income attributable to noncontrolling interest		(70,170	)		(59,653	)		(43,290	)
Less: Net income attributable to unvested restricted share grants		(281	)		(236	)		(294	)
Net income attributable to UHS—basic and diluted	$	680,247		$	545,107		$	510,439
Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		98,797			98,826			98,033
Total basic earnings per share	$	6.89		$	5.52		$	5.21
Diluted earnings per share attributable to UHS:
Weighted average number of common shares		98,797			98,826			98,033
Net effect of dilutive stock options and grants based on the treasury stock method		1,897			1,718			1,328
Weighted average number of common shares and equivalents—diluted		100,694			100,544			99,361
Total diluted earnings per share	$	6.76		$	5.42		$	5.14

Fair Value of Financial Instruments

Use of Estimates

Mergers and Acquisitions

GPO Agreement/Minority Ownership Interest

Provider Taxes

Recent Accounting Standards

Y) Recent Accounting Standards:

Foreign Currency Translation

Business and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Uncompensated Care

	(dollar amounts in thousands)
	2015					2014					2013
	Amount		%			Amount		%			Amount		%
Charity care	$	506,571		42	%	$	515,435		45	%	$	593,474		59	%
Uninsured discounts		696,463		58	%		620,587		55	%		405,296		41	%
Total uncompensated care	$	1,203,034		100	%	$	1,136,022		100	%	$	998,770		100	%

Estimated Cost of Providing Uncompensated Care

	(amounts in thousands)
	2015		2014		2013
Estimated cost of providing charity care	$	77,557	$	78,475	$	95,675
Estimated cost of providing uninsured discounts related care		106,630		94,484		65,338
Estimated cost of providing uncompensated care	$	184,187	$	172,959	$	161,013

Changes in Carrying Amount of Goodwill

Changes in the carrying amount of goodwill for the two years ended December 31, 2015 were as follows (in thousands):

	Acute Care Services			Behavioral Health Services			Total Consolidated
Balance, January 1, 2014	$	383,011		$	2,666,005		$	3,049,016
Goodwill acquired during the period		4,088			246,124			250,212
Adjustments to goodwill (a)		0			(8,015	)		(8,015	)
Balance, December 31, 2014		387,099			2,904,114			3,291,213
Goodwill acquired during the period		2,480			316,427			318,907
Goodwill divested during the period		0			(1,497	)		(1,497	)
Adjustments to goodwill (a)		(72	)		(12,437	)		(12,509	)
Balance, December 31, 2015	$	389,507		$	3,206,607		$	3,596,114

Amounts Recognized in AOCI

The amounts recognized in AOCI for the two years ended December 31, 2015 were as follows (in thousands):

	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Foreign Currency Translation Adjustment			Minimum Pension Liability			Total AOCI
Balance, January 1, 2014, net of income tax	$	(14,170	)	$	0		$	(10,640	)	$	(24,810	)
2014 activity:
Pretax amount		17,332			(2,431	)		(14,270	)		631
Income tax effect		(6,409	)		0			5,356			(1,053	)
Change, net of income tax		10,923			(2,431	)		(8,914	)		(422	)
Balance, January 1, 2015, net of income tax		(3,247	)		(2,431	)		(19,554	)		(25,232	)
2015 activity:
Pretax amount		4,634			(1,728	)		2,177			5,083
Income tax effect		(2,163	)		0			(817	)		(2,980	)
Change, net of income tax		2,471			(1,728	)		1,360			2,103
Balance, December 31, 2015, net of income tax	$	(776	)	$	(4,159	)	$	(18,194	)	$	(23,129	)

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:

	Twelve Months Ended December 31,
	2015			2014			2013
Basic and diluted:
Net Income	$	750,698		$	604,996		$	554,023
Less: Net income attributable to noncontrolling interest		(70,170	)		(59,653	)		(43,290	)
Less: Net income attributable to unvested restricted share grants		(281	)		(236	)		(294	)
Net income attributable to UHS—basic and diluted	$	680,247		$	545,107		$	510,439
Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		98,797			98,826			98,033
Total basic earnings per share	$	6.89		$	5.52		$	5.21
Diluted earnings per share attributable to UHS:
Weighted average number of common shares		98,797			98,826			98,033
Net effect of dilutive stock options and grants based on the treasury stock method		1,897			1,718			1,328
Weighted average number of common shares and equivalents—diluted		100,694			100,544			99,361
Total diluted earnings per share	$	6.76		$	5.42		$	5.14

Acquisitions and Divestitures (Tables)

12 Months Ended

Dec. 31, 2015

Business Combinations [Abstract]

Aggregate Net Purchase Price Allocation to Assets and Liabilities based on Estimated Fair Values

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their preliminary estimated fair values as follows:

	Amount (000s)
Working capital, net	$	(7,000	)
Property & equipment		116,000
Goodwill		319,000
Other assets		128,000
Income tax assets, net of deferred tax liabilities		(22,000	)
Cash paid in 2015 for acquisitions	$	534,000

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their preliminary estimated fair values as follows:

	Amount (000s)
Working capital, net	$	(41,000	)
Property & equipment		174,000
Goodwill		250,000
Other assets		59,000
Income tax assets, net of deferred tax liabilities		4,000
Debt		(16,000	)
Other		1,000
Cash paid in 2014 for acquisitions	$	431,000

Results of Operations Reflected as Discontinued Operations

	2013
Net revenues	$	7,813
Income (loss) from discontinued operations, before income Taxes		932
Gain on divestiture		3,080
Income from discontinued operations, before income tax Expense		4,012
Income tax expense		(1,506	)
Income from discontinued operations, net of income taxes	$	2,506

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721533-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721665-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1474-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=51719941&loc=SL51724579-110230

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721663-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2941-110230

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721659-107760

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721671-107760

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5D
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721677-107760

+ Details

Long-Term Debt (Tables)

12 Months Ended

Dec. 31, 2015

Debt Disclosure [Abstract]

Summary of Long-Term Debt

A summary of long-term debt follows:

	December 31,
	2015			2014
	(amounts in thousands)
Long-term debt:
Notes payable and Mortgages payable (including obligations under capitalized leases of $24,900 in 2015 and $21,600 in 2014) and term loans with varying maturities through 2027; weighted average interest rates of 6.8% in 2015 and 6.4% in 2014 (see Note 7 regarding capitalized leases)	$	27,513		$	41,257
Revolving credit and on-demand credit facility		304,900			140,500
Term Loan A, net of unamortized discount of $1,593 in 2015 and $2,035 in 2014		1,717,940			1,761,872
Revenue bonds, interest at floating rates of 0.05% at December 31, 2014		—			5,300
Accounts receivable securitization program		400,000			330,000
3.75% Senior Secured Notes due 2019, net of unamortized discount of $155 in 2015 and $198 in 2014		299,845			299,802
4.75% Senior Secured Notes due 2022, net of unamortized discount of $177 in 2015 and $204 in 2014		299,823			299,796
7.125% Senior Secured Notes due 2016, including unamortized net premium of $4 in 2015 and $7 in 2014		400,004			400,007
Total debt		3,450,025			3,278,534
Less-Amounts due within one year		(62,722	)		(68,319	)
Long-term debt	$	3,387,303		$	3,210,215

Aggregate Scheduled Maturities of Debt Outstanding

The aggregate scheduled maturities of our total debt outstanding as of December 31, 2015 are as follows:

	(000s)
2016	$	62,722
2017		91,254
2018		491,514
2019		2,486,965
2020		1,650
Later		315,920
Total	$	3,450,025

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

Common Stock (Tables)

12 Months Ended

Dec. 31, 2015

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

	Additional dollars authorized for repurchase (in thousands)		Total number of shares purchased		Total number of shares cancelled		Average price paid per share for forfeited restricted shares	Total number of shares purchased as part of publicly announced programs		Average price pad per share for shares purchased as part of publicly announced program		Aggregate purchase price paid (in thousands)		Aggregate purchase price paid for shares purchased as part of publicly announced program		Maximum number of shares that may yet be purchased under the program		Maximum number of dollars that may yet be purchased under the program (in thousands)
Balance as of January 1, 2013																	767,704	N/A
2013		—		427,170		—	N/A		—	N/A		$	27,201	N/A			767,704	N/A
2014		400,000		1,029,164		767,704	N/A		548,192	$	105.71	$	100,749	$	57,950	N/A		$	342,050
2015	$	—		1,819,503		—	N/A		1,326,207	$	125.34	$	224,260	$	166,222	N/A		$	175,828
Total for three year period ended December 31, 2015	$	400,000		3,275,837		767,704	N/A		1,874,399	$	119.60	$	352,210	$	224,172

Weighted-Average Assumptions Fair Value of Option Grants

The weighted-average assumptions reflected below were based upon twenty-five option grants for the five-year period ending December 31, 2015, twenty-one option grants for the five-year period ending December 31, 2014 and eighteen option grants for the five-year period ended December 31, 2013.

Year Ended December 31,	2015			2014			2013
Volatility		33	%		35	%		36	%
Interest rate		1	%		1	%		1	%
Expected life (years)		3.4			3.4			3.6
Forfeiture rate		10	%		10	%		11	%
Dividend yield		0.4	%		0.4	%		0.5	%

Stock Option Activity

The table below summarizes our stock option activity during each of the last three years:

Outstanding Options	Number of Shares			Average Option Price		Range (High-Low)
Balance, January 1, 2013		7,436,238		$	36.31	$54.79-$16.22
Granted		2,889,750		$	53.51	$79.79-$53.38
Exercised		(2,288,666	)	$	32.27	$54.79-$16.22
Cancelled		(416,364	)	$	43.93	$53.38-$16.22
Balance, January 1, 2014		7,620,958		$	43.63	$79.79-$30.32
Granted		2,845,500		$	78.65	$102.21-$78.17
Exercised		(2,277,469	)	$	38.50	$73.65-$30.32
Cancelled		(291,538	)	$	55.63	$78.17-$36.95
Balance, January 1, 2015		7,897,451		$	57.29	$102.21-$36.95
Granted		3,039,350		$	117.70	$142.43-$108.29
Exercised		(2,256,454)		$	48.97	$102.21-$36.95
Cancelled		(280,164)		$	83.63	$134.70-$36.95
Balance, December 31, 2015		8,400,183		$	80.50	$142.43-$36.95
Outstanding options vested and exercisable as of December 31, 2015		1,671,216		$	52.19	$102.21-$36.95

Information about Unvested Options

The following table provides information about unvested options for the year December 31, 2015:

	Shares			Weighted Average Grant Date Fair Value
Unvested options as of January 1, 2015		6,485,029		$	14.36
Granted		3,039,350		$	21.37
Vested		(2,515,248	)	$	13.38
Cancelled		(280,164	)	$	17.36
Unvested options as of December 31, 2015		6,728,967		$	17.77

Information about all Outstanding Options

The following table provides information regarding all options outstanding at December 31, 2015:

	Options Outstanding		Options Exercisable
Number of options outstanding		8,400,183		1,671,216
Weighted average exercise price	$	80.50	$	52.19
Aggregate intrinsic value as of December 31, 2015	$	328,564,543	$	112,466,544
Weighted average remaining contractual life		3.0		1.9

Weighted Average Remaining Contractual Life for Options Outstanding and Weighted Average Exercise Price Per Share for Exercisable Options

The weighted average remaining contractual life for options outstanding and weighted average exercise price per share for exercisable options at December 31, 2015 were as follows:

Exercise Price	Options Outstanding		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)		Exercisable Options		Weighted Average Exercise Price Per Share		Expected to Vest Options (a)		Weighted Average Exercise Price Per Share
	Shares						Shares				Shares
$36.95 – $46.97		1,298,145	$	37.13		1.0		717,517	$	37.25		574,626	$	36.97
$53.38 – $73.65		1,805,950		53.49		2.0		571,450		53.45		1,098,889		53.50
$78.17 – $96.98		2,321,238		78.31		3.2		380,249		78.25		1,295,612		78.34
$102.21 – $142.43		2,974,850		117.54		4.2		2,000		102.21		1,980,776		117.52
Total		8,400,183	$	80.50		3.0		1,671,216	$	52.19		4,949,903	$	88.86

(a)	Assumes a weighted average forfeiture rate of 9.95%.

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2015

Income Tax Disclosure [Abstract]

Components of Income Tax Expense (Benefit)

Components of income tax expense/(benefit) are as follows (amounts in thousands):

	Year Ended December 31,
	2015			2014		2013
Current
Federal	$	363,734		$	248,172	$	256,545
Foreign		3,151			4,167		1,655
State		38,987			23,224		28,490
		405,872			275,563		286,690
Deferred
Federal		(15,912	)		41,583		25,341
Foreign		5,545			—		—
State		(302	)		7,525		3,278
		(10,669	)		49,108		28,619
Total	$	395,203		$	324,671	$	315,309

Components of Deferred Taxes

The components of deferred taxes are as follows (amounts in thousands):

	Year Ended December 31,
	2015			2014
Deferred income tax assets:
Self-insurance reserves	$	88,401		$	84,915
Compensation accruals		66,399			55,788
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets		62,541			60,521
Other currently non-deductible accrued liabilities		17,213			16,739
Net pension liability—OCI only		10,929			11,746
Doubtful accounts and other reserves		29,616			18,428
Other combined items—OCI only		457			2,615
		275,556			250,752
Less: Valuation Allowance		(52,567	)		(52,764	)
Net deferred income tax assets:		222,989			197,988
Deferred income tax liabilities:
Depreciable and amortizable assets		(400,809	)		(362,674	)
Other deferred tax liabilities		(2,960	)		(2,963	)
Net deferred income tax liabilities	$	(180,780	)	$	(167,649	)

Effective Tax Rates Calculation

	2015			2014			2013
Provision for income taxes	$	395,203		$	324,671		$	315,309
Income before income taxes		1,145,901			929,667			869,332
Effective tax rate		34.5	%		34.9	%		36.3	%

Reconciliation Between Federal Statutory Rate and Effective Tax Rate

A reconciliation between the federal statutory rate and the effective tax rate is as follows:

	Year Ended December 31,
	2015			2014			2013
Federal statutory rate		35.0	%		35.0	%		35.0	%
State taxes, net of federal income tax benefit		2.3	%		2.3	%		2.5	%
Divestiture gain		0.0	%		0.0	%		0.3	%
Other items		-0.6	%		0.0	%		0.4	%
Impact of income attributable to noncontrolling interests		-2.2	%		-2.4	%		-1.9	%
Effective tax rate		34.5	%		34.9	%		36.3	%

Net Deferred Tax Assets and Liabilities

The net deferred tax assets and liabilities are comprised as follows (amounts in thousands):

	Year Ended December 31,
	2015			2014
Current deferred taxes
Assets	$	135,120		$	115,870
Liabilities		—			(1,305	)
Total deferred taxes-current		135,120			114,565
Noncurrent deferred taxes
Assets		92,383			85,792
Liabilities		(408,283	)		(368,006	)
Total deferred taxes-noncurrent		(315,900	)		(282,214	)
Total deferred tax liabilities	$	(180,780	)	$	(167,649	)

Reconciliation of Unrecognized Tax Benefits

The tabular reconciliation of unrecognized tax benefits for the years ended December 31, 2015, 2014 and 2013 is as follows (amounts in thousands).

	As of December 31,
	2015			2014			2013
Balance at January 1,	$	2,402		$	3,369		$	6,824
Additions based on tax positions related to the current year		50			50			50
Additions for tax positions of prior years		111			195			283
Reductions for tax positions of prior years		(524	)		(1,212	)		(1,260	)
Settlements		(57	)		—			(2,528	)
Balance at December 31,	$	1,982		$	2,402		$	3,369

Lease Commitments (Tables)

12 Months Ended

Dec. 31, 2015

Leases [Abstract]

Summary of Property Under Capital Lease

A summary of property under capital lease follows (amounts in thousands):

	As of December 31,
	2015			2014
Land, buildings and equipment	$	45,665		$	40,782
Less: accumulated amortization		(27,169	)		(27,556	)
	$	18,496		$	13,226

Future Minimum Rental Payments Under Lease Commitments

Future minimum rental payments under lease commitments with a term of more than one year as of December 31, 2015, are as follows (amounts in thousands):

Year	Capital Leases			Operating Leases
	(000s)
2016	$	3,849		$	64,049
2017		3,929			42,989
2018		4,061			35,447
2019		3,996			29,721
2020		3,339			21,487
Later years		22,055			137,692
Total minimum rental	$	41,229		$	331,385
Less: Amount representing interest		(16,316	)
Present value of minimum rental commitments		24,913
Less: Current portion of capital lease obligations		(1,557	)
Long-term portion of capital lease obligations	$	23,356

Commitments and Contingencies (Table)

12 Months Ended

Dec. 31, 2015

Commitments And Contingencies Disclosure [Abstract]

Schedule of Changes in General and Professional Liability and Workers Compensation Reserves

Below is a schedule showing the changes in our general and professional liability and workers’ compensation reserves during the three years ended December 31, 2015 (amount in thousands):

	General and
	Professional			Workers’
	Liability			Compensation			Total
Balance at January 1, 2013	$	278,599		$	65,954		$	344,553
Plus: Accrued insurance expense, net of commercial premiums paid (a)		(35,182	)		31,361			(3,821	)
Less: Payments made in settlement of self-insured claims		(37,127	)		(33,517	)		(70,644	)
Balance at January 1, 2014		206,290			63,798			270,088
Plus: Accrued insurance expense, net of commercial premiums paid (a)		22,601			36,675			59,276
Less: Payments made in settlement of self-insured claims		(35,987	)		(33,659	)		(69,646	)
Balance at January 1, 2015		192,904			66,814			259,718
Plus: Accrued insurance expense, net of commercial premiums paid		58,460			32,435			90,895
Less: Payments made in settlement of self-insured claims		(47,391	)		(31,746	)		(79,137	)
Balance at December 31, 2015	$	203,973		$	67,503		$	271,476

(a)	General and professional liability amounts are net of adjustments recorded during 2014 and 2013, as discussed below.

Relationship with Universal Health Realty Income Trust and Other Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2015

Remaining Renewal Options and Terms for Each of Three Hospital Facilities Leased from Trust

The table below details the renewal options and terms for each of our three hospital facilities leased from the Trust:

Hospital Name

Type of Facility

Annual

Minimum

Rent

End of Lease Term

Renewal

Term

(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

Pension Plan (Tables)

12 Months Ended

Dec. 31, 2015

Compensation And Retirement Disclosure [Abstract]

Reconciliation of Defined Benefit Pension Plan

The following table shows the reconciliation of the defined benefit pension plan as of December 31, 2015 and 2014:

	2015			2014
	(000s)
Change in plan assets:
Fair value of plan assets at beginning of year	$	116,697		$	106,469
Actual return (loss) on plan assets		(3,223	)		16,470
Benefits paid		(6,086	)		(5,605	)
Administrative expenses		(549	)		(637	)
Fair value of plan assets at end of year	$	106,839		$	116,697
Change in benefit obligation:
Benefit obligation at beginning of year	$	127,342		$	103,558
Service cost		1,051			966
Interest cost		4,912			4,986
Benefits paid		(6,086	)		(5,605	)
Actuarial (gain) loss		(9,039	)		23,437
Benefit obligation at end of year	$	118,180		$	127,342
Amounts recognized in the Consolidated Balance Sheet:
Other non-current liabilities		11,341			10,645
Total amounts recognized at end of year	$	11,341		$	10,645

Components of Net Periodic Pension Cost (Benefit)

	2015			2014			2013
	(000s)
Components of net periodic cost (benefit)
Service cost	$	1,051		$	966		$	1,060
Interest cost		4,912			4,985			4,528
Expected return on plan assets		(6,254	)		(7,772	)		(7,601	)
Recognized actuarial loss		3,164			1,107			3,305
Net periodic cost	$	2,873		$	(714	)	$	1,292

Measurement Dates

	2015	2014
Measurement Dates
Benefit obligations	12/31/2015	12/31/2014
Fair value of plan assets	12/31/2015	12/31/2014

Weighted-average Assumptions for Net Periodic Benefit Cost

	2015			2014
Weighted average assumptions as of December 31
Discount rate		4.34	%		3.95	%
Rate of compensation increase		4.00	%		4.00	%

Weighted Average Assumptions

	2015			2014			2013
Weighted-average assumptions for net periodic benefit cost calculations
Discount rate		3.95	%		4.95	%		4.05	%
Expected long-term rate of return on plan assets		5.50	%		7.50	%		7.50	%
Rate of compensation increase		4.00	%		4.00	%		4.00	%

Market Values of Our Pension Plan Assets

The market values of our pension plan assets at December 31, 2015 and December 31, 2014 by asset category are as follows:

December 31, 2015	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	8,520	$	—	$	8,520	$	—
U.S. Mid Cap		2,613		—		2,613		—
U.S. Small Cap		2,649		—		2,649		—
International Developed		6,406		—		6,406		—
Emerging Markets		4,114		—		4,114		—
Fixed income:
Core Fixed Income		23,782		—		23,782		—
Long Duration Fixed Income		55,931		—		55,931		—
Real Estate:
REIT Fund		2,212		—		2,212		—
Cash/Currency:
Cash Equivalents		612		—		612		—
Total market value	$	106,839	$	—	$	106,839	$	—

December 31, 2014	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	9,212	$	—	$	9,212	$	—
U.S. Mid Cap		2,852		—		2,852		—
U.S. Small Cap		2,626		—		2,626		—
International Developed		6,181		—		6,181		—
Emerging Markets		4,139		—		4,139		—
Fixed income:
Core Fixed Income		27,062		—		27,062		—
Long Duration Fixed Income		61,718		—		61,718		—
Real Estate:
REIT Fund		2,395		—		2,395		—
Cash/Currency:
Cash Equivalents		512		—		512		—
Total market value	$	116,697	$	—	$	116,697	$	—

Estimated Future Benefit

There will be benefit payments under this plan beyond 2025.

Estimated Future Benefit Payments (000s)
2016	$	6,086
2017		6,343
2018		6,563
2019		6,753
2020		6,900
2021-2025		35,657
Total	$	68,302

Plan Assets

	2015			2014
Plan Assets
Asset Category
Equity securities		23	%		21	%
Fixed income securities		75	%		76	%
Other		2	%		3	%
Total		100	%		100	%

Asset Allocation Policy and Ranges Established in accordance with Overall Risk and Return Objectives of Portfolio

The following asset allocation policy and ranges have been established in accordance with the overall risk and return objectives of the portfolio:

	As of 12/31/2015			Permitted Range
Total Equity		23	%	10-30%
Total Fixed Income		75	%	70-90%
Other		2	%	0-10%

Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Segment Reporting

2015	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	16,847,944		$	7,456,397		$	—		$	24,304,341
Gross outpatient revenues	$	9,604,952		$	839,884		$	15,794		$	10,460,630
Total net revenues	$	4,632,564		$	4,400,335		$	10,552		$	9,043,451
Income (loss) before allocation of corporate overhead and income taxes	$	519,630		$	1,021,823		$	(395,552	)	$	1,145,901
Allocation of corporate overhead	$	(197,699	)	$	(117,203	)	$	314,902		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	321,931		$	904,620		$	(80,650	)	$	1,145,901
Total assets	$	3,413,879		$	5,867,088		$	353,146		$	9,634,113

2014	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	14,943,102		$	6,689,753			—		$	21,632,855
Gross outpatient revenues	$	8,147,031		$	784,309		$	34,238		$	8,965,578
Total net revenues	$	4,178,103		$	4,012,216		$	14,769		$	8,205,088
Income (loss) before allocation of corporate overhead and income taxes	$	465,328		$	944,068		$	(479,729	)	$	929,667
Allocation of corporate overhead	$	(178,781	)	$	(98,811	)	$	277,592		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	286,547		$	845,257		$	(202,137	)	$	929,667
Total assets	$	3,362,870		$	5,286,960		$	324,613		$	8,974,443

2013	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	13,469,269		$	6,294,046			—		$	19,763,315
Gross outpatient revenues	$	6,828,307		$	744,510		$	40,460		$	7,613,277
Total net revenues	$	3,602,874		$	3,725,513		$	39,486		$	7,367,873
Income (loss) before allocation of corporate overhead and income taxes	$	342,191		$	895,869		$	(368,728	)	$	869,332
Allocation of corporate overhead	$	(184,444	)	$	(89,447	)	$	273,891		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	157,747		$	806,422		$	(94,837	)	$	869,332
Total assets	$	3,125,626		$	4,966,182		$	219,915		$	8,311,723

Quarterly Results (Tables)

12 Months Ended

Dec. 31, 2015

Quarterly Financial Information Disclosure [Abstract]

Summary of Quarterly Financial Data

The following tables summarize the quarterly financial data for the two years ended December 31, 2015 and 2014:

2015	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	2,225,353	$	2,275,204	$	2,227,655	$	2,315,239	$	9,043,451
Net income	$	194,323	$	201,404	$	163,654	$	191,317	$	750,698
Less: Net income attributable to noncontrolling interests	$	20,024	$	19,211	$	13,367	$	17,568	$	70,170
Net income attributable to UHS	$	174,299	$	182,193	$	150,287	$	173,749	$	680,528
Earnings per share attributable to UHS-Basic:
Total basic earnings per share	$	1.76	$	1.84	$	1.52	$	1.76	$	6.89
Earnings per share attributable to UHS-Diluted:
Total diluted earnings per share	$	1.73	$	1.80	$	1.48	$	1.74	$	6.76

2014	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,938,314	$	2,051,766	$	2,038,717	$	2,176,291	$	8,205,088
Net income	$	151,852	$	166,614	$	96,038	$	190,492	$	604,996
Less: Net income attributable to noncontrolling interests	$	13,774	$	14,943	$	13,241	$	17,695	$	59,653
Net income attributable to UHS	$	138,078	$	151,671	$	82,797	$	172,797	$	545,343
Earnings per share attributable to UHS-Basic:
Total basic earnings per share	$	1.40	$	1.53	$	0.84	$	1.75	$	5.52
Earnings per share attributable to UHS-Diluted:
Total diluted earnings per share	$	1.38	$	1.51	$	0.82	$	1.71	$	5.42

Supplemental Condensed Consolidating Financial Information (Tables)

12 Months Ended

Dec. 31, 2015

Condensed Financial Information Of Parent Company Only Disclosure [Abstract]

Condensed Consolidating Statements of Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2015
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	6,798,664		$	3,018,364		$	(32,304	)	$	9,784,724
Less: Provision for doubtful accounts		0			481,294			259,979			0			741,273
Net revenues		0			6,317,370			2,758,385			(32,304	)		9,043,451
Operating charges:
Salaries, wages and benefits		0			3,014,296			1,198,091			0			4,212,387
Other operating expenses		0			1,459,607			690,341			(30,143	)		2,119,805
Supplies expense		0			583,644			390,444			0			974,088
Depreciation and amortization		0			280,985			117,633			0			398,618
Lease and rental expense		0			58,394			38,740			(2,161	)		94,973
Electronic health records incentive income		0			(12,232	)		(3,583	)		0			(15,815	)
		0			5,384,694			2,431,666			(32,304	)		7,784,056
Income from operations		0			932,676			326,719			0			1,259,395

Interest expense		107,665			4,695			1,134			0			113,494
Interest (income) expense, affiliate		0			86,494			(86,494	)		0			0
Equity in net income of consolidated affiliates		(746,984	)		(215,119	)		0			962,103			0
Income before income taxes		639,319			1,056,606			412,079			(962,103	)		1,145,901

Provision for income taxes		(41,209	)		354,611			81,801			0			395,203
Net income		680,528			701,995			330,278			(962,103	)		750,698

Less: Income attributable to noncontrolling interests		0			0			70,170			0			70,170
Net income attributable to UHS	$	680,528		$	701,995		$	260,108		$	(962,103	)	$	680,528

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	6,225,997		$	2,707,294		$	(29,220	)	$	8,904,071
Less: Provision for doubtful accounts		0			471,181			227,802			0			698,983
Net revenues		0			5,754,816			2,479,492			(29,220	)		8,205,088
Operating charges:
Salaries, wages and benefits		0			2,757,738			1,087,723			0			3,845,461
Other operating expenses		0			1,342,745			607,098			(27,100	)		1,922,743
Supplies expense		0			546,578			349,115			0			895,693
Depreciation and amortization		0			269,490			106,134			0			375,624
Lease and rental expense		0			58,619			37,494			(2,120	)		93,993
Electronic health records incentive income		0			(19,480	)		(8,422	)		0			(27,902	)
Costs related to extinguishment of debt		36,171			0			0			0			36,171
		36,171			4,955,690			2,179,142			(29,220	)		7,141,783
Income from operations		(36,171	)		799,126			300,350			0			1,063,305

Interest expense		127,528			4,516			1,594			0			133,638
Interest (income) expense, affiliate		0			88,246			(88,246	)		0			0
Equity in net income of consolidated affiliates		(646,386	)		(184,385	)		0			830,771			0
Income before income taxes		482,687			890,749			387,002			(830,771	)		929,667

Provision for income taxes		(62,656	)		305,320			82,007			0			324,671
Net income		545,343			585,429			304,995			(830,771	)		604,996

Less: Income attributable to noncontrolling interests		0			0			59,653			0			59,653
Net income attributable to UHS	$	545,343		$	585,429		$	245,342		$	(830,771	)	$	545,343

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	5,734,385		$	2,789,348		$	(28,644	)	$	8,495,089
Less: Provision for doubtful accounts		0			657,106			470,110			0			1,127,216
Net revenues		0			5,077,279			2,319,238			(28,644	)		7,367,873
Operating charges:
Salaries, wages and benefits		0			2,573,205			1,031,415			0			3,604,620
Other operating expenses		0			1,047,856			531,747			(26,808	)		1,552,795
Supplies expense		0			510,078			311,011			0			821,089
Depreciation and amortization		0			236,958			100,214			0			337,172
Lease and rental expense		0			62,518			37,076			(1,836	)		97,758
Electronic health records incentive income		0			(43,027	)		(17,997	)		0			(61,024	)
		0			4,387,588			1,993,466			(28,644	)		6,352,410
Income from operations		0			689,691			325,772			0			1,015,463

Interest expense		139,793			3,365			2,973			0			146,131
Interest (income) expense, affiliate		0			84,640			(84,640	)		0			0
Equity in net income of consolidated affiliates		(597,020	)		(141,004	)		0			738,024			0
Income before income taxes		457,227			742,690			407,439			(738,024	)		869,332

Provision for income taxes		(53,506	)		262,346			106,469			0			315,309
Net income		510,733			480,344			300,970			(738,024	)		554,023

Less: Income attributable to noncontrolling interests		0			0			43,290			0			43,290
Net income attributable to UHS	$	510,733		$	480,344		$	257,680		$	(738,024	)	$	510,733

Condensed Consolidating Statements of Comprehensive Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2015
(amounts in thousands)

	Parent			Guarantors			Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	680,528		$	701,995		$	330,278	$	(962,103	)	$	750,698
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		4,970			0			0		0			4,970
Amortization of terminated hedge		(336	)		0			0		0			(336	)
Minimum pension liability		2,177			2,177			0		(2,177	)		2,177
Foreign currency translation adjustment		(1,728	)		(1,728	)		0		1,728			(1,728	)
Other comprehensive income before tax		5,083			449			0		(449	)		5,083
Income tax expense related to items of other comprehensive income		2,980			817			0		(817	)		2,980
Total other comprehensive income, net of tax		2,103			(368	)		0		368			2,103
Comprehensive income		682,631			701,627			330,278		(961,735	)		752,801
Less: Comprehensive income attributable to noncontrolling interests		0			0			70,170		0			70,170
Comprehensive income attributable to UHS	$	682,631		$	701,627		$	260,108	$	(961,735	)	$	682,631

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014
(amounts in thousands)

	Parent			Guarantors			Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	545,343		$	585,429		$	304,995	$	(830,771	)	$	604,996
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		17,668			0			0		0			17,668
Amortization of terminated hedge		(336	)		0			0		0			(336	)
Minimum pension liability		(14,270	)		(14,270	)		0		14,270			(14,270	)
Foreign currency translation adjustment		(2,431	)		(2,431	)		0		2,431			(2,431	)
Other comprehensive income before tax		631			(16,701	)		0		16,701			631
Income tax expense related to items of other comprehensive income		1,053			(5,356	)		0		5,356			1,053
Total other comprehensive income, net of tax		(422	)		(11,345	)		0		11,345			(422	)
Comprehensive income		544,921			574,084			304,995		(819,426	)		604,574
Less: Comprehensive income attributable to noncontrolling interests		0			0			59,653		0			59,653
Comprehensive income attributable to UHS	$	544,921		$	574,084		$	245,342	$	(819,426	)	$	544,921

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013
(amounts in thousands)

	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	510,733		$	480,344	$	300,970	$	(738,024	)	$	554,023
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		16,963			0		0		0			16,963
Amortization of terminated hedge		(336	)		0		0		0			(336	)
Minimum pension liability		14,657			14,657		0		(14,657	)		14,657
Other comprehensive income before tax		31,284			14,657		0		(14,657	)		31,284
Income tax expense related to items of other comprehensive income		11,940			5,670		0		(5,670	)		11,940
Total other comprehensive income, net of tax		19,344			8,987		0		(8,987	)		19,344
Comprehensive income		530,077			489,331		300,970		(747,011	)		573,367
Less: Comprehensive income attributable to noncontrolling interests		0			0		43,290		0			43,290
Comprehensive income attributable to UHS	$	530,077		$	489,331	$	257,680	$	(747,011	)	$	530,077

Condensed Consolidating Balance Sheet

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEET
AS OF DECEMBER 31, 2015
(amounts in thousands)

	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	47,192		$	14,036		$	0		$	61,228
Accounts receivable, net		0		918,699			383,730			0			1,302,429
Supplies		0		72,499			43,538			0			116,037
Deferred income taxes		132,975		2,145			0			0			135,120
Other current assets		0		89,973			13,517			0			103,490
Total current assets		132,975		1,130,508			454,821			0			1,718,304

Investments in subsidiaries		7,760,156		1,876,415			0			(9,636,571	)		0

Intercompany receivable		80,764		0			747,709			(828,473	)		0
Intercompany note receivable		0		0			1,242,937			(1,242,937	)		0

Property and equipment		0		4,722,050			1,808,519			0			6,530,569
Less: accumulated depreciation		0		(1,845,746	)		(848,845	)		0			(2,694,591	)
		0		2,876,304			959,674			0			3,835,978
Other assets:
Goodwill		0		3,070,061			526,053			0			3,596,114
Deferred charges		25,877		5,530			3,950			0			35,357
Other		14,251		394,998			39,111			0			448,360
	$	8,014,023	$	9,353,816		$	3,974,255		$	(11,707,981	)	$	9,634,113
Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	60,368	$	1,223		$	1,131		$	0		$	62,722
Accounts payable and accrued liabilities		19,996		744,137			269,564			0			1,033,697
Federal and state taxes		3,987		0			0			0			3,987
Total current liabilities		84,351		745,360			270,695			0			1,100,406

Intercompany payable		0		828,473			0			(828,473	)		0
Intercompany note payable		0		1,242,937			0			(1,242,937	)		0

Other noncurrent liabilities		1,982		206,287			70,565			0			278,834
Long-term debt		3,362,143		16,790			8,370			0			3,387,303
Deferred income taxes		315,900		0			0			0			315,900

Redeemable noncontrolling interests		0		0			242,509			0			242,509
Equity:
UHS common stockholders’ equity		4,249,647		6,313,969			3,322,602			(9,636,571	)		4,249,647
Noncontrolling interest		0		0			59,514			0			59,514
Total equity		4,249,647		6,313,969			3,382,116			(9,636,571	)		4,309,161
	$	8,014,023	$	9,353,816		$	3,974,255		$	(11,707,981	)	$	9,634,113

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEET
AS OF DECEMBER 31, 2014
(amounts in thousands)

	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	21,784		$	10,285		$	0		$	32,069
Accounts receivable, net		0		933,971			348,764			0			1,282,735
Supplies		0		67,847			40,268			0			108,115
Deferred income taxes		113,822		743			0			0			114,565
Other current assets		0		62,431			15,223			0			77,654
Total current assets		113,822		1,086,776			414,540			0			1,615,138

Investments in subsidiaries		7,013,540		1,661,296			0			(8,674,836	)		0

Intercompany receivable		103,808		0			408,682			(512,490	)		0
Intercompany note receivable		0		0			1,222,637			(1,222,637	)		0

Property and equipment		0		4,494,567			1,717,463			0			6,212,030
Less: accumulated depreciation		0		(1,686,192	)		(846,149	)		0			(2,532,341	)
		0		2,808,375			871,314			0			3,679,689
Other assets:
Goodwill		0		2,764,555			526,658			0			3,291,213
Deferred charges		32,379		5,402			2,538			0			40,319
Other		9,601		283,302			55,181			0			348,084
	$	7,273,150	$	8,609,706		$	3,501,550		$	(10,409,963	)	$	8,974,443
Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	44,874	$	1,260		$	22,185		$	0		$	68,319
Accounts payable and accrued liabilities		20,245		1,051,309			41,508			0			1,113,062
Federal and state taxes		1,446		0			0			0			1,446
Total current liabilities		66,565		1,052,569			63,693			0			1,182,827

Intercompany payable		0		512,490			0			(512,490	)		0
Intercompany note payable		0		1,222,637			0			(1,222,637	)		0

Other noncurrent liabilities		1,322		189,456			77,777			0			268,555
Long-term debt		3,187,103		20,212			2,900			0			3,210,215
Deferred income taxes		282,214		0			0			0			282,214

Redeemable noncontrolling interests		0		0			239,552			0			239,552
Equity:
UHS common stockholders’ equity		3,735,946		5,612,342			3,062,494			(8,674,836	)		3,735,946
Noncontrolling interest		0		0			55,134			0			55,134
Total equity		3,735,946		5,612,342			3,117,628			(8,674,836	)		3,791,080
	$	7,273,150	$	8,609,706		$	3,501,550		$	(10,409,963	)	$	8,974,443

Condensed Consolidating Statements of Cash Flows

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2015
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash (used in) provided by operating activities	$	(21,287	)	$	655,439		$	386,746		$	0	$	1,020,898

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(209,355	)		(169,966	)		0		(379,321	)
Acquisition of property and businesses					(513,382	)		(20,273	)				(533,655	)
Proceeds received from sale of assets and businesses		0			647			2,744			0		3,391
Increase in insurance subsidiary investments		0			(3,300	)		0			0		(3,300	)
Net cash used in investing activities		0			(725,390	)		(187,495	)		0		(912,885	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(42,133	)		(3,459	)		(22,574	)		0		(68,166	)
Additional borrowings		234,400			0			0			0		234,400
Financing costs		(515	)		0			0			0		(515	)
Repurchase of common shares		(209,782	)		0			0			0		(209,782	)
Dividends paid		(39,532	)		0			0			0		(39,532	)
Issuance of common stock		8,441			0			0			0		8,441
Excess income tax benefits related to stock-based compensation		47,364			0			0			0		47,364
Profit distributions to noncontrolling interests		0			0			(62,220	)		0		(62,220	)
Proceeds received from sale/leaseback of real property		0			0			12,765			0		12,765
Changes in intercompany balances with affiliates, net		23,044			100,427			(123,471	)		0		0
Net cash provided by (used in) financing activities		21,287			96,968			(195,500	)		0		(77,245	)

Effect of exchange rate changes on cash and cash equivalents		0			(1,609	)		0			0		(1,609	)

Increase in cash and cash equivalents		0			25,408			3,751			0		29,159
Cash and cash equivalents, beginning of period		0			21,784			10,285			0		32,069
Cash and cash equivalents, end of period	$	0		$	47,192		$	14,036		$	0	$	61,228

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	18,579		$	687,101		$	330,196		$	0	$	1,035,876

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(230,102	)		(161,048	)		0		(391,150	)
Acquisition of property and businesses		0			(422,081	)		(9,305	)		0		(431,386	)
Proceeds received from sale of assets and businesses		0			11,450			3,728			0		15,178
Costs incurred for purchase and implementation of electronic health records application		0			(13,488	)		0			0		(13,488	)
Increase in insurance subsidiary investments		0			(12,000	)		0			0		(12,000	)
Net cash used in investing activities		0			(666,221	)		(166,625	)		0		(832,846	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(866,748	)		(867	)		(11,514	)		0		(879,129	)
Additional borrowings		830,000			0			0			0		830,000
Financing costs		(14,976	)		0			0			0		(14,976	)
Repurchase of common shares		(100,749	)		0			0			0		(100,749	)
Dividends paid		(29,665	)		0			0			0		(29,665	)
Issuance of common stock		6,863			0			0			0		6,863
Excess income tax benefits related to stock-based compensation		33,912			0			0			0		33,912
Profit distributions to noncontrolling interests		0			0			(33,680	)		0		(33,680	)
Changes in intercompany balances with affiliates, net		122,784			(5,444	)		(117,340	)		0		0
Net cash used in financing activities		(18,579	)		(6,311	)		(162,534	)		0		(187,424	)

Effect of exchange rate changes on cash and cash equivalents		0			(775	)		0			0		(775	)

Increase in cash and cash equivalents		0			13,794			1,037			0		14,831
Cash and cash equivalents, beginning of period		0			7,990			9,248			0		17,238
Cash and cash equivalents, end of period	$	0		$	21,784		$	10,285		$	0	$	32,069

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013
(amounts in thousands)

	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	17,946		$	587,083		$	279,212		$	0	$	884,241

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(269,419	)		(89,074	)		0		(358,493	)
Acquisition of property and businesses		0			(8,094	)		(4,542	)		0		(12,636	)
Proceeds received from sale of assets and businesses		0			7,916			29,566			0		37,482
Costs incurred for purchase and implementation of electronic health records application		0			(49,811	)		0			0		(49,811	)
Net cash used in investing activities		0			(319,408	)		(64,050	)		0		(383,458	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(429,996	)		(109	)		(10,119	)		0		(440,224	)
Additional borrowings		15,761			0			0			0		15,761
Financing costs		(231	)		0			0			0		(231	)
Repurchase of common shares		(27,201	)		0			0			0		(27,201	)
Dividends paid		(19,621	)		0			0			0		(19,621	)
Issuance of common stock		5,708			0			0			0		5,708
Excess income tax benefits related to stock-based compensation		20,121			0			0			0		20,121
Profit distributions to noncontrolling interests		0			0			(61,329	)		0		(61,329	)
Changes in intercompany balances with affiliates, net		417,513			(271,525	)		(145,988	)		0		0
Net cash used in financing activities		(17,946	)		(271,634	)		(217,436	)		0		(507,016	)

Decrease in cash and cash equivalents		0			(3,959	)		(2,274	)		0		(6,233	)
Cash and cash equivalents, beginning of period		0			11,949			11,522			0		23,471
Cash and cash equivalents, end of period	$	0		$	7,990		$	9,248		$	0	$	17,238

Business and Summary of Significant Accounting Policies - Additional Information (Detail)				12 Months Ended
	Oct. 01, 2015 USD ($)	Sep. 01, 2015 USD ($)	Jan. 01, 2014	Dec. 31, 2015 USD ($) Facility shares	Dec. 31, 2014 USD ($) shares	Dec. 31, 2013 USD ($) shares
Summary Of Business And Significant Accounting Policies [Line Items]
Establishment of partial reserve in the allowance for doubtful accounts for self-pay balances outstanding from the date of discharge, in days				90 days
Establishment of fully reserve for self-pay balances outstanding from the date of discharge, in days				90 days
Establishment of fully reserve in the allowance for doubtful accounts for third party liability accounts from the date of discharge, in days				180 days
Patients treated at hospitals for non elective services gross income less than federal poverty guidelines				400.00%
Percentage of uninsured discount extended for unqualified charity patients after modification			60.00%
Percentage of uninsured discount extended for unqualified charity patients before modification			30.00%
Net of allowance for doubtful accounts				$ 399,000,000	$ 325,000,000
Provision for doubtful accounts				741,273,000	698,983,000	$ 1,127,216,000
Capitalize interest expense				304,000	0	4,900,000
Depreciation expense				337,500,000	314,500,000	285,600,000
Impairment of goodwill or indefinite-lived intangible assets	$ 0	$ 0			0	$ 0
Intangible assets, net				219,000,000	98,000,000
Intangible assets, net of accumulated amortization				25,000,000	19,000,000
Amount of estimated future payments related to physician-related contractual commitments				1,000,000	2,000,000
Amount of potential future financial obligations				$ 1,000,000
Acute care facilities with outside owners holding non-controlling minority interest \| Facility				6
Redeemable non-controlling interest balances				$ 243,000,000	240,000,000
Non-controlling interest balances				60,000,000	55,000,000
Net favorable cash inflows associated with forward exchange contracts				$ 22,900,000	$ 15,600,000
Anti-dilutive weighted average stock options excluded from computation of earnings per share \| shares				765,000	2,250	4,000
Revenue from Medicaid programs				$ 9,784,724,000	$ 8,904,071,000	$ 8,495,089,000
Increase (decrease) in net revenue					140,000,000
Increase (decrease) in other operating expense						84,000,000
State Medicaid programs
Summary Of Business And Significant Accounting Policies [Line Items]
Revenue from Medicaid programs				307,000,000	295,000,000	213,000,000
Revenue offset amount				137,000,000	140,000,000	84,000,000
Net aggregate benefit				170,000,000	155,000,000	130,000,000
Net revenues				46,000,000	59,000,000	$ 54,000,000
Restricted Stock
Summary Of Business And Significant Accounting Policies [Line Items]
Restricted stock, vesting period						7 years
Tradename
Summary Of Business And Significant Accounting Policies [Line Items]
Intangible assets, net				124,000,000
Medicare Licenses
Summary Of Business And Significant Accounting Policies [Line Items]
Intangible assets, net				57,000,000	57,000,000
Certificates of Need
Summary Of Business And Significant Accounting Policies [Line Items]
Intangible assets, net				12,000,000	12,000,000
Contract Relationships and Other
Summary Of Business And Significant Accounting Policies [Line Items]
Intangible assets, net				$ 25,000,000
Contract Relationships
Summary Of Business And Significant Accounting Policies [Line Items]
Intangible assets, net					29,000,000
Building and Building Improvements \| Minimum
Summary Of Business And Significant Accounting Policies [Line Items]
Property and equipment, useful lives, maximum years				20 years
Building and Building Improvements \| Maximum
Summary Of Business And Significant Accounting Policies [Line Items]
Property and equipment, useful lives, maximum years				40 years
Equipment \| Minimum
Summary Of Business And Significant Accounting Policies [Line Items]
Property and equipment, useful lives, maximum years				3 years
Equipment \| Maximum
Summary Of Business And Significant Accounting Policies [Line Items]
Property and equipment, useful lives, maximum years				15 years
Acute Care Hospitals
Summary Of Business And Significant Accounting Policies [Line Items]
Provision for doubtful accounts				$ 631,000,000	$ 590,000,000	$ 1,020,000,000
Medicare And Medicaid \| Net Revenue \| Customer Concentration Risk
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of revenue				35.00%	38.00%	39.00%
Care Entities \| Net Revenue
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of revenue				52.00%	50.00%	49.00%
Illinois
Summary Of Business And Significant Accounting Policies [Line Items]
Accounts receivable				$ 28,000,000	$ 44,000,000
Illinois \| Financing Receivables in Excess 60 Days Past Due
Summary Of Business And Significant Accounting Policies [Line Items]
Receivables due outstanding in excess of 60 days				12,000,000	23,000,000
Texas
Summary Of Business And Significant Accounting Policies [Line Items]
Accounts receivable				80,000,000	$ 102,000,000
Texas \| Uncompensated Care Program
Summary Of Business And Significant Accounting Policies [Line Items]
Accounts receivable				47,000,000
Texas \| Disproportionate Share Hospital Program
Summary Of Business And Significant Accounting Policies [Line Items]
Accounts receivable				9,000,000
Texas \| Delivery System Reform Incentive Pool
Summary Of Business And Significant Accounting Policies [Line Items]
Accounts receivable				$ 24,000,000
Las Vegas, Nevada \| Acute Care Facilities
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of non-controlling, minority ownership interests held by outside owners				28.00%
Las Vegas, Nevada \| Net Revenue \| Geographic Concentration Risk
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of revenue				13.00%	14.00%	14.00%
Washington, District of Columbia \| Acute Care Facilities
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of non-controlling, minority ownership interests held by outside owners				20.00%
Laredo, Texas \| Acute Care Facilities
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of non-controlling, minority ownership interests held by outside owners				11.00%
Philadelphia, Pennsylvania \| Behavioral Health Care Facility
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of non-controlling, minority ownership interests held by outside owners				20.00%

Summary of Changes in Carrying Amount of Goodwill (Detail) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Goodwill [Line Items]

Goodwill, Beginning Balance

$ 3,291,213

$ 3,049,016

Goodwill acquired during the period

318,907

250,212

Goodwill divested during the period

(1,497)

Adjustments to goodwill

^[1]

(12,509)

(8,015)

Goodwill, Ending Balance

3,596,114

3,291,213

Acute Care Services

Goodwill [Line Items]

Goodwill, Beginning Balance

387,099

383,011

Goodwill acquired during the period

2,480

4,088

Goodwill divested during the period

Adjustments to goodwill

^[1]

(72)

Goodwill, Ending Balance

389,507

387,099

Behavioral Health Services

Goodwill [Line Items]

Goodwill, Beginning Balance

2,904,114

2,666,005

Goodwill acquired during the period

316,427

246,124

Goodwill divested during the period

(1,497)

Adjustments to goodwill

^[1]

(12,437)

(8,015)

Goodwill, Ending Balance

$ 3,206,607

$ 2,904,114

[1]	The decrease in the Behavioral Health Services’ goodwill consists primarily of foreign currency translation adjustments.

Amounts Recognized in AOCI (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, beginning balance	$ (3,247)	$ (14,170)
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Pre tax amount	4,634	17,332
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Income tax effect	(2,163)	(6,409)
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Change, net of income tax	2,471	10,923
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, ending balance	(776)	(3,247)	$ (14,170)
Foreign Currency Translation Adjustment, beginning balance	(2,431)	0
Foreign Currency Translation Adjustment, Pretax amount	(1,728)	(2,431)	0
Foreign Currency Translation Adjustment, Income tax effect	0	0
Foreign Currency Translation Adjustment, Change, net of income tax	(1,728)	(2,431)
Foreign Currency Translation Adjustment, ending balance	(4,159)	(2,431)	0
Minimum Pension Liability, beginning balance	(19,554)	(10,640)
Minimum Pension Liability, Pre tax amount	2,177	(14,270)
Minimum pension liability, income tax effect	(817)	5,356	5,670
Minimum Pension Liability, Change, net of income tax	1,360	(8,914)
Minimum Pension Liability, ending balance	(18,194)	(19,554)	(10,640)
Total AOCI, beginning balance	(25,232)	(24,810)
Total AOCI, Pre tax amount	5,083	631	31,284
Total AOCI, Income tax effect	(2,980)	(1,053)	(11,940)
Total AOCI, Change, net of income tax	2,103	(422)	19,344
Total AOCI, ending balance	$ (23,129)	$ (25,232)	$ (24,810)

Computation of Basic and Diluted Earnings per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Basic and diluted:
Net Income									$ 750,698	$ 604,996	$ 554,023
Less: Net income attributable to noncontrolling interest									(70,170)	(59,653)	(43,290)
Less: Net income attributable to unvested restricted share grants									(281)	(236)	(294)
Net income attributable to UHS—basic and diluted									$ 680,247	$ 545,107	$ 510,439
Weighted average number of common shares—basic									98,797	98,826	98,033
Total basic earnings per share	$ 1.76	$ 1.52	$ 1.84	$ 1.76	$ 1.75	$ 0.84	$ 1.53	$ 1.40	$ 6.89	$ 5.52	$ 5.21
Weighted average number of common shares									98,797	98,826	98,033
Net effect of dilutive stock options and grants based on the treasury stock method									1,897	1,718	1,328
Weighted average number of common shares and equivalents—diluted									100,694	100,544	99,361
Total diluted earnings per share	$ 1.74	$ 1.48	$ 1.80	$ 1.73	$ 1.71	$ 0.82	$ 1.51	$ 1.38	$ 6.76	$ 5.42	$ 5.14

Acquisitions and Divestitures - Additional Information (Detail) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015 USD ($) Facility Bed	Sep. 30, 2015 USD ($) Bed Hospital	Jun. 30, 2015 USD ($)	Mar. 31, 2015 USD ($) Bed	Dec. 31, 2014 USD ($) Bed	Sep. 30, 2014 USD ($) Facility Bed Hospital	Jun. 30, 2014 USD ($) Bed	Mar. 31, 2014 USD ($) Bed	Dec. 31, 2015 USD ($) Facility $ / shares	Dec. 31, 2014 USD ($) Bed $ / shares	Dec. 31, 2013 USD ($) Facility $ / shares	Dec. 31, 2012 Bed
Business Acquisition [Line Items]
Number of hospitals \| Facility									3		3
Indefinite lived Tradenames	$ 124,000								$ 124,000
Net revenues	$ 2,315,239	$ 2,227,655	$ 2,275,204	$ 2,225,353	$ 2,176,291	$ 2,038,717	$ 2,051,766	$ 1,938,314	9,043,451	$ 8,205,088	$ 7,367,873
Unaudited pro forma net revenues									9,170,000	8,350,000
Unaudited pro forma net income attributable to UHS									$ 690,000	$ 545,000
Unaudited pro forma net income attributable to UHS per diluted share \| $ / shares									$ 6.85	$ 5.42
Aggregate cash proceeds from divestiture of businesses									$ 3,000	$ 15,000
Aggregate pre-tax net gain on the divestiture											3,080
2013 Divestiture of Assets and Businesses \| Peak Behavioral Health Services
Business Acquisition [Line Items]
Net cash proceeds from divestiture of assets and businesses							24,000				37,000
Aggregate pre-tax net gain on the divestiture							$ 3,000				3,000
2012 Divestiture of Assets and Businesses \| Peak Behavioral Health Services
Business Acquisition [Line Items]
Number of beds \| Bed												104
2015 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Acquisition, cash paid									534,000
Net revenues									$ 30,000
Behavioral Health Services
Business Acquisition [Line Items]
Number of beds \| Bed				46
Alpha Hospitals Holdings Limited
Business Acquisition [Line Items]
Number of beds \| Bed		305
Number of hospitals \| Hospital		4
Foundations Recovery Network, LLC
Business Acquisition [Line Items]
Number of beds \| Bed	322
Number of facilities \| Facility	4
Number of outpatient centers \| Facility	8
2014 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Acquisition, cash paid										431,000
Unaudited pro forma net revenues										8,280,000
Unaudited pro forma net income attributable to UHS										$ 558,000
Unaudited pro forma net income attributable to UHS per diluted share \| $ / shares										$ 5.55
2013 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Acquisition, cash paid											13,000
Unaudited pro forma net revenues											7,620,000
Unaudited pro forma net income attributable to UHS											$ 522,000
Unaudited pro forma net income attributable to UHS per diluted share \| $ / shares											$ 5.25
Cygnet Health Care Limited
Business Acquisition [Line Items]
Number of beds \| Bed						723				124
Number of hospitals \| Hospital						15
Number of facilities \| Facility						17
Net revenues										$ 175,000
Number of nursing homes \| Hospital						2
Acquired Company Two
Business Acquisition [Line Items]
Number of beds \| Bed							124
Palo Verde Behavioral Health
Business Acquisition [Line Items]
Number of beds \| Bed								48
The Bridgeway
Business Acquisition [Line Items]
Number of beds \| Bed					103
Cygnet Hospital-Harrow
Business Acquisition [Line Items]
Number of beds \| Bed					44

Aggregate Net Purchase Price Allocation to Assets and Liabilities based on Estimated Fair Values (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Business Acquisition [Line Items]
Goodwill	$ 3,596,114	$ 3,291,213	$ 3,049,016
2015 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Working capital, net	(7,000)
Property & equipment	116,000
Goodwill	319,000
Other assets	128,000
Income tax assets, net of deferred tax liabilities	(22,000)
Cash paid for acquisitions	$ 534,000
2014 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Working capital, net		(41,000)
Property & equipment		174,000
Goodwill		250,000
Other assets		59,000
Income tax assets, net of deferred tax liabilities		4,000
Debt		(16,000)
Other		1,000
Cash paid for acquisitions		$ 431,000

Results of Operations Reflected as Discontinued Operations (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2013 USD ($)
Business Combinations [Abstract]
Net revenues	$ 7,813
Income (loss) from discontinued operations, before income Taxes	932
Gain on divestiture	3,080
Income from discontinued operations, before income tax Expense	4,012
Income tax expense	(1,506)
Income from discontinued operations, net of income taxes	$ 2,506

- Definition

Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

+ References + Details

- Definition

Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.

+ References + Details

- Definition

Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.12)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.14)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3B
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 13
-Article 7

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 15
-Article 5

+ Details

Financial Instruments - Additional Information (Detail)	3 Months Ended				12 Months Ended
Financial Instruments - Additional Information (Detail)	Dec. 31, 2015 USD ($) Derivative	Sep. 30, 2015 USD ($) Derivative	Jun. 30, 2015 USD ($) Derivative	Mar. 31, 2011 USD ($) Derivative	Dec. 31, 2015 USD ($) Derivative	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Derivative [Line Items]
Number of additional forward starting interest rate swaps \| Derivative		4		7
Maturity date of interest rate cash flow hedges				May 31, 2015
Two Point Three Eight Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Number of additional forward starting interest rate swaps \| Derivative				4
Fixed rate payable on interest rate swap				2.38%
One Point Nine One Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Number of additional forward starting interest rate swaps \| Derivative				3
Fixed rate payable on interest rate swap				1.91%
One Point Three One Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Number of additional forward starting interest rate swaps \| Derivative					9
Maturity date of interest rate cash flow hedges					Apr. 15, 2019
Fixed rate payable on interest rate swap	1.31%				1.31%
One Point Four Zero Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Number of additional forward starting interest rate swaps \| Derivative			4
Maturity date of interest rate cash flow hedges			Apr. 15, 2019
Fixed rate payable on interest rate swap			1.40%
One Point Two Three Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Maturity date of interest rate cash flow hedges		Apr. 15, 2019
Average fixed rate payable on interest rate swap		1.23%
One Point Two One Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Number of additional forward starting interest rate swaps \| Derivative	1
Maturity date of interest rate cash flow hedges	Apr. 19, 2019
Fixed rate payable on interest rate swap	1.21%				1.21%
Interest Rate Swap
Derivative [Line Items]
Fair value of our interest rate swaps, net	$ 1,000,000				$ 1,000,000	$ 6,000,000
Fair value of our interest rate swaps, liability	6,000,000				6,000,000	6,000,000
Fair value of our interest rate swaps, asset	5,000,000				5,000,000
Fair Value Hedge
Derivative [Line Items]
Fair value of hedges outstanding	0				0	$ 0	$ 0
Cash Flow Hedging
Derivative [Line Items]
Notional amount of interest rate cash flow hedges				$ 825,000,000
Cash Flow Hedging \| Two Point Three Eight Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Notional amount of interest rate cash flow hedges				600,000,000
Cash Flow Hedging \| One Point Nine One Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Notional amount of interest rate cash flow hedges				$ 225,000,000
Cash Flow Hedging \| One Point Three One Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Notional amount of interest rate cash flow hedges	1,000,000,000				1,000,000,000
Cash Flow Hedging \| One Point Four Zero Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Notional amount of interest rate cash flow hedges			$ 500,000,000
Cash Flow Hedging \| Forward Starting Interest Rate Swaps
Derivative [Line Items]
Notional amount of interest rate cash flow hedges		$ 400,000,000
Cash Flow Hedging \| One Point Two Three Percent Forward Starting Interest Rate Swaps One
Derivative [Line Items]
Notional amount of interest rate cash flow hedges		100,000,000
Cash Flow Hedging \| One Point Two Three Percent Forward Starting Interest Rate Swaps \| Interest Rate Swap Two
Derivative [Line Items]
Notional amount of interest rate cash flow hedges		200,000,000
Cash Flow Hedging \| One Point Two Three Percent Forward Starting Interest Rate Swaps Three
Derivative [Line Items]
Notional amount of interest rate cash flow hedges		$ 100,000,000
Cash Flow Hedging \| One Point Two One Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Notional amount of interest rate cash flow hedges	$ 100,000,000				$ 100,000,000

Summary of Long-Term Debt (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Total debt	$ 3,450,025	$ 3,278,534
Less-Amounts due within one year	(62,722)	(68,319)
Long-term debt	3,387,303	3,210,215
Term Loan A
Debt Instrument [Line Items]
Line of credit facility amount outstanding	1,717,940	1,761,872
3.750% Senior Secured Notes due 2019
Debt Instrument [Line Items]
Senior Notes	299,845	299,802
4.750% Senior Secured Notes due 2022
Debt Instrument [Line Items]
Senior Notes	299,823	299,796
7.125% Senior Secured Notes due 2016
Debt Instrument [Line Items]
Senior Notes	400,004	400,007
Notes Payable And Mortgages Payable
Debt Instrument [Line Items]
Notes payable and Mortgages payable (including obligations under capitalized leases of $24,900 in 2015 and $21,600 in 2014) and term loans with varying maturities through 2027; weighted average interest rates of 6.8% in 2015 and 6.4% in 2014 (see Note 7 regarding capitalized leases)	27,513	41,257
Revolving Credit And Demand Notes
Debt Instrument [Line Items]
Line of credit facility amount outstanding	304,900	140,500
Revenue Bonds
Debt Instrument [Line Items]
Revenue bonds, interest at floating rates of 0.05% at December 31, 2014		5,300
Accounts Receivable Securitization Program
Debt Instrument [Line Items]
Accounts receivable securitization program	$ 400,000	$ 330,000

Summary of Long-Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Obligations under capitalized leases	$ 24,913
Term Loan A
Debt Instrument [Line Items]
Unamortized discount	$ 1,593	$ 2,035
3.750% Senior Secured Notes due 2019
Debt Instrument [Line Items]
Debt instruments, maturity date	2019
Unamortized discount	$ 155	198
Senior notes, interest rate	3.75%
4.750% Senior Secured Notes due 2022
Debt Instrument [Line Items]
Debt instruments, maturity date	2022
Unamortized discount	$ 177	204
Senior notes, interest rate	4.75%
7.125% Senior Secured Notes due 2016
Debt Instrument [Line Items]
Debt instruments, maturity date	2016
Senior notes, interest rate	7.125%
Unamortized net premium	$ 4	7
Notes Payable And Mortgages Payable
Debt Instrument [Line Items]
Obligations under capitalized leases	$ 24,900	$ 21,600
Weighted average interest	6.80%	6.40%
Term Loans With Varying Maturities
Debt Instrument [Line Items]
Debt instruments, maturity date	2027
Revenue Bonds
Debt Instrument [Line Items]
Interest at floating rates		0.05%

Long-Term Debt - Additional Information (Detail) - USD ($)			12 Months Ended
	Aug. 07, 2014	Jul. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Aug. 01, 2014	Oct. 31, 2013	Jun. 30, 2008	Jun. 30, 2006
Debt Instrument [Line Items]
Reduction of long-term debt			$ 68,166,000	$ 879,129,000	$ 440,224,000
Costs related to extinguishment of debt			$ 0	$ 36,171,000	$ 0
Rate adjustment to weighted average federal funds rate for credit facility borrowings				0.50%
Rate adjustment to one month Eurodollar rate on credit facility borrowings				1.00%
Effective interest rate			2.40%	3.10%	3.60%
Long-term debt			$ 3,387,303,000	$ 3,210,215,000
Fair value of debt			3,500,000,000	3,300,000,000
Accounts Receivable Securitization Facility
Debt Instrument [Line Items]
Accounts receivable securitization program, additional capacity			$ 0
3.750% Senior Secured Notes due 2019
Debt Instrument [Line Items]
Senior notes, interest rate			3.75%
Unamortized discount			$ 155,000	198,000
4.750% Senior Secured Notes due 2022
Debt Instrument [Line Items]
Senior notes, interest rate			4.75%
Unamortized discount			$ 177,000	204,000
7.00% Senior Unsecured Notes
Debt Instrument [Line Items]
Reduction of long-term debt		$ 250,000,000		$ 250,000,000
Senior notes, interest rate		7.00%		7.00%
Debt instrument redemption, date			Jul. 31, 2014
Unsecured notes make-whole redemption price		104.56%
Write-off deferred charges, original issue discount and make-whole premiums paid		$ 11,000,000		$ 11,000,000
Unamortized discount				5,000,000
Write-off deferred charges				20,000,000
Senior notes, maturity date			Oct. 01, 2018
Accounts Receivable Securitization Program
Debt Instrument [Line Items]
Accounts receivable securitization program			$ 400,000,000
Senior Notes 7.125%
Debt Instrument [Line Items]
Senior notes, issued									$ 250,000,000
Senior notes, interest rate									7.125%
Senior notes, maturity date			Jun. 30, 2016
Senior notes, repayment terms			Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year.
Line of credit facility additional borrowing capacity								$ 150,000,000
Credit Agreement And Securitization
Debt Instrument [Line Items]
Average amounts outstanding under Credit Agreement, Prior Credit Agreement, demand notes and accounts receivable securitization programs			$ 2,100,000,000	$ 2,400,000,000	$ 2,900,000,000
Effective interest rate			1.70%	1.80%	2.20%
Maximum amounts outstanding at any month-end			$ 2,300,000,000	$ 2,700,000,000	$ 3,000,000,000
Amendment of Credit Facility
Debt Instrument [Line Items]
Line of credit facility, starting date	Aug. 07, 2014		Aug. 07, 2014
Line of credit facility, maturity month	2019-08		2019-08
Accounts receivable securitization program credit facility, borrowing capacity			$ 400,000,000			$ 360,000,000	$ 275,000,000
Amendment of Credit Facility \| Accounts Receivable Securitization Facility
Debt Instrument [Line Items]
Line of credit facility, starting date			Aug. 01, 2014
Line of credit facility, extended maturity date			Dec. 21, 2018
Line of credit facility, starting Period			2015-12
Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, borrowing capacity	$ 800,000,000		$ 800,000,000
Line of credit facility amount outstanding			$ 300,000,000
Current applicable margins			1.50%
Line of credit facility, available borrowing capacity			$ 461,000,000
Letters of credit, outstanding			34,000,000
Revolving Credit Facility \| Short Term on Demand Credit Facility
Debt Instrument [Line Items]
Line of credit facility amount outstanding			5,000,000
Revolving Credit Facility \| Letter of Credit
Debt Instrument [Line Items]
Line of credit facility, borrowing capacity			$ 125,000,000
Revolving Credit Facility \| ABR-based loans
Debt Instrument [Line Items]
Current applicable margins			0.50%
Revolving Credit Facility \| Minimum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated Leverage Ratio			0.50%
Revolving Credit Facility \| Minimum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated Leverage Ratio			1.50%
Revolving Credit Facility \| Maximum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated Leverage Ratio			1.25%
Revolving Credit Facility \| Maximum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated Leverage Ratio			2.25%
Term Loan A
Debt Instrument [Line Items]
Line of credit facility amount outstanding			$ 1,717,940,000	1,761,872,000
Unamortized discount			$ 1,593,000	2,035,000
Current applicable margins			1.50%
Term Loan A \| ABR-based loans
Debt Instrument [Line Items]
Current applicable margins			0.50%
Term Loan A \| Minimum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated Leverage Ratio			0.50%
Term Loan A \| Minimum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated Leverage Ratio			1.50%
Term Loan A \| Maximum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated Leverage Ratio			1.25%
Term Loan A \| Maximum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated Leverage Ratio			2.25%
Term Loan A \| Quarterly installment payments commence in the fourth quarter of 2014 through September, 2016
Debt Instrument [Line Items]
Scheduled principal payments made				11,000,000
Term Loan A \| Quarterly installment payments after September, 2016
Debt Instrument [Line Items]
Scheduled principal payments made				$ 22,000,000
Term Loan A \| Amendment of Credit Facility
Debt Instrument [Line Items]
Line of credit facility, borrowing capacity	1,775,000,000
Line of credit facility amount outstanding			$ 1,720,000,000
Term Loan B Facility
Debt Instrument [Line Items]
Reduction of long-term debt			$ 550,000,000
Line of credit facility, maturity year			2016
New Senior Secured Notes \| 3.750% Senior Secured Notes due 2019
Debt Instrument [Line Items]
Senior notes, issued	$ 300,000,000
Senior notes, interest rate	3.75%
Senior notes, maturity date			Aug. 01, 2019
Senior notes, interest payment, commencement date			Feb. 01, 2015
New Senior Secured Notes \| 4.750% Senior Secured Notes due 2022
Debt Instrument [Line Items]
Senior notes, issued	$ 300,000,000
Senior notes, interest rate	4.75%
Senior notes, maturity date			Aug. 01, 2022

Aggregate Scheduled Maturities of Debt Outstanding (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Debt Disclosure [Abstract]
2016	$ 62,722	$ 68,319
2017	91,254
2018	491,514
2019	2,486,965
2020	1,650
Later	315,920
Total debt	$ 3,450,025	$ 3,278,534

Common Stock - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Jul. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase programs authorized to purchase, value	$ 400,000,000			$ 400,000,000
Stock repurchased, value	224,260,000	$ 100,749,000	$ 27,201,000
Compensation cost recognized	39,971,000	31,092,000	27,783,000
Excess tax benefit from share based compensation	$ 47,364,000	$ 33,912,000	$ 20,121,000
Stock options granted during period (net of cancellations)	3,039,350	2,845,500	2,889,750
Total in-the-money value of all stock options exercised during the year	$ 154,100,000	$ 112,500,000	$ 70,900,000
Stock issued during period, net of cancellations	1,300,000
Class B
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchased, value	$ 18,000	10,000	4,000
Shares reserved	2,800,000
Issuance upon conversion of shares	24,056,061
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized, pre-tax charge	$ 38,000,000	29,200,000	25,800,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized, after-tax	2,000,000	$ 1,900,000	$ 2,000,000
Unrecognized compensation cost	$ 67,700,000
Unrecognized compensation cost vesting period	2 years 8 months 12 days
Unvested Stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 67,700,000
Unrecognized compensation cost vesting period	2 years 8 months 12 days
Stock Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchased, shares	1,874,399
Stock repurchased, value	$ 224,172,000
Income Tax Withholding Obligations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchased, shares	493,296	480,972	427,170
Stock repurchased, value	$ 58,000,000	$ 42,700,000	$ 27,200,000
Stock Repurchase Programs Twenty Fifteen \| Stock Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchased, shares	1,326,207
Stock repurchased, value	$ 166,222,000
Stock Repurchase Programs Twenty Fourteen
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase programs authorized to purchase, value		$ 400,000,000
Stock repurchased, shares		548,192
Stock repurchased, value		$ 57,950,000
Stock Repurchase Programs Twenty Thirteen
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchased, shares			0
Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted during period (net of cancellations)	2,900,000	2,800,000	2,600,000
Weighted-average grant date fair value of option granted	$ 21.37	$ 17.23	$ 13.33
Common Stock remain available for issuance		6,900,000
Stock Incentive Plan \| Class B
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved	29,500,000
2005 Employees' Restricted Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized	$ 68,213	$ 75,303	$ 90,587
Common Stock remain available for issuance	1,500,000
Stock issued under employee stock purchase plan	17,789	26,189	10,000
Special Dividend
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividends declared and paid, per share	$ 0.40	$ 0.30	$ 0.20
Dividends declared and paid	$ 39,500,000	$ 29,700,000	$ 19,600,000

Schedule of Information Related to Stock Repurchase Programs (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Jul. 31, 2014	Dec. 31, 2012
Class of Stock [Line Items]
Additional dollars authorized for repurchase	$ 400,000,000			$ 400,000,000
Total number of shares purchased	3,275,837
Total number of shares cancelled	767,704
Aggregate purchase price paid	$ 352,210,000
Aggregate purchase price paid for shares purchased as part of publicly announced program	$ 224,260,000	$ 100,749,000	$ 27,201,000
Stock Repurchase Program
Class of Stock [Line Items]
Total number of shares purchased as part of publicly announced programs	1,874,399
Average price pad per share for shares purchased as part of publicly announced program	$ 119.60
Aggregate purchase price paid for shares purchased as part of publicly announced program	$ 224,172,000
Stock Repurchase Programs Twenty Twelve
Class of Stock [Line Items]
Maximum number of shares that may yet be purchased under the program					767,704
Stock Repurchase Programs Twenty Thirteen
Class of Stock [Line Items]
Total number of shares purchased			427,170
Total number of shares purchased as part of publicly announced programs			0
Aggregate purchase price paid			$ 27,201,000
Maximum number of shares that may yet be purchased under the program			767,704
Stock Repurchase Programs Twenty Fourteen
Class of Stock [Line Items]
Additional dollars authorized for repurchase		$ 400,000,000
Total number of shares purchased		1,029,164
Total number of shares cancelled		767,704
Total number of shares purchased as part of publicly announced programs		548,192
Average price pad per share for shares purchased as part of publicly announced program		$ 105.71
Aggregate purchase price paid		$ 100,749,000
Aggregate purchase price paid for shares purchased as part of publicly announced program		57,950,000
Maximum number of dollars that may yet be purchased under the program		$ 342,050,000
Stock Repurchase Programs Twenty Fifteen
Class of Stock [Line Items]
Total number of shares purchased	1,819,503
Aggregate purchase price paid	$ 224,260,000
Maximum number of dollars that may yet be purchased under the program	$ 175,828,000
Stock Repurchase Programs Twenty Fifteen \| Stock Repurchase Program
Class of Stock [Line Items]
Total number of shares purchased as part of publicly announced programs	1,326,207
Average price pad per share for shares purchased as part of publicly announced program	$ 125.34
Aggregate purchase price paid for shares purchased as part of publicly announced program	$ 166,222,000

Assumptions Used in Black-Scholes Model to Determine Fair Value for Stock Option Awards Granted (Detail)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Volatility	33.00%	35.00%	36.00%
Interest rate	1.00%	1.00%	1.00%
Expected life (years)	3 years 4 months 24 days	3 years 4 months 24 days	3 years 7 months 6 days
Forfeiture rate	10.00%	10.00%	11.00%
Dividend yield	0.40%	0.40%	0.50%

Summary of Option Activities (Detail) - $ / shares	12 Months Ended
Summary of Option Activities (Detail) - $ / shares	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Option, Number of shares, beginning balance	7,897,451	7,620,958	7,436,238
Granted, Number of Shares	3,039,350	2,845,500	2,889,750
Exercised, Number of Shares	(2,256,454)	(2,277,469)	(2,288,666)
Cancelled, Number of Shares	(280,164)	(291,538)	(416,364)
Outstanding Option, Number of shares, ending balance	8,400,183	7,897,451	7,620,958
Outstanding options vested and exercisable, Number of Shares	1,671,216
Outstanding Option, Average Option Price, beginning balance	$ 57.29	$ 43.63	$ 36.31
Granted, Average Option Price	117.70	78.65	53.51
Exercised, Average Option Price	48.97	38.50	32.27
Cancelled, Average Option Price	83.63	55.63	43.93
Outstanding Option, Average Option Price, ending balance	80.50	57.29	43.63
Outstanding options vested and exercisable, Average option price	52.19
54.79 -$16.22
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High			54.79
Range, Low			16.22
79.79 -$53.38
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High			79.79
Range, Low			53.38
53.38 -$16.22
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High			53.38
Range, Low			$ 16.22
79.79-$30.32
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High		79.79
Range, Low		30.32
102.21-$78.17
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High		102.21
Range, Low		78.17
73.65-$30.32
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High		73.65
Range, Low		30.32
78.17-$36.95
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High		78.17
Range, Low		$ 36.95
102.21-$36.95
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	102.21
Range, Low	36.95
$142.43-$108.29
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	142.43
Range, Low	108.29
$134.70-$36.95
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	134.70
Range, Low	36.95
$142.43-$36.95
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	142.43
Range, Low	$ 36.95

Schedule of Information about Unvested Options (Detail)	12 Months Ended
Schedule of Information about Unvested Options (Detail)	Dec. 31, 2015 $ / shares shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Unvested options, Shares, beginning balance \| shares	6,485,029
Granted, Shares \| shares	3,039,350
Vested, Shares \| shares	(2,515,248)
Cancelled, Shares \| shares	(280,164)
Unvested options, Shares, ending balance \| shares	6,728,967
Unvested options, Weighted Average Grant Date Fair Value Per Share, beginning balance \| $ / shares	$ 14.36
Granted, Weighted Average Grant Date Fair Value Per Share \| $ / shares	21.37
Vested, Weighted Average Grant Date Fair Value Per Share \| $ / shares	13.38
Canceled, Weighted Average Grant Date Fair Value Per Share \| $ / shares	17.36
Unvested options, Weighted Average Grant Date Fair Value Per Share, ending balance \| $ / shares	$ 17.77

Schedule of Information about All Outstanding Options (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Number, Options Outstanding	8,400,183	7,897,451	7,620,958	7,436,238
Weighted average exercise price, Options Outstanding	$ 80.50	$ 57.29	$ 43.63	$ 36.31
Aggregate intrinsic value, Options Outstanding	$ 328,564,543
Weighted average remaining contractual life, Options Outstanding	3 years
Number, Options Exercisable	1,671,216
Weighted Average Exercise Price, Options Exercisable	$ 52.19
Aggregate intrinsic value, Options Exercisable	$ 112,466,544
Weighted average remaining contractual life, Options Exercisable	1 year 10 months 24 days

Schedule of Weighted Average Remaining Contractual Life for Options Outstanding and Weighted Average Exercise Price Per Share for Exercisable Options (Detail) - $ / shares

12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Options Outstanding, Shares

8,400,183

7,897,451

7,620,958

7,436,238

Options Outstanding, Weighted Average Exercise Price Per Share

$ 80.50

$ 57.29

$ 43.63

$ 36.31

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

3 years

Number, Options Exercisable

1,671,216

Weighted Average Exercise Price, Options Exercisable

$ 52.19

Expected to Vest Options , Shares

^[1]

4,949,903

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 88.86

Range One

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

36.95

Range, High

$ 46.97

Options Outstanding, Shares

1,298,145

Options Outstanding, Weighted Average Exercise Price Per Share

$ 37.13

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

1 year

Number, Options Exercisable

717,517

Weighted Average Exercise Price, Options Exercisable

$ 37.25

Expected to Vest Options , Shares

^[1]

574,626

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 36.97

Range Two

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

53.38

Range, High

$ 73.65

Options Outstanding, Shares

1,805,950

Options Outstanding, Weighted Average Exercise Price Per Share

$ 53.49

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

2 years

Number, Options Exercisable

571,450

Weighted Average Exercise Price, Options Exercisable

$ 53.45

Expected to Vest Options , Shares

^[1]

1,098,889

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 53.50

Range Three

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

78.17

Range, High

$ 96.98

Options Outstanding, Shares

2,321,238

Options Outstanding, Weighted Average Exercise Price Per Share

$ 78.31

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

3 years 2 months 12 days

Number, Options Exercisable

380,249

Weighted Average Exercise Price, Options Exercisable

$ 78.25

Expected to Vest Options , Shares

^[1]

1,295,612

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 78.34

Range Four

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

102.21

Range, High

$ 142.43

Options Outstanding, Shares

2,974,850

Options Outstanding, Weighted Average Exercise Price Per Share

$ 117.54

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

4 years 2 months 12 days

Number, Options Exercisable

2,000

Weighted Average Exercise Price, Options Exercisable

$ 102.21

Expected to Vest Options , Shares

^[1]

1,980,776

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 117.52

[1]	Assumes a weighted average forfeiture rate of 9.95%.

Components of Income Tax Expense Benefit (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Current, Federal	$ 363,734	$ 248,172	$ 256,545
Current, Foreign	3,151	4,167	1,655
Current, State	38,987	23,224	28,490
Current, Total	405,872	275,563	286,690
Deferred, Federal	(15,912)	41,583	25,341
Deferred, Foreign	5,545
Deferred, State	(302)	7,525	3,278
Deferred, Total	(10,669)	49,108	28,619
Provision for income taxes	$ 395,203	$ 324,671	$ 315,309

Components of Deferred Taxes (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Self-insurance reserves	$ 88,401	$ 84,915
Compensation accruals	66,399	55,788
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets	62,541	60,521
Other currently non-deductible accrued liabilities	17,213	16,739
Net pension liability—OCI only	10,929	11,746
Doubtful accounts and other reserves	29,616	18,428
Other combined items—OCI only	457	2,615
Deferred income tax assets, Gross	275,556	250,752
Less: Valuation Allowance	(52,567)	(52,764)
Net deferred income tax assets:	222,989	197,988
Depreciable and amortizable assets	(400,809)	(362,674)
Other deferred tax liabilities	(2,960)	(2,963)
Net deferred income tax liabilities	$ (180,780)	$ (167,649)

Income Taxes - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($) Facility	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Income Taxes [Line Items]
Favorable discrete tax items	$ 1,000	$ 1,000	$ 1,000
Foreign pre-tax earnings	$ 41,000	15,000	6,000
Effective income tax rate, foreign	20.25%
Undistributed foreign earnings	$ 53,000
Unrecognizable deferred tax liability related to foreign earnings	8,000
Deferred federal and state tax benefit	42,000	17,000
Future taxable income, amount	1,080,000
Deferred state tax benefit (net of the federal benefit)	(302)	7,525	$ 3,278
Net operating losses	62,541	60,521
Deferred foreign tax benefit	5,545
Valuation allowances	52,567	52,764
Increase in estimated liabilities for uncertain tax positions	1,000	1,000
Decrease in estimated liabilities for uncertain tax positions due to the lapse of the statute of limitations	1,000
Impact of unrecognized tax benefits if recognized	$ 1,000	2,000
Period of expiration of the statute of limitations for certain jurisdictions	Within the next twelve months
Jurisdictions statutes of limitations expiration period	12 months
Maximum
Income Taxes [Line Items]
Accrued interest and penalties	$ 1,000	1,000
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years	4 years
Minimum
Income Taxes [Line Items]
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years	3 years
Allowance in relation to state tax benefit
Income Taxes [Line Items]
Valuation allowances	$ 51,000	50,000
Net Operating Losses
Income Taxes [Line Items]
Increase in valuation allowance	1,000
Foreign Net Operating Losses
Income Taxes [Line Items]
Increase in valuation allowance	2,000	$ 3,000
State and Local Jurisdiction
Income Taxes [Line Items]
Deferred state tax benefit (net of the federal benefit)	53,000
Foreign Tax Authority
Income Taxes [Line Items]
Net operating losses	$ 20,000
Behavioral Health Services
Income Taxes [Line Items]
Number of additional facilities acquired \| Facility	5

Effective Tax Rates Calculation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 395,203	$ 324,671	$ 315,309
Income before income taxes	$ 1,145,901	$ 929,667	$ 869,332
Effective tax rate	34.50%	34.90%	36.30%

Reconciliation between Federal Statutory Rate and Effective Tax Rate (Detail)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Federal statutory rate	35.00%	35.00%	35.00%
State taxes, net of federal income tax benefit	2.30%	2.30%	2.50%
Divestiture gain	0.00%	0.00%	0.30%
Other items	(0.60%)	0.00%	0.40%
Impact of income attributable to noncontrolling interests	(2.20%)	(2.40%)	(1.90%)
Effective tax rate	34.50%	34.90%	36.30%

Net Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Current deferred taxes, Assets	$ 135,120	$ 115,870
Current deferred taxes, Liabilities		(1,305)
Total deferred taxes-current	135,120	114,565
Noncurrent deferred taxes, Assets	92,383	85,792
Noncurrent deferred taxes, Liabilities	(408,283)	(368,006)
Total deferred taxes-noncurrent	(315,900)	(282,214)
Net deferred income tax liabilities	$ (180,780)	$ (167,649)

Reconciliation of Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Balance at January 1,	$ 2,402	$ 3,369	$ 6,824
Additions based on tax positions related to the current year	50	50	50
Additions for tax positions of prior years	111	195	283
Reductions for tax positions of prior years	(524)	(1,212)	(1,260)
Settlements	(57)		(2,528)
Balance at December 31,	$ 1,982	$ 2,402	$ 3,369

Summary of Property under Capital Lease (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Leases [Abstract]
Land, buildings and equipment	$ 45,665	$ 40,782
Less: accumulated amortization	(27,169)	(27,556)
Property under capital lease, Total	$ 18,496	$ 13,226

Future Minimum Rental Payments under Lease Commitments (Detail) $ in Thousands	Dec. 31, 2015 USD ($)
Leases [Abstract]
Capital Leases, 2016	$ 3,849
Capital Leases, 2017	3,929
Capital Leases, 2018	4,061
Capital Leases, 2019	3,996
Capital Leases, 2020	3,339
Capital Leases, Later years	22,055
Capital Leases, Total minimum rental	41,229
Less: Amount representing interest	(16,316)
Present value of minimum rental commitments	24,913
Less: Current portion of capital lease obligations	(1,557)
Long-term portion of capital lease obligations	23,356
Operating Leases, 2016	64,049
Operating Leases, 2017	42,989
Operating Leases, 2018	35,447
Operating Leases, 2019	29,721
Operating Leases, 2020	21,487
Operating Leases, Later years	137,692
Operating Leases, Total minimum rental	$ 331,385

Commitments and Contingencies - Additional Information (Detail) £ in Millions		1 Months Ended	3 Months Ended	12 Months Ended
	Oct. 31, 2012 USD ($) Facility	Sep. 30, 2015 Hospital	Sep. 30, 2014 Facility	Dec. 31, 2015 GBP (£)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)	Dec. 31, 2011 USD ($)	Dec. 31, 2015 USD ($)	Nov. 30, 2010 USD ($)	Nov. 30, 2010 GBP (£)
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability					$ 259,718,000	$ 270,088,000	$ 344,553,000		$ 271,476,000
Compensation liability claims					67,000,000				68,000,000
Compensation and related benefits					32,000,000				34,000,000
Payment suspension period increased		180 days
Combined estimated future purchase obligations									171,000,000
Defined benefit pension plan estimated payments through 2089									224,000,000
Other retirement plan liabilities									18,000,000
Revenue Cycle Data Processing Services
Commitments and Contingencies Disclosure [Line Items]
Combined estimated future purchase obligations									70,000,000
Electronic Health Records Application
Commitments and Contingencies Disclosure [Line Items]
Combined estimated future purchase obligations									100,000,000
Estimated Minimum Liabilities For Physician Commitments
Commitments and Contingencies Disclosure [Line Items]
Combined estimated future purchase obligations									1,000,000
Construction Commitment
Commitments and Contingencies Disclosure [Line Items]
Combined estimated future purchase obligations									110,000,000
Related to Certain Equipment
Commitments and Contingencies Disclosure [Line Items]
Combined estimated future purchase obligations									242,000,000
Commercial Health Insurer and Self-insured Employee Benefit Plans
Commitments and Contingencies Disclosure [Line Items]
Combined estimated future purchase obligations									68,000,000
Location 1
Commitments and Contingencies Disclosure [Line Items]
Minimum Insurance Deductible									50,000
Location 2
Commitments and Contingencies Disclosure [Line Items]
Minimum Insurance Deductible									250,000
Earthquake
Commitments and Contingencies Disclosure [Line Items]
Minimum Insurance Deductible									250,000
Earthquake \| PUERTO RICO
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses									25,000,000
Maximum insurance deductible									25,000
Flood \| Location 1
Commitments and Contingencies Disclosure [Line Items]
Maximum insurance deductible									500,000
Flood \| Location 2
Commitments and Contingencies Disclosure [Line Items]
Maximum insurance deductible									250,000
Professional And General Liability \| Psi Subsidiaries
Commitments and Contingencies Disclosure [Line Items]
Reduction in professional and general liability self-insurance reserves relating to prior years					20,000,000	81,000,000
Weighting given to company-specific metrics							100.00%	75.00%
General industry metrics							0.00%	25.00%
Cygnet Health Care Limited
Commitments and Contingencies Disclosure [Line Items]
Number of facilities \| Facility			17
Property insurance \| £				£ 180
Maximum \| WindStormsMember
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses									$ 1,000,000,000
Percentage of insurance deductible									5.00%
Maximum \| Earthquake
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses									$ 250,000,000
Maximum \| Earthquake \| UNITED STATES
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses									$ 100,000,000
Percentage of insurance deductible									5.00%
Minimum \| WindStormsMember
Commitments and Contingencies Disclosure [Line Items]
Percentage of insurance deductible									3.00%
Minimum \| Earthquake \| UNITED STATES
Commitments and Contingencies Disclosure [Line Items]
Percentage of insurance deductible									1.00%
Professional Liability \| Cygnet Health Care Limited
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability \| £											£ 10
General Liability \| Cygnet Health Care Limited
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability \| £											£ 25
General and Professional Liability
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability					192,904,000	206,290,000	$ 278,599,000		$ 203,973,000
Self-insured for professional and general liability, current					51,000,000				$ 48,000,000
Subsidiaries \| Professional Liability \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability										$ 10,000,000
Subsidiaries \| General Liability \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability										$ 3,000,000
Subsidiaries \| General And Professional Liability Insurance Policies
Commitments and Contingencies Disclosure [Line Items]
Percentage of liability for claims paid under commercially insured coverage									10.00%
Subsidiaries \| General And Professional Liability Insurance Policies \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Purchased several excess policies through commercial insurance carriers per occurrence					$ 250,000,000	$ 200,000,000			$ 250,000,000
Liability for claims paid under commercially insured coverage									60,000,000
Subsidiaries \| General And Professional Liability Insurance Policies \| Minimum
Commitments and Contingencies Disclosure [Line Items]
Liability for claims paid under commercially insured coverage									10,000,000
Psychiatric Solutions Inc \| General And Professional Liability Insurance Policies \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability									$ 3,000,000
Behavioral Health Facilities Acquired From Ascend Health Corporation
Commitments and Contingencies Disclosure [Line Items]
Number of facilities \| Facility	9
Behavioral Health Facilities Acquired From Ascend Health Corporation \| General And Professional Liability Insurance Policies
Commitments and Contingencies Disclosure [Line Items]
Minimum Insurance Deductible	$ 100,000
Behavioral Health Facilities Acquired From Ascend Health Corporation \| General And Professional Liability Insurance Policies \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability	$ 12,000,000
Behavioral Health Care Facilities
Commitments and Contingencies Disclosure [Line Items]
Number of facilities \| Facility	21
DPW
Commitments and Contingencies Disclosure [Line Items]
Repayment of legal settlement amount on demand								$ 4,000,000
Percentage of federal share on payments								55.00%
DPW \| Pennsylvania
Commitments and Contingencies Disclosure [Line Items]
Number of behavioral health care hospitals \| Hospital		7

Commitments and Contingencies - Schedule of Changes in General and Professional Liability and Workers Compensation Reserves (Detail) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Commitments and Contingencies Disclosure [Line Items]

Beginning balance

$ 259,718

$ 270,088

$ 344,553

Plus: Accrued insurance expense, net of commercial premiums paid

90,895

59,276

^[1]

(3,821)

^[1]

Less: Payments made in settlement of self-insured claims

(79,137)

(69,646)

(70,644)

Ending balance

271,476

259,718

270,088

General and Professional Liability

Commitments and Contingencies Disclosure [Line Items]

Beginning balance

192,904

206,290

278,599

Plus: Accrued insurance expense, net of commercial premiums paid

58,460

22,601

^[1]

(35,182)

^[1]

Less: Payments made in settlement of self-insured claims

(47,391)

(35,987)

(37,127)

Ending balance

203,973

192,904

206,290

Workers’ Compensation

Commitments and Contingencies Disclosure [Line Items]

Beginning balance

66,814

63,798

65,954

Plus: Accrued insurance expense, net of commercial premiums paid

32,435

36,675

^[1]

31,361

^[1]

Less: Payments made in settlement of self-insured claims

(31,746)

(33,659)

(33,517)

Ending balance

$ 67,503

$ 66,814

$ 63,798

[1]	General and professional liability amounts are net of adjustments recorded during 2014 and 2013, as discussed below.

Relationship with Universal Health Realty Income Trust and Other Related Party Transactions - Additional Information (Detail)	1 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2014 USD ($) Bed	Mar. 31, 2015 USD ($) Facility RenewalOption	Dec. 31, 2015 USD ($) Facility Hospital	Dec. 31, 2014 USD ($) Hospital	Dec. 31, 2013 USD ($) Facility Hospital
Related Party Transaction [Line Items]
Number of hospital facilities \| Facility			3		3
Chief Executive Officer
Related Party Transaction [Line Items]
Estimated payments to acquire life insurance policies			$ 25,000,000
Payments to acquire life insurance policies			1,300,000	$ 1,300,000	$ 1,300,000
Chief Executive Officer \| Trust Owned by Chief Executive Officer
Related Party Transaction [Line Items]
Estimated payments to acquire life insurance policies			8,000,000
Minimum \| Chief Executive Officer
Related Party Transaction [Line Items]
Estimated death benefit proceeds			$ 33,000,000
Relationship with Universal Health Realty Income Trust
Related Party Transaction [Line Items]
Trust outstanding shares held, percentage			5.90%
Advisory fee earned			$ 2,800,000	$ 2,500,000	$ 2,400,000
Percentage of advisory fee on average invested real estate assets			0.70%	0.70%	0.70%
Pre-tax share of income from the Trust			$ 1,400,000	$ 3,200,000	$ 842,000
Share of gain included in the share of trust			500,000	2,300,000
Carrying value of investment in Trust	$ 9,300,000		8,700,000	9,300,000
Market value of investment in Trust	37,900,000		39,400,000	37,900,000
Rent expense under operating leases			$ 15,600,000	$ 16,800,000	$ 16,400,000
Number of hospital facilities \| Hospital			3	4	4
Non-controlling ownership interests by subsidiaries			100.00%
Lease renewal period, years			5 years
Aggregate construction cost/sales proceeds		$ 13,000,000
Aggregate rent expense paid	1,100,000	$ 900,000
Estimated purchase price of The Bridgeway's real property	$ 17,300,000			$ 17,300,000
Notice period on renewal of lease			90 days
Period of rights of refusal to leased facilities			180 days
Relationship with Universal Health Realty Income Trust \| Behavioral Health Facility
Related Party Transaction [Line Items]
Number of beds \| Bed	103
Relationship with Universal Health Realty Income Trust \| Texas
Related Party Transaction [Line Items]
Lease initial terms		10 years
Number of free-standing emergency departments to be acquired \| Facility		2
Number of renewal options at existing lease rates \| RenewalOption		6
Renewal options term at existing lease rates		5 years
Renewal options term at fair market lease rates		5 years
Relationship with Universal Health Realty Income Trust \| Minimum
Related Party Transaction [Line Items]
Lease initial terms			13 years
Relationship with Universal Health Realty Income Trust \| Maximum
Related Party Transaction [Line Items]
Lease initial terms			15 years

Remaining Renewal Options and Terms for Hospital Facilities Leased from Trust (Detail)

12 Months Ended

Dec. 31, 2015

USD ($)

McAllen Medical Center

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

$ 5,485,000

2016-12

15 years

^[1]

Wellington Regional Medical Center

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

$ 3,030,000

2016-12

15 years

^[2]

Southwest Healthcare System, Inland Valley Campus

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

$ 2,648,000

2016-12

15 years

^[2]

[1]	We have three 5-year renewal options at existing lease rates (through 2031).
[2]	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

Remaining Renewal Options and Terms for Hospital Facilities Leased from Trust (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2015 RenewalOption
McAllen Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	3
Renewal options term at existing lease rates	5 years
McAllen Medical Center \| Maximum
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2031
Wellington Regional Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	1
Renewal options term at existing lease rates	5 years
Number of renewal options at fair market lease rates	2
Renewal options term at fair market lease rates	5 years
Wellington Regional Medical Center \| Maximum
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Wellington Regional Medical Center \| Minimum
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2022
Southwest Healthcare System, Inland Valley Campus
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	1
Renewal options term at existing lease rates	5 years
Number of renewal options at fair market lease rates	2
Renewal options term at fair market lease rates	5 years
Southwest Healthcare System, Inland Valley Campus \| Maximum
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Southwest Healthcare System, Inland Valley Campus \| Minimum
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2022

Pension Plan - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Amount of contributions to contributory plan		$ 40.7	$ 35.7	$ 29.9
Accumulated benefit obligation		117.7	126.4
Fair value of plan assets exceeded accumulated benefit obligation		$ 10.9	$ 9.7
Scenario, Forecast
Defined Benefit Plan Disclosure [Line Items]
Estimated net loss that will be amortized from accumulated other comprehensive income over the next fiscal year	$ (3.1)

Schedule of Reconciliation of Defined Benefit Pension Plan (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Pension Plans And Defined Benefit Postretirement Plans Disclosure [Abstract]
Fair value of plan assets at beginning of year	$ 116,697	$ 106,469
Actual return (loss) on plan assets	(3,223)	16,470
Benefits paid	(6,086)	(5,605)
Administrative expenses	(549)	(637)
Fair value of plan assets at end of year	106,839	116,697	$ 106,469
Benefit obligation at beginning of year	127,342	103,558
Service cost	1,051	966	1,060
Interest cost	4,912	4,986
Actuarial (gain) loss	(9,039)	23,437
Benefit obligation at end of year	118,180	127,342	$ 103,558
Other non-current liabilities	11,341	10,645
Total amounts recognized at end of year	$ 11,341	$ 10,645

Components of Net Periodic Pension Cost Benefit (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 1,051	$ 966	$ 1,060
Interest cost	4,912	4,986
Expected return on plan assets	(6,254)	(7,772)	(7,601)
Recognized actuarial loss	3,164	1,107	3,305
Net periodic cost	2,873	(714)	1,292
Components of net periodic cost (benefit)
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 4,912	$ 4,985	$ 4,528

Schedule of Weighted Average Assumptions (Detail)	12 Months Ended
Schedule of Weighted Average Assumptions (Detail)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Compensation And Retirement Disclosure [Abstract]
Discount rate	4.34%	3.95%
Rate of compensation increase	4.00%	4.00%
Discount rate	3.95%	4.95%	4.05%
Expected long-term rate of return on plan assets	5.50%	7.50%	7.50%
Rate of compensation increase	4.00%	4.00%	4.00%

Schedule of Market Values of Pension Plan Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 106,839	$ 116,697	$ 106,469
Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	106,839	116,697
Cash \| Cash Equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	612	512
Cash \| Fair Value, Inputs, Level 2 \| Cash Equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	612	512
U.S. Large Cap \| Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8,520	9,212
U.S. Large Cap \| Equity Securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8,520	9,212
U.S. Mid Cap \| Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,613	2,852
U.S. Mid Cap \| Equity Securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,613	2,852
U.S. Small Cap \| Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,649	2,626
U.S. Small Cap \| Equity Securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,649	2,626
International Developed \| Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,406	6,181
International Developed \| Equity Securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,406	6,181
Emerging Markets \| Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4,114	4,139
Emerging Markets \| Equity Securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4,114	4,139
Core Fixed Income \| Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	23,782	27,062
Core Fixed Income \| Fixed Income Securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	23,782	27,062
Long Duration Fixed Income \| Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	55,931	61,718
Long Duration Fixed Income \| Fixed Income Securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	55,931	61,718
REIT Fund \| Real Estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,212	2,395
REIT Fund \| Real Estate \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 2,212	$ 2,395

Schedule of Estimated Future Benefit Payments (Detail) $ in Thousands	Dec. 31, 2015 USD ($)
Compensation And Retirement Disclosure [Abstract]
2016	$ 6,086
2017	6,343
2018	6,563
2019	6,753
2020	6,900
2021-2025	35,657
Total	$ 68,302

Schedule of Plan Assets Category (Detail)	12 Months Ended
Schedule of Plan Assets Category (Detail)	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plan Disclosure [Line Items]
Asset Allocation	100.00%	100.00%
Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Asset Allocation	23.00%	21.00%
Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Asset Allocation	75.00%	76.00%
Other
Defined Benefit Plan Disclosure [Line Items]
Asset Allocation	2.00%	3.00%

Schedule of Asset Allocation Policy and Ranges for Overall Risk and Return Objectives of Portfolio (Detail)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	100.00%	100.00%
Equity Funds
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	23.00%
Permitted Range, minimum	10.00%
Permitted Range, maximum	30.00%
Fixed Income Funds
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	75.00%
Permitted Range, minimum	70.00%
Permitted Range, maximum	90.00%
Other
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	2.00%	3.00%
Permitted Range, minimum	0.00%
Permitted Range, maximum	10.00%

Segment Reporting (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
Segment Reporting (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Gross inpatient revenues									$ 24,304,341	$ 21,632,855	$ 19,763,315
Gross outpatient revenues									10,460,630	8,965,578	7,613,277
Total net revenues	$ 2,315,239	$ 2,227,655	$ 2,275,204	$ 2,225,353	$ 2,176,291	$ 2,038,717	$ 2,051,766	$ 1,938,314	9,043,451	8,205,088	7,367,873
Income (loss) before allocation of corporate overhead and income taxes									1,145,901	929,667	869,332
Allocation of corporate overhead									0	0	0
Income (loss) after allocation of corporate overhead and before income taxes									1,145,901	929,667	869,332
Total assets	9,634,113				8,974,443				9,634,113	8,974,443	8,311,723
Acute Care Hospital Services
Segment Reporting Information [Line Items]
Gross inpatient revenues									16,847,944	14,943,102	13,469,269
Gross outpatient revenues									9,604,952	8,147,031	6,828,307
Total net revenues									4,632,564	4,178,103	3,602,874
Income (loss) before allocation of corporate overhead and income taxes									519,630	465,328	342,191
Allocation of corporate overhead									(197,699)	(178,781)	(184,444)
Income (loss) after allocation of corporate overhead and before income taxes									321,931	286,547	157,747
Total assets	3,413,879				3,362,870				3,413,879	3,362,870	3,125,626
Behavioral Health Services
Segment Reporting Information [Line Items]
Gross inpatient revenues									7,456,397	6,689,753	6,294,046
Gross outpatient revenues									839,884	784,309	744,510
Total net revenues									4,400,335	4,012,216	3,725,513
Income (loss) before allocation of corporate overhead and income taxes									1,021,823	944,068	895,869
Allocation of corporate overhead									(117,203)	(98,811)	(89,447)
Income (loss) after allocation of corporate overhead and before income taxes									904,620	845,257	806,422
Total assets	5,867,088				5,286,960				5,867,088	5,286,960	4,966,182
Other
Segment Reporting Information [Line Items]
Gross outpatient revenues									15,794	34,238	40,460
Total net revenues									10,552	14,769	39,486
Income (loss) before allocation of corporate overhead and income taxes									(395,552)	(479,729)	(368,728)
Allocation of corporate overhead									314,902	277,592	273,891
Income (loss) after allocation of corporate overhead and before income taxes									(80,650)	(202,137)	(94,837)
Total assets	$ 353,146				$ 324,613				$ 353,146	$ 324,613	$ 219,915

Quarterly Results (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]
Net revenues	$ 2,315,239	$ 2,227,655	$ 2,275,204	$ 2,225,353	$ 2,176,291	$ 2,038,717	$ 2,051,766	$ 1,938,314	$ 9,043,451	$ 8,205,088	$ 7,367,873
Net income	191,317	163,654	201,404	194,323	190,492	96,038	166,614	151,852	750,698	604,996	554,023
Less: Net income attributable to noncontrolling interests	17,568	13,367	19,211	20,024	17,695	13,241	14,943	13,774	70,170	59,653	43,290
Net income attributable to UHS	$ 173,749	$ 150,287	$ 182,193	$ 174,299	$ 172,797	$ 82,797	$ 151,671	$ 138,078	$ 680,528	$ 545,343	$ 510,733
Total basic earnings per share	$ 1.76	$ 1.52	$ 1.84	$ 1.76	$ 1.75	$ 0.84	$ 1.53	$ 1.40	$ 6.89	$ 5.52	$ 5.21
Total diluted earnings per share	$ 1.74	$ 1.48	$ 1.80	$ 1.73	$ 1.71	$ 0.82	$ 1.51	$ 1.38	$ 6.76	$ 5.42	$ 5.14

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Quarterly Results - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014
Implementation of EHR applications
Quarterly Financial Information [Line Items]
Unfavorable pre-tax reduction		$ 8.0	$ 6.9	$ 8.3		$ 7.9	$ 7.1	$ 8.9
Unfavorable after-tax reduction		$ 5.0	$ 4.4	$ 5.3		$ 4.5	$ 3.9	$ 4.9
Tax reduction per diluted share		$ 0.05	$ 0.05	$ 0.05		$ 0.04	$ 0.04	$ 0.05
EHR applications
Quarterly Financial Information [Line Items]
Tax reduction per diluted share	$ 0.03				$ 0.08
Favorable pre-tax reduction	$ 4.9				$ 13.8
Favorable after-tax reduction	$ 3.1				$ 8.6
Resulting from the gain realized on the sale of a non-operating investment
Quarterly Financial Information [Line Items]
Tax reduction per diluted share								$ 0.07
Favorable pre-tax reduction								$ 10.1
Favorable after-tax reduction								$ 6.3
Related to extinguishment of debt from the early redemption of previously outstanding $250 million 7.00% senior unsecured notes and the repayment of $550 million of previously outstanding Term Loan B facility
Quarterly Financial Information [Line Items]
Unfavorable pre-tax reduction						$ 36.2
Unfavorable after-tax reduction						$ 22.7
Tax reduction per diluted share						$ 0.23
Incurred in connection with the previously disclosed $65 million settlement of the Garden City matter
Quarterly Financial Information [Line Items]
Unfavorable pre-tax reduction						$ 44.0
Unfavorable after-tax reduction						$ 27.6
Tax reduction per diluted share						$ 0.27
Professional and general liability self-insurance reserves
Quarterly Financial Information [Line Items]
Tax reduction per diluted share					$ 0.12
Favorable pre-tax reduction					$ 19.7
Favorable after-tax reduction					$ 11.7

Supplemental Condensed Consolidating Statements of Income (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Condensed Financial Statements Captions [Line Items]
Net revenues before provision for doubtful accounts									$ 9,784,724	$ 8,904,071	$ 8,495,089
Less: Provision for doubtful accounts									741,273	698,983	1,127,216
Net revenues	$ 2,315,239	$ 2,227,655	$ 2,275,204	$ 2,225,353	$ 2,176,291	$ 2,038,717	$ 2,051,766	$ 1,938,314	9,043,451	8,205,088	7,367,873
Operating charges:
Salaries, wages and benefits									4,212,387	3,845,461	3,604,620
Other operating expenses									2,119,805	1,922,743	1,552,795
Supplies expense									974,088	895,693	821,089
Depreciation and amortization									398,618	375,624	337,172
Lease and rental expense									94,973	93,993	97,758
Electronic health records incentive income									(15,815)	(27,902)	(61,024)
Costs related to extinguishment of debt									0	36,171	0
Operating Expenses, Total									7,784,056	7,141,783	6,352,410
Income from operations									1,259,395	1,063,305	1,015,463
Interest expense									113,494	133,638	146,131
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									0	0	0
Income before income taxes									1,145,901	929,667	869,332
Provision for income taxes									395,203	324,671	315,309
Net income	191,317	163,654	201,404	194,323	190,492	96,038	166,614	151,852	750,698	604,996	554,023
Less: Income attributable to noncontrolling interests	17,568	13,367	19,211	20,024	17,695	13,241	14,943	13,774	70,170	59,653	43,290
Net income attributable to UHS	$ 173,749	$ 150,287	$ 182,193	$ 174,299	$ 172,797	$ 82,797	$ 151,671	$ 138,078	680,528	545,343	510,733
Parent
Condensed Financial Statements Captions [Line Items]
Net revenues before provision for doubtful accounts									0	0	0
Less: Provision for doubtful accounts									0	0	0
Net revenues									0	0	0
Operating charges:
Salaries, wages and benefits									0	0	0
Other operating expenses									0	0	0
Supplies expense									0	0	0
Depreciation and amortization									0	0	0
Lease and rental expense									0	0	0
Electronic health records incentive income									0	0	0
Costs related to extinguishment of debt										36,171
Operating Expenses, Total									0	36,171	0
Income from operations									0	(36,171)	0
Interest expense									107,665	127,528	139,793
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									(746,984)	(646,386)	(597,020)
Income before income taxes									639,319	482,687	457,227
Provision for income taxes									(41,209)	(62,656)	(53,506)
Net income									680,528	545,343	510,733
Less: Income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									680,528	545,343	510,733
Guarantors
Condensed Financial Statements Captions [Line Items]
Net revenues before provision for doubtful accounts									6,798,664	6,225,997	5,734,385
Less: Provision for doubtful accounts									481,294	471,181	657,106
Net revenues									6,317,370	5,754,816	5,077,279
Operating charges:
Salaries, wages and benefits									3,014,296	2,757,738	2,573,205
Other operating expenses									1,459,607	1,342,745	1,047,856
Supplies expense									583,644	546,578	510,078
Depreciation and amortization									280,985	269,490	236,958
Lease and rental expense									58,394	58,619	62,518
Electronic health records incentive income									(12,232)	(19,480)	(43,027)
Costs related to extinguishment of debt										0
Operating Expenses, Total									5,384,694	4,955,690	4,387,588
Income from operations									932,676	799,126	689,691
Interest expense									4,695	4,516	3,365
Interest (income) expense, affiliate									86,494	88,246	84,640
Equity in net income of consolidated affiliates									(215,119)	(184,385)	(141,004)
Income before income taxes									1,056,606	890,749	742,690
Provision for income taxes									354,611	305,320	262,346
Net income									701,995	585,429	480,344
Less: Income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									701,995	585,429	480,344
Non Guarantors
Condensed Financial Statements Captions [Line Items]
Net revenues before provision for doubtful accounts									3,018,364	2,707,294	2,789,348
Less: Provision for doubtful accounts									259,979	227,802	470,110
Net revenues									2,758,385	2,479,492	2,319,238
Operating charges:
Salaries, wages and benefits									1,198,091	1,087,723	1,031,415
Other operating expenses									690,341	607,098	531,747
Supplies expense									390,444	349,115	311,011
Depreciation and amortization									117,633	106,134	100,214
Lease and rental expense									38,740	37,494	37,076
Electronic health records incentive income									(3,583)	(8,422)	(17,997)
Costs related to extinguishment of debt										0
Operating Expenses, Total									2,431,666	2,179,142	1,993,466
Income from operations									326,719	300,350	325,772
Interest expense									1,134	1,594	2,973
Interest (income) expense, affiliate									(86,494)	(88,246)	(84,640)
Equity in net income of consolidated affiliates									0	0	0
Income before income taxes									412,079	387,002	407,439
Provision for income taxes									81,801	82,007	106,469
Net income									330,278	304,995	300,970
Less: Income attributable to noncontrolling interests									70,170	59,653	43,290
Net income attributable to UHS									260,108	245,342	257,680
Consolidating Adjustments
Condensed Financial Statements Captions [Line Items]
Net revenues before provision for doubtful accounts									(32,304)	(29,220)	(28,644)
Less: Provision for doubtful accounts									0	0	0
Net revenues									(32,304)	(29,220)	(28,644)
Operating charges:
Salaries, wages and benefits									0	0	0
Other operating expenses									(30,143)	(27,100)	(26,808)
Supplies expense									0	0	0
Depreciation and amortization									0	0	0
Lease and rental expense									(2,161)	(2,120)	(1,836)
Electronic health records incentive income									0	0	0
Costs related to extinguishment of debt										0
Operating Expenses, Total									(32,304)	(29,220)	(28,644)
Income from operations									0	0	0
Interest expense									0	0	0
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									962,103	830,771	738,024
Income before income taxes									(962,103)	(830,771)	(738,024)
Provision for income taxes									0	0	0
Net income									(962,103)	(830,771)	(738,024)
Less: Income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									$ (962,103)	$ (830,771)	$ (738,024)

Supplemental Condensed Consolidating Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Condensed Financial Statements Captions [Line Items]
Net income	$ 191,317	$ 163,654	$ 201,404	$ 194,323	$ 190,492	$ 96,038	$ 166,614	$ 151,852	$ 750,698	$ 604,996	$ 554,023
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges									4,970	17,668	16,963
Amortization of terminated hedge									(336)	(336)	(336)
Minimum pension liability									2,177	(14,270)	14,657
Foreign currency translation adjustment									(1,728)	(2,431)	0
Other comprehensive income (loss) before tax									5,083	631	31,284
Income tax expense related to items of other comprehensive income									2,980	1,053	11,940
Total other comprehensive income (loss), net of tax									2,103	(422)	19,344
Comprehensive income									752,801	604,574	573,367
Less: Comprehensive income attributable to noncontrolling interests									70,170	59,653	43,290
Comprehensive income attributable to UHS									682,631	544,921	530,077
Parent
Condensed Financial Statements Captions [Line Items]
Net income									680,528	545,343	510,733
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges									4,970	17,668	16,963
Amortization of terminated hedge									(336)	(336)	(336)
Minimum pension liability									2,177	(14,270)	14,657
Foreign currency translation adjustment									(1,728)	(2,431)
Other comprehensive income (loss) before tax									5,083	631	31,284
Income tax expense related to items of other comprehensive income									2,980	1,053	11,940
Total other comprehensive income (loss), net of tax									2,103	(422)	19,344
Comprehensive income									682,631	544,921	530,077
Less: Comprehensive income attributable to noncontrolling interests									0	0	0
Comprehensive income attributable to UHS									682,631	544,921	530,077
Guarantors
Condensed Financial Statements Captions [Line Items]
Net income									701,995	585,429	480,344
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges									0	0	0
Amortization of terminated hedge									0	0	0
Minimum pension liability									2,177	(14,270)	14,657
Foreign currency translation adjustment									(1,728)	(2,431)
Other comprehensive income (loss) before tax									449	(16,701)	14,657
Income tax expense related to items of other comprehensive income									817	(5,356)	5,670
Total other comprehensive income (loss), net of tax									(368)	(11,345)	8,987
Comprehensive income									701,627	574,084	489,331
Less: Comprehensive income attributable to noncontrolling interests									0	0	0
Comprehensive income attributable to UHS									701,627	574,084	489,331
Non Guarantors
Condensed Financial Statements Captions [Line Items]
Net income									330,278	304,995	300,970
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges									0	0	0
Amortization of terminated hedge									0	0	0
Minimum pension liability									0	0	0
Foreign currency translation adjustment									0	0
Other comprehensive income (loss) before tax									0	0	0
Income tax expense related to items of other comprehensive income									0	0	0
Total other comprehensive income (loss), net of tax									0	0	0
Comprehensive income									330,278	304,995	300,970
Less: Comprehensive income attributable to noncontrolling interests									70,170	59,653	43,290
Comprehensive income attributable to UHS									260,108	245,342	257,680
Consolidating Adjustments
Condensed Financial Statements Captions [Line Items]
Net income									(962,103)	(830,771)	(738,024)
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges									0	0	0
Amortization of terminated hedge									0	0	0
Minimum pension liability									(2,177)	14,270	(14,657)
Foreign currency translation adjustment									1,728	2,431
Other comprehensive income (loss) before tax									(449)	16,701	(14,657)
Income tax expense related to items of other comprehensive income									(817)	5,356	(5,670)
Total other comprehensive income (loss), net of tax									368	11,345	(8,987)
Comprehensive income									(961,735)	(819,426)	(747,011)
Less: Comprehensive income attributable to noncontrolling interests									0	0	0
Comprehensive income attributable to UHS									$ (961,735)	$ (819,426)	$ (747,011)

Supplemental Condensed Consolidating Balance Sheet (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 61,228	$ 32,069	$ 17,238	$ 23,471
Accounts receivable, net	1,302,429	1,282,735
Supplies	116,037	108,115
Deferred income taxes	135,120	114,565
Other current assets	103,490	77,654
Total current assets	1,718,304	1,615,138
Investments in subsidiaries	0	0
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	6,530,569	6,212,030
Less: accumulated depreciation	(2,694,591)	(2,532,341)
Property, plant and equipment, net, Total	3,835,978	3,679,689
Other assets:
Goodwill	3,596,114	3,291,213	3,049,016
Deferred charges	35,357	40,319
Other	448,360	348,084
Total assets	9,634,113	8,974,443	8,311,723
Current liabilities:
Current maturities of long-term debt	62,722	68,319
Accounts payable and accrued liabilities	1,033,697	1,113,062
Federal and state taxes	3,987	1,446
Total current liabilities	1,100,406	1,182,827
Intercompany payable	0	0
Intercompany note payable	0	0
Other noncurrent liabilities	278,834	268,555
Long-term debt	3,387,303	3,210,215
Deferred income taxes	315,900	282,214
Redeemable noncontrolling interests	242,509	239,552
Equity:
UHS common stockholders’ equity	4,249,647	3,735,946
Noncontrolling interest	59,514	55,134
Total Equity	4,309,161	3,791,080	3,300,229	2,765,949
Liabilities and Equity, Total	9,634,113	8,974,443
Parent
Current assets:
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	0	0
Supplies	0	0
Deferred income taxes	132,975	113,822
Other current assets	0	0
Total current assets	132,975	113,822
Investments in subsidiaries	7,760,156	7,013,540
Intercompany receivable	80,764	103,808
Intercompany note receivable	0	0
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property, plant and equipment, net, Total	0	0
Other assets:
Goodwill	0	0
Deferred charges	25,877	32,379
Other	14,251	9,601
Total assets	8,014,023	7,273,150
Current liabilities:
Current maturities of long-term debt	60,368	44,874
Accounts payable and accrued liabilities	19,996	20,245
Federal and state taxes	3,987	1,446
Total current liabilities	84,351	66,565
Intercompany payable	0	0
Intercompany note payable	0	0
Other noncurrent liabilities	1,982	1,322
Long-term debt	3,362,143	3,187,103
Deferred income taxes	315,900	282,214
Redeemable noncontrolling interests	0	0
Equity:
UHS common stockholders’ equity	4,249,647	3,735,946
Noncontrolling interest	0	0
Total Equity	4,249,647	3,735,946
Liabilities and Equity, Total	8,014,023	7,273,150
Guarantors
Current assets:
Cash and cash equivalents	47,192	21,784	7,990	11,949
Accounts receivable, net	918,699	933,971
Supplies	72,499	67,847
Deferred income taxes	2,145	743
Other current assets	89,973	62,431
Total current assets	1,130,508	1,086,776
Investments in subsidiaries	1,876,415	1,661,296
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	4,722,050	4,494,567
Less: accumulated depreciation	(1,845,746)	(1,686,192)
Property, plant and equipment, net, Total	2,876,304	2,808,375
Other assets:
Goodwill	3,070,061	2,764,555
Deferred charges	5,530	5,402
Other	394,998	283,302
Total assets	9,353,816	8,609,706
Current liabilities:
Current maturities of long-term debt	1,223	1,260
Accounts payable and accrued liabilities	744,137	1,051,309
Federal and state taxes	0	0
Total current liabilities	745,360	1,052,569
Intercompany payable	828,473	512,490
Intercompany note payable	1,242,937	1,222,637
Other noncurrent liabilities	206,287	189,456
Long-term debt	16,790	20,212
Deferred income taxes	0	0
Redeemable noncontrolling interests	0	0
Equity:
UHS common stockholders’ equity	6,313,969	5,612,342
Noncontrolling interest	0	0
Total Equity	6,313,969	5,612,342
Liabilities and Equity, Total	9,353,816	8,609,706
Non Guarantors
Current assets:
Cash and cash equivalents	14,036	10,285	9,248	11,522
Accounts receivable, net	383,730	348,764
Supplies	43,538	40,268
Deferred income taxes	0	0
Other current assets	13,517	15,223
Total current assets	454,821	414,540
Investments in subsidiaries	0	0
Intercompany receivable	747,709	408,682
Intercompany note receivable	1,242,937	1,222,637
Property and equipment	1,808,519	1,717,463
Less: accumulated depreciation	(848,845)	(846,149)
Property, plant and equipment, net, Total	959,674	871,314
Other assets:
Goodwill	526,053	526,658
Deferred charges	3,950	2,538
Other	39,111	55,181
Total assets	3,974,255	3,501,550
Current liabilities:
Current maturities of long-term debt	1,131	22,185
Accounts payable and accrued liabilities	269,564	41,508
Federal and state taxes	0	0
Total current liabilities	270,695	63,693
Intercompany payable	0	0
Intercompany note payable	0	0
Other noncurrent liabilities	70,565	77,777
Long-term debt	8,370	2,900
Deferred income taxes	0	0
Redeemable noncontrolling interests	242,509	239,552
Equity:
UHS common stockholders’ equity	3,322,602	3,062,494
Noncontrolling interest	59,514	55,134
Total Equity	3,382,116	3,117,628
Liabilities and Equity, Total	3,974,255	3,501,550
Consolidating Adjustments
Current assets:
Cash and cash equivalents	0	0	$ 0	$ 0
Accounts receivable, net	0	0
Supplies	0	0
Deferred income taxes	0	0
Other current assets	0	0
Total current assets	0	0
Investments in subsidiaries	(9,636,571)	(8,674,836)
Intercompany receivable	(828,473)	(512,490)
Intercompany note receivable	(1,242,937)	(1,222,637)
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property, plant and equipment, net, Total	0	0
Other assets:
Goodwill	0	0
Deferred charges	0	0
Other	0	0
Total assets	(11,707,981)	(10,409,963)
Current liabilities:
Current maturities of long-term debt	0	0
Accounts payable and accrued liabilities	0	0
Federal and state taxes	0	0
Total current liabilities	0	0
Intercompany payable	(828,473)	(512,490)
Intercompany note payable	(1,242,937)	(1,222,637)
Other noncurrent liabilities	0	0
Long-term debt	0	0
Deferred income taxes	0	0
Redeemable noncontrolling interests	0	0
Equity:
UHS common stockholders’ equity	(9,636,571)	(8,674,836)
Noncontrolling interest	0	0
Total Equity	(9,636,571)	(8,674,836)
Liabilities and Equity, Total	$ (11,707,981)	$ (10,409,963)

Supplemental Condensed Consolidating Statements of Cash flows (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Condensed Financial Statements Captions [Line Items]
Net cash (used in) provided by operating activities	$ 1,020,898	$ 1,035,876	$ 884,241
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(379,321)	(391,150)	(358,493)
Acquisition of property and businesses	(533,655)	(431,386)	(12,636)
Proceeds received from sale of assets and businesses	3,391	15,178	37,482
Costs incurred for purchase and implementation of electronic health records application	0	(13,488)	(49,811)
Increase in insurance subsidiary investments	(3,300)	(12,000)	0
Net cash used in investing activities	(912,885)	(832,846)	(383,458)
Cash Flows from Financing Activities:
Reduction of long-term debt	(68,166)	(879,129)	(440,224)
Additional borrowings	234,400	830,000	15,761
Financing costs	(515)	(14,976)	(231)
Repurchase of common shares	(209,782)	(100,749)	(27,201)
Dividends paid	(39,532)	(29,665)	(19,621)
Issuance of common stock	8,441	6,863	5,708
Excess income tax benefits related to stock based compensation	47,364	33,912	20,121
Profit distributions to noncontrolling interests	(62,220)	(33,680)	(61,329)
Proceeds received from sale/leaseback of real property	12,765	0	0
Changes in intercompany balances with affiliates, net	0	0	0
Net cash used in financing activities	(77,245)	(187,424)	(507,016)
Effect of exchange rate changes on cash and cash equivalents	(1,609)	(775)	0
Increase (decrease) in cash and cash equivalents	29,159	14,831	(6,233)
Cash and cash equivalents, beginning of period	32,069	17,238	23,471
Cash and cash equivalents, end of period	61,228	32,069	17,238
Parent
Condensed Financial Statements Captions [Line Items]
Net cash (used in) provided by operating activities	(21,287)	18,579	17,946
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0	0
Acquisition of property and businesses		0	0
Proceeds received from sale of assets and businesses	0	0	0
Costs incurred for purchase and implementation of electronic health records application		0	0
Increase in insurance subsidiary investments	0	0
Net cash used in investing activities	0	0	0
Cash Flows from Financing Activities:
Reduction of long-term debt	(42,133)	(866,748)	(429,996)
Additional borrowings	234,400	830,000	15,761
Financing costs	(515)	(14,976)	(231)
Repurchase of common shares	(209,782)	(100,749)	(27,201)
Dividends paid	(39,532)	(29,665)	(19,621)
Issuance of common stock	8,441	6,863	5,708
Excess income tax benefits related to stock based compensation	47,364	33,912	20,121
Profit distributions to noncontrolling interests	0	0	0
Proceeds received from sale/leaseback of real property	0
Changes in intercompany balances with affiliates, net	23,044	122,784	417,513
Net cash used in financing activities	21,287	(18,579)	(17,946)
Effect of exchange rate changes on cash and cash equivalents	0	0
Increase (decrease) in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	0	0	0
Guarantors
Condensed Financial Statements Captions [Line Items]
Net cash (used in) provided by operating activities	655,439	687,101	587,083
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(209,355)	(230,102)	(269,419)
Acquisition of property and businesses	(513,382)	(422,081)	(8,094)
Proceeds received from sale of assets and businesses	647	11,450	7,916
Costs incurred for purchase and implementation of electronic health records application		(13,488)	(49,811)
Increase in insurance subsidiary investments	(3,300)	(12,000)
Net cash used in investing activities	(725,390)	(666,221)	(319,408)
Cash Flows from Financing Activities:
Reduction of long-term debt	(3,459)	(867)	(109)
Additional borrowings	0	0	0
Financing costs	0	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Excess income tax benefits related to stock based compensation	0	0	0
Profit distributions to noncontrolling interests	0	0	0
Proceeds received from sale/leaseback of real property	0
Changes in intercompany balances with affiliates, net	100,427	(5,444)	(271,525)
Net cash used in financing activities	96,968	(6,311)	(271,634)
Effect of exchange rate changes on cash and cash equivalents	(1,609)	(775)
Increase (decrease) in cash and cash equivalents	25,408	13,794	(3,959)
Cash and cash equivalents, beginning of period	21,784	7,990	11,949
Cash and cash equivalents, end of period	47,192	21,784	7,990
Non Guarantors
Condensed Financial Statements Captions [Line Items]
Net cash (used in) provided by operating activities	386,746	330,196	279,212
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(169,966)	(161,048)	(89,074)
Acquisition of property and businesses	(20,273)	(9,305)	(4,542)
Proceeds received from sale of assets and businesses	2,744	3,728	29,566
Costs incurred for purchase and implementation of electronic health records application		0	0
Increase in insurance subsidiary investments	0	0
Net cash used in investing activities	(187,495)	(166,625)	(64,050)
Cash Flows from Financing Activities:
Reduction of long-term debt	(22,574)	(11,514)	(10,119)
Additional borrowings	0	0	0
Financing costs	0	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Excess income tax benefits related to stock based compensation	0	0	0
Profit distributions to noncontrolling interests	(62,220)	(33,680)	(61,329)
Proceeds received from sale/leaseback of real property	12,765
Changes in intercompany balances with affiliates, net	(123,471)	(117,340)	(145,988)
Net cash used in financing activities	(195,500)	(162,534)	(217,436)
Effect of exchange rate changes on cash and cash equivalents	0	0
Increase (decrease) in cash and cash equivalents	3,751	1,037	(2,274)
Cash and cash equivalents, beginning of period	10,285	9,248	11,522
Cash and cash equivalents, end of period	14,036	10,285	9,248
Consolidating Adjustments
Condensed Financial Statements Captions [Line Items]
Net cash (used in) provided by operating activities	0	0	0
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0	0
Acquisition of property and businesses		0	0
Proceeds received from sale of assets and businesses	0	0	0
Costs incurred for purchase and implementation of electronic health records application		0	0
Increase in insurance subsidiary investments	0	0
Net cash used in investing activities	0	0	0
Cash Flows from Financing Activities:
Reduction of long-term debt	0	0	0
Additional borrowings	0	0	0
Financing costs	0	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Excess income tax benefits related to stock based compensation	0	0	0
Profit distributions to noncontrolling interests	0	0	0
Proceeds received from sale/leaseback of real property	0
Changes in intercompany balances with affiliates, net	0	0	0
Net cash used in financing activities	0	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Increase (decrease) in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	$ 0	$ 0	$ 0

Valuation and Qualifying Accounts (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Allowance for Doubtful Accounts Receivable
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period	$ 324,648	$ 395,035	$ 311,387
Charges to costs and expenses (income)	741,273	698,983	1,127,216
Acquisitions of business		506
Write-off of uncollectible accounts	(667,124)	(769,876)	(1,043,568)
Balance at end of period	398,797	324,648	395,035
Valuation Allowance for Deferred Tax Assets
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period	52,764	46,841	44,511
Charges to costs and expenses (income)	(197)	5,923	2,330
Balance at end of period	$ 52,567	$ 52,764	$ 46,841

Uncompensated Care (Detail) - USD ($) $ in Thousands	12 Months Ended
Uncompensated Care (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Health Care Trust Fund [Line Items]
Uncompensated care	$ 1,203,034	$ 1,136,022	$ 998,770
Uncompensated care, percentage	100.00%	100.00%	100.00%
Charity Care
Health Care Trust Fund [Line Items]
Uncompensated care	$ 506,571	$ 515,435	$ 593,474
Uncompensated care, percentage	42.00%	45.00%	59.00%
Uninsured Discounts
Health Care Trust Fund [Line Items]
Uncompensated care	$ 696,463	$ 620,587	$ 405,296
Uncompensated care, percentage	58.00%	55.00%	41.00%

Schedule of Weighted Average Remaining Contractual Life for Options Outstanding and Weighted Average Exercise Price Per Share for Exercisable Options (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Weighted average forfeiture rate	9.95%

Lease Commitments - Additional Information (Detail)	12 Months Ended
Lease Commitments - Additional Information (Detail)	Dec. 31, 2015 USD ($) Facility	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($) Facility
Leases [Abstract]
Number of hospital facilities \| Facility	3		3
Additional capital lease obligations incurred \| $	$ 7,000,000	$ 16,000,000	$ 0

Schedule of Measurement Dates (Detail)	12 Months Ended
Schedule of Measurement Dates (Detail)	Dec. 31, 2015	Dec. 31, 2014
Benefit Obligation
Defined Benefit Plan Disclosure [Line Items]
Measurement Dates	12/31/2015	12/31/2014
Fair Value Of Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Measurement Dates	12/31/2015	12/31/2014

Supplemental Condensed Consolidating Financial Information - Additional Information (Detail)	Dec. 31, 2015
Guarantors
Supplementary Information [Line Items]
Percentage of ownership interests	100.00%